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When I first started on this PhD journey, I was excited to be part of a project that 
aimed to change the structure of the follow-up of patients undergoing bariatric 
surgery. It was intriguing to be part of an innovation project that would immediately 
affect the patient care and four years seemed like plenty of time to produce the results 
we anticipated. However, the start of the journey was a bumpy one and, due to 
organisational negotiations between the Health Trust and manufacturer of the 
feedback system, the project start was significantly delayed. This resulted in a 
different production of articles and thesis than originally planned, as the collection of 
data was, consequently, delayed. In our third paper, we used data collected before the 
implementation of the clinical feedback system. Nevertheless, the data is relevant for 
this thesis, as we studied the patients’ overall treatment satisfaction and associations 
with variables that could possibly affect patient satisfaction. The overarching themes 
in this thesis are follow-up care after bariatric surgery, Health-Related Quality of Life 
(HRQOL), overall treatment satisfaction and mental health. There has been, and 
continues to be, a need to find effective tools and strategies to address challenges 
with HRQOL and mental health in follow-up. Hopefully, the work in this thesis can 
contribute to this. 
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Abstract 
Background: Bariatric Surgery (BS) is acknowledged as an effective long-term 
treatment for patients with obesity. Even though most patients experience significant 
improvements in comorbidities and health-related quality of life (HRQOL), some 
patients do not experience improvement and some even experience a deterioration of 
HRQOL or mental health after surgery. This knowledge has been implemented in 
several guidelines for follow-up care after BS that emphasise the importance of 
focusing on HRQOL and mental health. However, there is a lack of concrete 
recommendations for how healthcare professionals can include HRQOL and mental 
health assessments in their daily practice. 
Aim: The aim of this research was to implement a patient-reported outcome 
monitoring with a clinical feedback system (PRO/CFS) in BS follow-up care. The 
specific aims were to assess the effectiveness of PRO/CFS on HRQOL through a 
review of systematic reviews (Study 1), to provide a detailed description of the 
PRO/CFS implemented in the bariatric surgery outpatient clinic and plans for 
evaluating the feasibility of this PRO/CFS (Study 2), to assess the patients’ overall 
treatment satisfaction five years after surgery (Study 3) and to assess whether a 
digital questionnaire developed for use in mental health services (the Norse Feedback 
(NF)) was valid for a population of patients undergoing BS (Study 4). 
Results: A PRO/CFS was implemented in the BS outpatient clinic at Helse Førde 
Hospital Trust on 1 February 2018. In study 1, five systematic reviews exploring the 
effectiveness of the PRO/CFS on HRQOL in patients in mental health treatment and 
in cancer care were included. The synthesis demonstrated inconsistent findings, 
however effectiveness of a PRO/CFS was found in patients undergoing mental health 
treatment and for symptom burden in patients with cancer. A key finding was the 
variability in how the concept of the PRO/CFS was understood in the individual trials 
included in the systematic reviews. In study 2, a detailed description was provided of 
the PRO/CFS implemented in two BS outpatient clinics. Furthermore, this paper 
provided a study protocol for planned quantitative and qualitative inquiries of 
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patients’ and healthcare professionals’ experiences with the PRO/CFS in the clinical 
consultations. In study 3, higher body-mass index, reduced mental component of 
HRQOL and reduced obesity-specific HRQOL were associated with reporting to be 
dissatisfied or unsure about the overall treatment outcomes. In study 4, 12 out of 19 
scales in the NF demonstrated satisfactory psychometric properties, but with large 
floor effects in several of the scales. In addition, 19 out of 21 scales in the NF showed 
moderate to small correlation with the Obesity-related Problems scale. The overall 
finding was that the NF is a promising tool in a PRO/CFS, but that the questionnaire 
needs to be adapted to the population of patients undergoing BS. 
Conclusion: Through the studies included in this thesis, the importance of including 
aspects such as HRQOL, mental health and treatment satisfaction in the clinical 
consultations after BS is emphasised. A digital PRO/CFS seems to be a feasible tool 
for including such assessments in follow-up care.  
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1.1. Theme for exploration 
The prevalence of obesity across the world is increasing (1, 2), including in Norway 
(3). In 2016, the prevalence of obesity among Norwegian adults was 23.1% and had 
tripled over the previous 30 years (4). Obesity may lead to such comorbidities as 
diabetes mellitus, hypertension, cardiovascular disease and pain (5). Health-Related 
Quality of Life (HRQOL) and mental health are also negatively affected in many 
persons with obesity (6, 7). We therefore need to establish strategies to improve these 
concerns in patients with obesity.  
The goal of  treatment for obesity is to reduce the risk of developing comorbidities 
and for the patient to live an active life (8). Bariatric surgery (BS) is the most 
effective treatment for obesity available today (9). Although effective, there is 
growing awareness that some patients experience challenges with HRQOL and 
mental health after surgery (10–12) and that the follow-up of these aspects in BS care 
must be enhanced (13). The structure of follow-up care after BS varies around the 
world and there are no uniform recommendations on how to include assessments of 
HRQOL and mental health in this care. The aim of this thesis was therefore to 
investigate whether patient-reported outcome monitoring with a clinical feedback 
system (PRO/CFS) would be feasible in BS follow-up care, with a special focus on 
HRQOL and mental health. 
1.2. Obesity 
The World Health Organisation defines obesity as “abnormal or excessive fat 
accumulation that may impair health” (2). The relationship between a higher body 
mass index (BMI) and comorbidities or mortality is well documented (14) and 
patients with a BMI of between 40–45 kg/m2 experience an average of two to four 
years reduced life expectancy (15). Obesity has various personal and societal 
consequences, as it is linked to such comorbid diseases as cardiovascular disease, 
diabetes mellitus, hypertension, some types of cancer and pain (5, 16, 17), and a 
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stronger association with reduced disease-free years is found with more severe 
obesity (18).  
BMI (weight in kilos divided by height in meters squared: kg/m2), which is the most 
widely used measure to classify obesity, (19) is used as the classification in this 
thesis. Obesity is defined as having a BMI ≥30 kg/m2 (20). Obesity is further 
subdivided into three classifications: Class 1 BMI 30–35 kg/m2, Class 2 BMI 35–40 
kg/m2 and Class 3 BMI ˃ 40 kg/m2 (20). Severe obesity refers to BMI ˃ 40 kg/m2 or 
BMI 35–39.9 kg/m2 with obesity-related comorbidities and is associated with the 
most severe health consequences (15). 
However, BMI may be an unreliable measure because, for some people and 
population groups, the obesity classifications do not correlate with the amount of 
harmful body fat. This applies to people who, due to a high muscle mass, have a high 
body weight or for some Asian populations (19, 21). Due to these uncertainties, other 
measures like waist circumference or waist-hip ratio are useful additional measures to 
indicate the amount of harmful abdominal fat (22, 23). More advanced procedures 
like body scanning are also available (24).  
Furthermore, patients with obesity have been shown to have a higher prevalence of 
mental health concerns compared to a population with normal BMI (7, 25, 26) and 
depression and eating disorders in particular are associated with obesity (25, 27). The 
relationship between mental health illnesses and obesity is not fully understood (28–
30), but the association between obesity and depression seems to be bidirectional (29, 
31, 32). A Norwegian cohort study found an association between waist-hip ratio and 
depression (33). Obesity has also been linked to reduced physical and mental aspects 
of HRQOL (6).  
Due to the possible negative consequences of obesity, as well as the multifaceted 
causes, obesity is now widely recognised as a chronic disease (34, 35). The simple 
explanation for the aetiology of obesity is that the individual consumes more energy 
than is expended. However, the energy balance is now recognised as a complex 
interaction of genes, hormones and metabolic and psychological factors that affect the 
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energy balance in the individual (5, 36–40). The content of food and how the food is 
processed are also factors that contribute to the development of obesity (41, 42). 
Furthermore, an important finding is that the body increases the production of 
appetite hormones when a person is losing weight (43, 44). 
1.3. Treatment of obesity 
Due to the complex aetiology of obesity (45, 46), various treatments are available and 
there is no one treatment that is optimal for all patients (47). The treatment of obesity 
is mainly divided into two modalities: conservative lifestyle modification or BS. 
Common to both treatment modalities are a lifelong focus on weight management 
through increased activity and a healthy diet. In addition, pharmaceutical treatment is 
an option for weight loss, either in combination with lifestyle modification or BS or 
as a standalone treatment. Common to all treatment strategies is the need for a 
patient-centred focus that incorporates the patient’s goals and preferences (48). 
1.3.1 Conservative lifestyle modification 
Conservative lifestyle modification is often the first choice of treatment, as this is less 
invasive compared to BS. Conservative lifestyle modification often consists of 
intensive lifestyle interventions over weeks or months. The therapies may comprise 
special diets, often with a very restricted calorie content, intensive physical activity 
treatment, behaviour modification or often a combination of all three (49). The 
advantages of lifestyle modification treatments are that they are accessible to many 
patients, an option for patients who do not satisfy the inclusion criteria for surgery, 
they are often inexpensive  and have been found to be safe (49).  
On the positive side, a weight loss of 5–15% of the patient’s initial weight has 
positive effects on diabetes, blood pressure and lipids (50, 51), thereby improving 
metabolic syndrome (52). Despite broad access to the treatment, the positive effects 
and low risks of intensive lifestyle modification, the long-term effects of this 
intervention are disappointing, as patients struggle to maintain the weight loss after 
the intervention has been terminated (53, 54). A systematic review found that there 
was a minor non-significant difference in weight after 48 months when comparing 
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lifestyle intervention to no intervention (49) and these findings have also been 
documented by others (55–57). However, a recent publication by the Look AHEAD 
study group documented that intensive lifestyle intervention reduced the risk of non-
fatal cardiovascular events after ten years in patients with a known cardiovascular 
disease at baseline (58). A challenge with conservative lifestyle interventions may be 
poor adherence to the programmes, resulting in weight regain (5, 59). Consequently, 
effective lifestyle treatments and follow-up strategies that lead to sustained changes 
in the patients’ lives must be established. 
1.3.2 Pharmacological interventions 
Various medications have been developed to induce weight loss in people with 
obesity. What they have in common is a lack of robust evidence for the effectiveness 
of these medications in the long term (60). There is, however, some evidence that the 
medications induce weight loss and contribute to improvements in obesity-related 
quality of life. Furthermore, the medications are associated with more negative side 
effects than lifestyle-interventions alone, but these side effects are not severe for most 
patients (60–62). Recent studies have investigated the utility of pharmacotherapy 
after BS to prevent weight regain (63). Further research should explore the utility of 
medications as a supplement to conservative lifestyle interventions or BS to maintain 
long-term weight loss. 
1.3.3 Bariatric surgery 
A treatment for obesity that is growing in popularity is BS. Internationally accepted 
criteria for patients undergoing BS as a treatment are a BMI ≥ 40.0 or 35.0–39.9 
kg/m2 with obesity-related diseases. There are several different procedures available 
that can be divided into restrictive procedures and malabsorptive procedures (9, 64). 
Restrictive procedures refer to procedures in which only the size of the stomach is 
reduced, whereas malabsorptive procedures refer to operations in which part of the 
small intestine is bypassed in addition to limiting the size of the stomach. This bypass 
of the small intestine contributes to a reduced uptake of nutrients (9). BS is found to 
be a safe treatment (65) and is the only treatment option today that contributes to 
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sustainable weight loss for the majority of patients (9, 66, 67). There are, however, 
also serious possible complications to the surgery, such as anastomotic leakage and 
bleeding, even though these are relatively rare (9, 65).  Nutritional deficiencies are a 
more common negative side effect after surgery and often require long-term follow-
up (68).  
Surpassing the restrictive and malabsorptive effects of the surgery, recent evidence 
has documented that an alteration to appetite-regulating hormones is an additional 
effect of the surgery. The hormones that increase appetite are shown to decrease, 
whereas hormones that reduce appetite are shown to increase (69). The hypothesis is 
that the effect is due to the removal of the part of the stomach where the appetite 
hormones are produced.  
The organisation of follow-up after BS varies considerably around the world. Most 
common is follow-up at a bariatric centre for the first two years after surgery. The 
patients may meet with different healthcare professionals during the consultations, 
often depending on the resources of the bariatric clinic. The bariatric team most 
typically consists of surgeons, physicians, nurses, dietitians and physical therapists, 
although psychologists may also be included in the teams. This multidisciplinary 
approach is in line with recommendations in European guidelines to provide the best 
care for patients after BS (70). BS is offered in all health regions in Norway and a 
national register (SOReg-Norge) has been established to evaluate the outcomes of 
surgical treatment in Norway (71). 
BS consists of a variety of procedures. The most common procedures worldwide are 
the Roux-en-Y Gastric Bypass (RYGB) and Laparoscopic Sleeve Gastrectomy (LSG) 
(72), which is in line with the popularity of the procedures performed in Norway in 
2018 (73). A less popular but effective procedure is the Biliopancreatic Diversion 
with Duodenal Switch (BPD/DS) (74).  
The work carried out for this thesis involved the LSG and BPD/DS, which are 
explained below.  
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Laparoscopic Sleeve Gastrectomy (LSG) 
The LSG is a procedure in which the size of the stomach is reduced. The LSG was 
originally introduced as the first step of a two-stage procedure of biliopancreatic 
diversion in the early 1990s. However, the developer, Marceau, found that patients 
lost weight and had few complications after the first procedure (75). The procedure 
was further modified by Ganger in the late 1990s (76) and is now accepted as a 
standalone procedure. When performing an LSG, the stomach is divided vertically 
from the oesophagus to the duodenum. This creates a small sleeve and only 10–20% 
of the stomach is kept (77, 78). Weight loss results from the restrictive procedure and 
it has also been hypothesised that the removal of the fundus contributes to changes in 
satiety hormones (77).  
The LSG is found to be a safe procedure, with positive weight and metabolic 
outcomes and remission of comorbidities and complications compared to other 
procedures, including RYGB and BPD/DS (79–82). A recently published study found 
that patients operated with LSG experienced greater weight loss and were more 
satisfied than patients operated with gastric banding (83) 
Biliopancreatic Diversion with Duodenal Switch (BPD/DS)  
BPD/DS is a procedure in which the size of the stomach is reduced to contain 150–
250 ml, somewhat larger than the LSG. In addition, the first part of the duodenum is 
bypassed (duodenal switch) to reduce the uptake of nutrients (84). BPD/DS have 
demonstrated superiority when it comes to weight loss and remission of 
comorbidities, but the occurrence of such severe complications as nutritional 
deficiencies, abdominal pain, diarrhoea and dumping syndrome is higher with 
BPD/DS than with RYGB and LSG. BPD/DS is also a more technically complicated 
procedure (74). Due to these aspects, BPD/DS is not widely performed worldwide. At 
Helse Førde Hospital Trust, BPD/DS was the procedure performed when BS was 
established as a treatment at the hospital, whereas the procedure of choice is currently 
LSG. 
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1.4  Patient-Reported Outcome Measures (PROMS) 
Patient-Reported Outcome Measures (PROMS) refers to health issues reported by the 
patient, typically by means of a questionnaire (85, 86). PROMS can be defined as ‘an 
outcome reported directly by patients themselves and not interpreted by an observer’ 
(87). To elaborate on this definition, this means that the data collected from the 
patients is their subjective perceptions of a construct and not something that can be 
measured objectively (as, for example, blood pressure, weight or blood sugar). 
PROMS are often used to measure how patients experience symptoms related to a 
disease, their perceived mental health or HRQOL. Furthermore, PROMS may be both 
generic and disease-specific. The generic questionnaires measure a construct across 
patient populations, whereas disease-specific instruments measures constructs that are 
particularly relevant for a specific disease (85). These aspects make PROMS suitable 
for implementation in routine care after BS to facilitate a structured assessment of 
HRQOL and mental health. In addition to PROMS, the patients frequently respond to 
patient-reported experience measures (PREMS), which measure patients’ experiences 
with, for example, a clinical consultation or organisation of healthcare services. 
Patient-reported outcomes (PROs) and patient-reported outcomes measures 
(PROMS) are used synonymously so, for reasons of consistency, PROMS is used 
throughout this thesis.  
Various questionnaires have been developed that measure HRQOL and are applied in 
research after BS. The most common questionnaires are the Short Form 36 (SF-36) 
and RAND 36-Item Short Form Health Survey (RAND-36), which are generic 
measures, and the Impact of Weight on Quality of Life-Lite Questionnaire (IWQOL-
Lite) and Obesity-related Problems scale (OP), which are disease-specific measures 
(6, 88). There exists a broad range of other validated measures that are commonly 
used in both research and clinical consultations, but a full overview of these would be 
outside the scope of this thesis. 
PROMS were initially developed for research purposes in order to obtain information 
from patients that could not be objectively assessed, whereas PROMS are currently 
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regarded as valuable tools to enhance patient involvement in clinical practice (85, 
89). A desire to make the services more patient-centred and, subsequently, evidence 
on the effectiveness of discussing PROMS with patients may have influenced the 
increase in the use of PROMS in clinical practice. However, although acknowledged 
as a valuable tool to enhance patient-provider communication and to empower 
patients, the systematic use of PROMS in clinical practice is not well implemented 
(89, 90). This means that, even though patients frequently respond to PROMS in their 
contact with healthcare services, PROMS are most typically collected for quality 
improvement or registry purposes and are not frequently integrated into clinical 
conversations between the patient and healthcare professional. Another paradox is 
that PROMS that were not originally designed to enhance communication between 
the patient and healthcare professional in clinical consultations are used for exactly 
this purpose. This requires further investigation. 
1.5  Patient-Reported Outcome Monitoring with a Clinical Feedback 
System (PRO/CFS) 
Patient-Reported Outcome Monitoring refers to a systematic collection of Patient-
Reported Outcome Measures (PROMS) and is widely applied in healthcare services 
(85). As described above, PROMS were originally developed for research purposes 
but, in the late 1980s and early 1990s, a systematic application of PROMS in clinical 
practice was recommended to improve the outcomes of patients in mental health 
treatment (91–95). Several PRO/CFS have been developed and found valid in mental 
health services (96). Even though it has been relatively long since the PRO/CFS was 
first introduced to routine clinical practice, PROMS are most typically implemented 
for research purposes or quality improvement initiatives in today’s healthcare 
services (94).  
Based on the aforementioned mental health challenges in some patients after BS, it 
can be assumed that the PRO/CFS in the follow-up after BS would contribute to 
improving the follow-up care for these patients. To inform the communication 
between patients and healthcare professionals, patients respond to a set of 
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questionnaires prior to the consultation. The information obtained from these 
questionnaires is fed back to the healthcare professional, patient or preferably both 
(97). Systems that collect PROMS and provide feedback are referred to as the 
PRO/CFS, Routine Outcome Monitoring with a Clinical Feedback System 
(ROM/CFS) or measurement feedback systems. For reasons of consistency in the 
thesis and the published articles, we use the term PRO/CFS, whereas all search terms 
were used when searching for relevant literature.  
The concept of providing patients with feedback from PROMS has already been 
investigated, but whether it is effective in the treatment of mental health disorders has 
not yet been established. In a Cochrane review, Kendrick et al. (96) found insufficient 
evidence to conclude a positive effect in terms of symptom burden in patients who 
receive feedback compared to patients who do not receive feedback. On the other 
hand, a more recent systematic review and meta-analysis found significant effects in 
favour feedback compared to practice as usual (98). This positive finding has also 
been found by others (93, 97, 99). In a qualitative study exploring patient experiences 
with the PRO/CFS, the patients reported that a PRO/CFS could be a useful part of 
treatment under certain conditions. The patients needed to know the purpose of 
collecting this information and how the results could affect their treatment. They also 
highlighted the importance of the healthcare professional paying close attention to 
what they had reported (100). The importance of receiving information about the 
purpose of the PRO/CFS was also a key finding in a recent systematic review (101). 
Discussing with the patient what he or she has reported is therefore a crucial aspect of 
making the PRO/CFS a useful part of treatment. This aspect is supported by the 
feedback intervention theory that emphasises a discussion of the PROMS with the 
patient during the consultation. The conversation should include the patient’s goals 
and preferences and, when interpreting the results, the patient’s responses must be 
viewed in light of empirical standards (92). It can also be expected that the outcome 
of a treatment is better when the patient experiences that the PRO/CFS addresses 
issues that correspond with his or her goal with the treatment, making it important to 
involve patients and healthcare professionals when designing the PRO/CFS. 
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The PRO/CFS has traditionally been analogous, with patients completing paper 
questionnaires. However, a digital PRO/CFS appear to be advantageous due to the 
possibility to generate summary reports in which patient responses are compared to 
normative data (94). Furthermore, a digital PRO/CFS provides the possibility to 
personalise the PROMS to be relevant during the course of treatment (102). This is 
referred to as idiographic adaptation, which means that the patients’ current responses 
are viewed in light of their previous responses (99, 102, 103). Through a system 
using idiographic adaptation, the adaptation to the patient can take place as follows: 
the patient answers a full set of items the first time he or she completes the 
questionnaire. If the patient responds below or above an empirically predefined 
trigger level, several items are ‘closed’ the next time the patient completes the 
questionnaire, thereby reducing the number of items to those most relevant for the 
individual. The patient then responds only to trigger items, as long as he or she do not 
show deterioration of symptoms. Personalisation is also relevant when the healthcare 
professional evaluates the summary report prior to the clinical consultation. In mental 
health treatment, two patients can demonstrate the same symptom burden in one area, 
but experience these areas very differently. For example, patients with a high 
symptom burden on depression with good social support may experience this as less 
problematic than patients with limited social support. Such patterns are important to 
explore in patients who have undergone BS in order to establish norms for this 
population of patients. For example, an increased risk of depression and suicidal 
ideation have been found in patients after BS compared to patients with obesity who 
have not been operated (10). However, the reasons for this association and whether 




2. Summary of previous research 
2.1. Follow-up care for patients undergoing bariatric surgery 
The concept of follow-up care in this thesis is understood to be the manner in which 
the patient is supported by the healthcare services when undergoing BS. This includes 
any preparations organised by the healthcare services before surgery and any contact 
between the patient and healthcare services after BS. This contact may be both 
planned consultations and unplanned consultations due to unforeseen events. In the 
Nordic guidelines, lifelong follow-up is recommended after bariatric surgery to assess 
levels of vitamins and minerals and to monitor weight (104, 105). 
The different comorbidities patients might present with, as well as the variability of 
unwanted outcomes after the surgery, make it important to tailor the follow-up to the 
individual patient (13, 106). After surgery, patients may need follow-up with regard 
to various aspects, such as nutritional challenges, altered body image (68, 107), 
reduced mental component of HRQOL (108) and psychological concerns like 
anxiety, depression and alcohol dependence (109, 110). A systematic review of 
qualitative studies found that patients experienced several challenges after BS and 
that they strived for normality and control of their situation. The review authors 
concluded a need for the long-term follow-up of psychological concerns after surgery 
to maintain positive changes and prevent negative mental health outcomes (111). 
These findings were confirmed in another qualitative review (112). The knowledge of 
the concerns that some patients experience after BS has been implemented into 
guidelines for BS follow-up (70, 113, 114).  
In a rapid review of qualitative studies, the review authors found that patients 
experienced the time after BS as a rollercoaster of changes and emphasised the need 
for follow-up by competent healthcare professionals with specific knowledge of the 
patient’s concerns (115). A qualitative study not included in the review found that 
patients who attended follow-up consultations appreciated the specialised care and 
possibility to contact the healthcare professionals by phone or email. The patients 
also had higher trust in the bariatric team than in their general practitioner. Barriers 
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for attending the follow-up consultations were a lack of personalised care and 
relevance for their specific concerns, a lack of continuity of the healthcare 
professional and distance from the clinic (116). Continuity of care and the availability 
of the healthcare professionals were also found to be important aspects of the follow-
up in another qualitative study exploring experiences with follow-up care (117). 
However, in that study, several of the patients experienced a lack of support from the 
bariatric team with regard to the challenges they experienced after BS. The authors 
concluded that there was a need for long-term and personalised follow-up by a 
multidisciplinary team (117). One reason for these experiences of unmet needs could 
be differences in what the patients and the healthcare professionals defined as 
important outcomes (118).  
Even though many high-quality follow-up programmes are offered, it is often 
challenging to get patients to attend the follow-up consultations. Bariatric care in 
general suffers from fairly high attrition rates in the postoperative follow-up (119–
121). Some studies have found that poor adherence to the follow-up is linked to 
poorer weight loss, whereas others have not found this association (119, 122, 123). A 
retrospective study of 148 patients that investigated predictors for successful weight 
loss up until 40 months after RYGB found that follow-up visits with a surgeon and 
attending support groups after surgery were positively correlated with successful 
weight loss (124). Support from the bariatric team was also found to be a facilitator 
for adherence to consultations in a qualitative study exploring patient experiences 
with follow-up care (125). However, for the consultations to be relevant for the 
patients, the healthcare professionals must be prepared and updated on the patients’ 
conditions and the topics addressed during the consultation must be relevant for the 
patients (126). As reasons for not attending the follow-up care, depression, pain, 
distance to the clinic, younger age, male gender and work issues have all been found 
to be important (119, 125, 127). 
Adherence to follow-up after BS also entails far more than attending consultations. A 
systematic review by Hood et al. (128) identified recommendations regarding vitamin 
use, physical activity, alcohol use and dietary compliance as important areas to assess 
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adherence, in addition to the appointment attendance adherence. A study of patients 
one year after LSG showed that patients who had attended follow-up sessions with a 
dietitian experienced greater weight loss, were more physically active and had less 
pain than patients who did not meet with a dietitian (129).  
As described above, follow-up care after BS must be tailored to the patient, as 
whether or not patients experience negative side effects and what these might be 
varies significantly. Undergoing BS is a life-changing event and most patients need 
guidance both before and after surgery. The best way to organise this preparation and 
follow-up has yet to been documented and further research needs to explore feasible 
structures and interventions for this follow-up.  
2.2  Health-Related Quality of Life (HRQOL) after bariatric surgery 
Studies have shown that persons with obesity are at increased risk of reduced 
HRQOL compared to persons with BMI in the normal range. This applies especially 
to the physical domain of HRQOL, whereas reduced mental HRQOL is present 
mainly in persons with BMI ˃ 40 kg/m² (6). Particularly noteworthy is that Kolotkin 
and Andersen (6) a review of systematic reviews showed that HRQOL was lower in 
persons who were interested in BS than in patients seeking other treatments for 
obesity and in persons with obesity who did not seek any treatment at all. HRQOL is 
an important measure in patients with obesity, as reduced HRQOL has been 
associated with negative clinical outcomes (130). 
One systematic review (88) and one review of systematic reviews (6) assessed how 
HRQOL changed from before surgery until after surgery and both included studies 
with a follow-up period of up to five years. Kolotkin and Andersen (6) had no 
limitations on the bariatric procedure in the reviews they included and found that BS 
patients had improved HRQOL measured with SF-36 when compared to patients 
undergoing other weight loss measures. Obesity specific measures on HRQOL 
improved more than generic measures at five years. Rausa et al. (88) only included 
studies that compared LRYGB and LSG in their review and found that HRQOL was 
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improved significantly from before surgery and remained improved at five years. 
However, the authors noted that there was a decrease in HRQOL from year two and 
onwards in several studies. Szmulewicz et al. (11) found in their systematic review of 
randomised controlled trials that the mental component of HRQOL was not improved 
in the long term. This trend is also found in other studies (12, 83, 108). 
A prospective study conducted in Norway measured HRQOL from before and up to 
two years after surgery in patients with and without obesity-related diseases (131). 
The findings were that both groups of patients experienced improvements in HRQOL 
in terms of both the physical and mental components. The group of patients without 
any diseases experienced greater improvement in the mental component of HRQOL 
than patients with obesity-related diseases. Another Norwegian study found that 
HRQOL was associated with weight loss four years after surgery (132), contrary to 
what Aasprang et al. found in their analyses after both five (133) and ten years (134) 
in patients who had undergone BPD/DS. A study of younger adults aged 18–25 also 
found that HRQOL was associated with weight loss at three years (135). A 
prospective Dutch study of nearly five thousand patients who reported HRQOL 
before and twelve months after surgery showed a significant improvement in the 
physical component score of the RAND-36, although with a minor change in the 
mental health score. The authors also found that suboptimal weight loss influenced 
HRQOL scores negatively (136). It should be noted, however, that the study had a 
relatively short follow-up period. Another interesting study, although limited by the 
small number of patients, evaluated the effect of moderate to intense physical activity 
on HRQOL and weight loss. The authors found that physical activity significantly 
improved HRQOL in patients three years after surgery (137). 
Even though most studies find an improvement in the physical component score and 
obesity-specific HRQOL compared to patient baseline measures, it is noteworthy that 
most studies also find that HRQOL is still below the scores in the general population 
– especially in the mental HRQOL dimensions.  
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There is a distinction between the ‘mental component’ of HRQOL and ‘mental 
health’. The mental component of HRQOL refers to how the patients’ mental well-
being affects their quality of life, whereas mental health refers to the consequences of 
mental health illness and is more oriented towards a diagnosis (138).  
2.3     Mental health after bariatric surgery 
In a population of patients accepted for BS, a higher prevalence of depression and 
anxiety was found than in a norm population (139). A recent systematic review and 
meta-analysis of 104 included studies found that perceived weight stigma was a 
strong factor for decreased mental health and quality of life (140). With this in mind, 
it is quite alarming that people with obesity face stigma both in society and from 
healthcare professionals (141–144). 
Furthermore, whether BS contributes to this higher presence of mental health 
concerns or whether the concerns are masked psychopathology from before surgery 
also seems somewhat uncertain. A prospective cohort study of nearly 25 000 patients 
who had undergone BS in Australia showed that there was an increase in the use of 
mental health services after BS compared to the use of these services before surgery. 
Self-harm in particular increased (145). Several studies show that patients are at a 
higher risk of depression, eating disorders, substance abuse and suicidal ideation after 
BS (10, 146–150), whereas others have documented a decreased prevalence and 
severity of depression after BS at least the first three years (7). The authors of a 
recent systematic review found initial improvement in anxiety, depression and 
disordered eating patterns, but also found that these changes did not sustain (151). 
Particularly alarming are the findings that suicidal ideation and problematic substance 
may increase after surgery (152–154), which requires urgent attention. 
A recent review found that the prevalence of most eating pathologies decreased after 
BS, with the exception of ‘grazing’, which means that the patient eats unplanned food 
frequently during the day (155). Similarly, Spirou et al. (151) found that most patients 
experienced improvement in terms of binge-eating diagnoses, but stated that, due to 
the physical restrictions after BS, binge eating patterns changed to other disordered 
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eating patterns like grazing or vomiting. Eating psychopathology clearly affects 
patient lives and has been associated with suboptimal weight loss and weight regain 
after BS (139, 156).  
The British Obesity Metabolic Surgery Society recently published guidelines in 
which all bariatric services are advised to offer preoperative mental health screening 
and triage of patients eligible for BS (13). Postoperative screening between six to 
nine months is also recommended. The authors emphasised that all members of a 
bariatric team should have expertise in the psychological challenges after surgery and 
that bariatric services should have access to specially trained personnel (i.e. 
psychologists) for patients with severe concerns (13). Other guidelines also 
recommend focusing on mental health in BS care (70, 114). The rationale for this 
screening of mental health concerns serves several purposes. One is to detect 
psychopathology that must be treated prior to the surgery, such as substance abuse or 
severe eating disorders (110). 
Several qualitative studies have aimed at exploring how patients experience the 
changes that occur after BS. A review of qualitative studies found that many patients 
experienced challenges in coping with the rapid changes in their appearance after 
surgery (112). Self-image and how this affected their identity was an important 
theme. Another theme was how challenging patients felt it was to gain control over 
how the treatment affected their lives. Several patients struggled with feelings of guilt 
or blame for having ended up obese while, on the other hand, experienced a sense of 
responsibility to succeed with this treatment. These feelings were especially 
prominent in patients in whom BS had failed (112). A qualitative study with nine 
focus groups involving 76 patients previously operated with BS found that many 
patients experienced an improvement in mental health concerns like depression and 
anxiety, whereas others experienced a worsening of mental health and a new onset 
addiction to alcohol and drugs (125). Natvik and colleagues (107) presents one 
patient’s story from an in-depth interview and discuss his experiences in light of 
previous research. Interestingly, although the patient had lost a large amount of 
weight and experienced a lot of new possibilities as a result, he was still stuck in old 
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habits in which his large body restricted him in everyday life due to space. Changing 
these perceptions of his body image and space perception demanded his active 
attention.  
Back in 2012, Weineland, Hayes and Dahl (157) had already highlighted the need for 
interventions targeting psychological health in patients undergoing BS. Even though 
different interventions addressing psychological concerns after BS have been 
developed, there is still a lack of long-term data on their effectiveness (148). A 
systematic review including 44 studies that investigated the effectiveness of 
psychosocial interventions before and after surgery found that interventions after BS 
did indeed improve symptoms of depression and anxiety and also improved quality of 
life (mental, social and physical quality of life), as well as satisfaction with treatment. 
Preoperative interventions that were not continued after surgery showed, not 
surprisingly, no long-term effect (158). Mental health is complex and to expect to 
identify simple causal relationships between obesity and mental health or bariatric 
surgery and mental health is unreasonable. Instead, these constructs must be viewed 
as bidirectional, by which they affect each other differently in different situations. 
All in all, the importance of screening patients for mental health challenges before 
and after surgery is quite evident. Interventions to address these challenges must be 
investigated in order for the healthcare professionals to have effective tools when 
dealing with patient concerns after BS. 
2.4  Patient-Reported Outcomes and PRO/CFS in the follow-up to 
bariatric surgery 
A systematic review assessing the use of PROMS after BS identified several 
validated questionnaires assessing satisfaction and HRQOL (159). The authors did 
not describe whether the PROMS were used for research purposes or as part of 
clinical practice in the included studies, but they concluded a need for validated 
questionnaires to assess patients in clinical practice. Generally, when PROMS are 
applied in the follow-up after BS, they are implemented for research purposes, 
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thereby providing the healthcare professionals with knowledge as to how to treat their 
patients. Examples can be found in two Norwegian studies, the one a randomised 
controlled trial (160) and the other cohort study (161) in which PROMS assessing 
HRQOL, mental health and eating habits were collected in order to evaluate the 
effectiveness of different treatment modalities. The findings from the PROMS were 
not discussed with the patient. 
In a prospective cohort study, the researchers assessed physical HRQOL in patients 
before and after BS through a digital PROMS instrument (162). All patients 
completed the digital questionnaire before each clinical consultation. Again, the 
collection of PROMS was performed for research purposes and not for clinical use. 
The authors report future plans to implement feedback from the PROMS into the 
clinical consultations, as well as a qualitative assessment of patient experiences. Such 
studies are welcome. 
Some studies, however, used feedback from PROMS in clinical practice with specific 
outcomes. One randomised controlled trial compared internet-based guided self-help 
with face-to-face cognitive behavioural therapy in patients with obesity and binge 
eating disorders. The authors concluded that face-to-face therapy was superior to 
internet-based guided self-help groups in reducing binge eating symptoms (163). 
Furthermore, in a prospective study, 37 patients who reported the amount and content 
of the food they had eaten received feedback through a web-based application on 
whether they had consumed the recommended amount of proteins. The authors 
reported that satisfaction with this application was high. However, the patients with 
an adequate intake of proteins were more likely to use the application (164) and 
knowledge as to whether this helps the patients who need guidance is still uncertain.  
As the PRO/CFS is a new concept in the follow-up after BS, findings from other 
patient populations may inform its utility in BS care. In a systematic review exploring 
patient experiences with PRO/CFS in mental health treatment, the review authors 
found that the patients experienced that the PRO/CFS facilitated collaborative 
practice between the patient and healthcare professional and also empowered the 
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patients, provided that they felt safe about the purpose of the PRO/CFS. To 
accomplish this, the patients highlighted the importance of discussing the results 
during therapy sessions and wanted the questionnaires to not only measure their 
symptoms, but also their resources and positive aspects of life (101). In a qualitative 
study, also from mental health treatment, patients reported that, when answering 
questionnaires, they began reflecting on their treatment progress and found it easier to 
address the topics that were important for them to discuss (165). The same research 
group tested the effectiveness of a PRO/CFS in a randomised controlled trial and 
found no overall effect of the PRO/CFS on treatment outcomes. However, subgroup 
analyses of patients who were not on track in treatment showed lower attrition rates 
from therapy in the intervention group (166).  
PRO/CFS has also been implemented into some somatic services, most recently in 
the follow-up care of patients with diabetes mellitus (167) and in patients undergoing 
ostomy care (168). In a pilot study in the diabetes outpatient clinic, the researchers 
explored the utility of a PRO/CFS in clinical consultations and found that such a 
system was both technically and practically feasible in patient care (169).  
As PRO/CFS has proven to be feasible in several areas of mental health services and 
also appears to be feasible in diabetes outpatient care, PRO/CFS may be a tool for 
facilitating patient-centred care in BS follow-up.  
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3.0 Aims of the thesis 
The overall aim of this project was to gain knowledge that could be used to improve 
the follow-up care of patients undergoing BS. Specifically, this knowledge is aimed 
at aiding the implementation of a novel PRO/CFS in follow-up at the BS outpatient 
clinic at Helse Førde Hospital Trust. The aims of the different parts of the project 
were as follows: 
Study 1: To summarise evidence from systematic reviews exploring the effectiveness 
of PRO/CFS on HRQOL and to discuss the utility of a PRO/CFS in the follow-up 
after BS. 
Study 2: To provide a detailed description of the development of and plans for 
implementation and to assess the feasibility of the PRO/CFS at Førde Hospital Trust. 
Study 3: To explore the overall satisfaction with treatment outcomes and the 
association with HRQOL and BMI five years after BS. 
Study 4: To explore the validity and reliability of the Norse Feedback in a population 




4.1  The innovation and its implementation 
A digital PRO/CFS was developed and implemented in the BS outpatient clinic at 
Helse Førde Hospital Trust from 1 February 2018 as a standard part of treatment for 
all patients. The planning of the PRO/CFS started in June 2016, when relevant 
questionnaires were identified by the doctoral student and two of the supervisors 
(JRA and AAa). A panel was then established to further determine the questionnaires 
and to pilot test the PRO/CFS. The panel consisted of two patients who had 
undergone BS, one nurse working in the BS outpatient clinic and three researchers 
(one professor, one PhD candidate (later associate professor) and the doctoral 
student). The involvement of the two patients and outpatient nurse was considered 
crucial to ensure the ecological validity of the PRO/CFS. The feedback from the 
patients contributed to important changes to the questionnaires. For example, the 
patients emphasised that a focus on support from family and friends and negative side 
effects of the surgery were not covered well enough by the initial questionnaires. 
The manufacturer Checkware was chosen as the software provider, as they already 
had an agreement with Helse West and delivered the software for the Norse Feedback 
in the mental health department at Helse Førde. An individual working with 
implementation of a PRO/CFS in the mental health department was also assigned the 
task of working in this project. Furthermore, to secure the safety of patient 
information, the patients needed two-factor identification authentication to access the 
PRO/CFS and only a limited number of healthcare professionals and researchers had 
access to the database.   
When the final version of the PRO/CFS was ready, the training of the outpatient 
nurse started in December 2017. This training consisted of two of the researchers 
serving as proxy patients in several ‘consultations’ in order to train the nurse in 
incorporating the results from the summary report into the clinical consultation and 
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how to provide feedback. Furthermore, the nurse received guidance on how to 
interpret the Norse Feedback questionnaire, as this measure entailed a broader 
assessment of mental health than the questionnaires with which the outpatient nurse 
was already familiar. After the PRO/CFS was implemented into routine practice, the 
doctoral student attended the first consultations with patients to support the outpatient 
nurse. The person employed to work with the implementation of the PRO/CFS in 
Helse Førde was available for technical support after the project launch.  
The patients were able to access the PRO/CFS either on their own computer or tablet 
or on a tablet available in the outpatient clinic area. After accessing the PRO/CFS via 
the patient’s personal two-factor identification device, the questionnaires 
automatically appear in an order predefined by the project group. After the 
questionnaires are completed, the nurse generates a summary report. The healthcare 
professional has access to both the summary report and the scoring in the individual 
questionnaires if there are responses that warrant further investigation. Prior to the 
consultation, the healthcare professional prepares by assessing the summary report. 
At the start of the consultation, the healthcare professional views the summary report 
together with the patient and starts by discussing the areas in which the patient has 




           
Figure 1 Process of the clinical consultation with a PRO/CFS as an integrated component (reprinted 
from paper II with permission from BMJ Open) 
During the implementation process, there were various challenges that had to be 
overcome. The implementation of the intervention was significantly delayed due to 
negotiations between the Regional Health Trust and the manufacturer on the joint 
agreement for using PRO/CFS in clinical practice throughout the Regional Health 
Trust. The negotiations resulted in a satellite solution in which the data is stored in a 
secure database at the manufacturer. This solution is acceptable to most health trusts 
in Norway. Another challenge at the start of the project was to communicate to 
patients that they needed to complete the PRO/CFS prior to the consultation. This 
was solved by adding a description in the letter inviting them to the consultation on 
the purpose of self-reporting and how to access the system from home. As a 
significant number of patients did not initially respond to the PRO/CFS prior to the 
consultation, a text message was sent by phone the day before the consultation to 
those patients who had not responded. Patients who had not responded to the 
PRO/CFS when meeting for the consultation were given the opportunity to complete 
the PRO/CFS on a tablet in a private area in the outpatient clinic. Some patients had 
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also forgotten their device to log in securely to the system when meeting for the 
consultation. To prevent these patients from being unable to complete the PRO/CFS, 
a personalised solution for the generation of secure log-in information was provided 
by the manufacturer of the PRO/CFS. 
With regard to those patients who needed an interpreter, the outpatient clinic did not 
have a solution to offer interpretation services to these patients while completing the 
PRO/CFS. This is a limitation of the project. 
4.1.1 Questionnaires incorporated into the PRO/CFS 
As a result of the work carried out by the joint panel, the final PRO/CFS consists of 
six questionnaires that assess health-related quality of life, mental health, eating self-
efficacy and bowel symptoms. 
Health-Related Quality of Life (HRQOL) 
The Short-Form 36 (SF-36) version 1.0 is a generic measurement of HRQOL and 
consists of 36 items that explore such areas as general health, physical health and 
mental health (170). The results of the questionnaire can be interpreted as eight sub 
scores (physical functioning, role-physical, bodily pain, general health, vitality, social 
functioning, role-emotional and mental health) and two summary scores (Mental 
Component Score (MCS) and Physical Component Score (PCS)). The scores range 
from 0 to 100, with higher scores indicating better functioning. In this project, we 
applied t-scores, with a score of 50 as the average for the general population. The 
questionnaire is used and found valid in research on BS in Norway (134) and is 
frequently used to assess HRQOL across diseases (171). In the summary report, the 
cut-off values were set to green over 45, yellow 42.1–45 and red below 42 based on 
the findings of significant impairment from previous research.  
The Obesity-related Problems scale (OP) is an obesity-specific HRQOL 
questionnaire that measures the psychosocial consequences of obesity (172). The 
questionnaire consists of eight items measuring social activities like arranging or 
attending parties, trying on or buying clothes and intimate situations. The items have 
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four-point response categories ranging from Definitely not bothered to Definitely 
bothered.  The total scores range from 0 to 100 and lower scores indicate better 
psychosocial functioning. In clinical use, the individual items provide useful 
information on which areas of social life the patient experiences as challenging. The 
questionnaire is widely used in research on obesity and has been validated for use 
after BS in Norway (173). The cut-off values in the summary report were set based 
on recommendations from Karlsson et al. (172), by which a score under 19 was 
green, 20–59.9 yellow and 60–100 red. 
The Patient-Reported Outcomes in Obesity (PROS) form is an obesity-specific 
HRQOL questionnaire that measures the physical, mental and psychosocial 
consequences of obesity (174). The questionnaire consists of eight items measuring 
how obesity affects physical activities, cause pain, whether the patient experiences 
discrimination and whether obesity affects sleep or sexuality. The items have four-
point response categories ranging from Considerably bothered to Not bothered. A 
total score for the eight items is calculated but, in clinical practice, the individual 
items contribute the most information on the patient’s concerns. The questionnaire 
was developed in Norway and found valid in a population with obesity (174). As a 
result of input from the two patients in the panel, one item on negative side effects, 
one item on excess skin, one item om social support and one item on overall 
treatment satisfaction were added to the questionnaire. Each item is presented in the 
summary report and the cut-off was set as follows: Not bothered green, Mildly 
bothered yellow, Moderately bothered and Considerably bothered red. To assess 
overall treatment satisfaction, the patients are asked the question How satisfied are 
you, all things considered, with the treatment outcome after bariatric surgery? The 
item has the response choices Very satisfied, Satisfied, Unsure and Dissatisfied. This 
item have previously been used in research on BS in Norway (134). 
Mental health 
The Norse Feedback (NF) version 2.0 is a questionnaire developed for clinical use in 
mental health treatment (175). The questionnaire consists of 23 scales in the four 
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domains of symptom expression, dysfunctional processes, functional consequences 
and resources. The questionnaire was designed for a digital PRO/CFS and the initial 
version of the NF was developed in collaboration between patients, therapists and 
researchers. The questionnaire is under iterative development using the plan-do-
study-act methodology, involving both qualitative and quantitative assessments of the 
questionnaire (176, 177). The plan-do-study-act methodology in refining the NF 
includes qualitative methodology organised as interviews and workshops with 
patients and therapists in mental health services and quantitative analyses through 
Item-Response Theory and classical testing for psychometric properties. The version 
used in this project consists of 93 items loading to 21 different scales and four single 
items not loading on any scale (physical health, sleep, sexuality and impulsivity). The 
scales Alliance and Needs in treatment were not included in the PRO/CFS, as the 
items loading to these scales were not considered relevant for the follow-up of 
patients undergoing BS.  
The items have seven-point response categories ranging from This is true for me to 
This is not at all true for me and include the possibility for the patient to answer Not 
relevant/Do not know/Refuse to answer. The summary report displays the raw scores 
from the patient’s responses, with cut-off values for the colours red, yellow or green 
used in the mental health services. 
Eating self-efficacy 
The Weight Efficacy Lifestyle Questionnaire Short Form (WEL-SF) is an eight-item 
questionnaire that measures the patient’s perceived ability to resist overeating (178). 
The patients respond to a 10-point scale ranging from Not confident to Very 
confident. The scores range from 0 to 80, with higher scores indicating better self-
efficacy. The cut-off values were set based on clinical judgement, with scores 70–80 
green, 60–69.9 yellow and below 60 red. The questionnaire is validated for patients 




The Gastrointestinal Symptom Rating Scale (GSRS) is a questionnaire that measures 
gastrointestinal symptoms like abdominal pain, reflux and diarrhoea (179). The 
questionnaire consists of 15 items in five domains (Abdominal Pain, Reflux, 
Indigestion, Diarrhoea and Constipation), with total scores ranging from 15 to 105, 
with higher scores indicating more gastrointestinal symptoms. The seven-point 
response categories vary from Not bothered at all to Severely bothered.  Each domain 
is presented in the summary report and the cut-off values were set based on clinical 
judgement with the following thresholds (total score in the dimension/number of 
items): 1–2 green, 3–5 yellow and ˃5 red. The questionnaire has been used in 
research after BS (180). 
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4.2  Study characteristics  
Given that the different studies in this thesis have different aims, populations and 
methods, the study characteristics are presented separately for each study. 
4.2.1 Study 1: Effect of PRO/CFS on HRQOL, a review of systematic reviews 
The methodology in Study 1 was a review of systematic reviews. The methodological 
criteria for a review of systematic reviews are identical to those relevant for a 
systematic review. A specific research question, comprehensive search for literature 
and transparency in how the studies are selected from the initial screening of 
references until the final inclusion are considered key methodological elements. 
Further, a rigorous assessment of quality and a structured analysis of data from the 
reviews are required (181–183).  
Sample: Inclusion criteria were systematic reviews that summarised controlled 
clinical trials on the effectiveness of PRO/CFS on HRQOL in any patient population. 
The reviews were included regardless of publication year. Furthermore, the reviews 
had to be assessed as having good or moderate quality in order to be eligible for 
inclusion (assessed with two different checklists). We also conducted separate 
systematic searches to identify individual trials from the field of obesity treatment.  
Screening and identification of studies: Systematic searches for systematic reviews 
were conducted in the following databases: Cochrane Central Register of Controlled 
Trials, PROSPERO, Epistemonikos, Health Technology Assessment, DARE, 
CINAHL, Medline, Embase, PsycINFO, BMJ Clinical Evidence, PDQEvidence and 
PubPsych. The search strategies were designed to meet the specific requirements of 
each individual database using Boolean and Proximity operators and truncations 
(184). Filters for maximum sensitivity for systematic reviews were applied in all 
databases. Furthermore, searches for ongoing or unpublished studies and grey 
literature were conducted in cllinicaltrials.gov and Google Scholar. Reference lists of 
relevant studies were screened for studies eligible for inclusion. Two experts in the 
field were also contacted for any studies not identified through the systematic 
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searches. These are all measures recommended for a comprehensive literature search 
(185). In addition, two review authors independently screened the results of the 
systematic searches, read relevant studies in full text and decided on the final 
inclusion of the systematic reviews. Data from the included reviews were extracted 
by one review author and quality-checked by a third review author. These steps are 
crucial to ensure quality in the screening and analysis process (186).  
Quality assessment and statistical analyses: The quality of the included reviews was 
assessed using the PRISMA checklist (187) and a checklist for systematic reviews 
from the Norwegian Knowledge Centre for the Health Services (188).  
Since the statistical data in the systematic reviews were presented in a manner that 
did not enable meta-analyses, narrative analyses were conducted. In addition, we 
accessed the individual trials included in the systematic reviews and presented the 
findings in forest plot analyses. Heterogeneity in the primary trials were assessed 
through population characteristics, type of intervention and study design. Bias refers 
to the risk of systematic errors that can affect the results of a study. There are various 
tools to assess bias in primary trials, such as the Cochrane Collaboration Risk of Bias 
Tool (189). In reviews of systematic reviews, the quality assessment involves an 
evaluation as to whether the included reviews have conducted risk of bias 
assessments in the included trials (181, 182). A bias that is particularly relevant for all 
types of reviews is selection bias, which refers to the review authors not identifying 
and including eligible studies in the review. 
4.2.2 Study 2: PRO/CFS in bariatric surgery care – study protocol and design 
The purpose of this study was to provide a detailed description on the PRO/CFS 
implemented in the BS follow-up and plans for evaluation of the PRO/CFS. This 
paper included a study protocol in which we described the plans to assess the 
feasibility of the PRO/CFS in the follow-up of patients undergoing BS. 
Sample: The following participants were considered eligible in the study protocol: 
Patients operated with BS at Helse Førde Hospital Trust or St. Olavs Hospital are 
eligible for inclusion in the planned quantitative and qualitative inquiries of their 
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experiences with a PRO/CFS integrated in the consultations. Healthcare professionals 
working in the outpatient clinics at the same hospitals are eligible for inclusion in the 
qualitative inquiries. The patients and healthcare professionals are eligible for 
inclusion if they have experience using the PRO/CFS as part of the clinical 
consultation. 
Measures and analyses: The Generic Short Patient Experiences Questionnaire (GS-
PEQ) will be administered to patients after the consultations for purposes of 
quantitative assessments of their experiences with the consultation. The GS-PEQ is a 
questionnaire developed to measure patient experiences with the specialist healthcare 
in Norway (190). The version used in this project was developed for use in somatic 
outpatient clinics and includes 12 items that ask patients about how they experience 
the information they receive about the treatment and their condition, how the 
healthcare professionals communicate, whether the patient has been able to influence 
the treatment and whether they experience that the treatment is adapted to their 
situation. The patients’ responses will be rated on a five-point scale ranging from Not 
at all to To a very large extent. In this study, the responses To a very large extent and 
To a large extent are regarded as indications that the patients experience consultations 
in which a PRO/CFS is a part of the treatment as useful. To further assess the 
healthcare professionals’ compliance with the intervention, a question asking whether 
the patient received feedback on their PROMS during the consultation will be added. 
Univariate and multivariable analyses of patient experiences and association with 
variables as biological sex, age, BMI, HRQOL, bowel symptoms and complications 
from the treatment will be conducted. 
The qualitative assessments of patient and healthcare professional experiences are 
planned through four focus group interviews with patients and one focus group with 
healthcare professionals accrued from both outpatient clinics. Six to eight participants 
are to be accrued in each group. The recruitment of patients will be performed by the 
clinical staff at the outpatient clinics, whereas the healthcare professionals will be 
recruited through an informational meeting followed by an invitation by email. Two 
researchers will conduct the interviews, during which one will be the moderator while 
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the other will be responsible for audio recording and notetaking. The data material 
from the interviews will initially be extracted separately by the two researchers, 
followed by a workshop during which agreement on the analyses will be reached. 
Participants in this workshop will be the two researchers and a third experienced 
qualitative researcher who was not involved in the initial data extraction. The data 
will be analysed through systematic text condensation according to Malterud’s 
adaptation of the procedure (191). This involves four steps, by which the first step is 
to read through the material to gain an overall impression and the second step is to 
start coding units of related meanings. The third step is to create a condensate of units 
from the different participants, while the final step is to synthesise these condensates 
into a more overall meaning of the material (191).   
4.2.3 Study 3: Overall treatment satisfaction 
Patients operated at Helse Førde Hospital Trust during 2001–2012 were prospectively 
included in the study. We accessed data from the local obesity registry on patients 
who had reached their five-year follow-up consultation after surgery during 2005–
2017. Overall treatment satisfaction five years after surgery was assessed, as long-
term outcomes after BS is important information considering the feasibility of BS as 
a treatment for obesity.  
Data from all patients who consented to having their information registered in the 
local obesity registry for research purposes were included in the analyses. Clinical 
information such as the type of surgery, BMI, excess weight loss, presence of any 
comorbid conditions and medication use, as well as any complications from treatment 
were registered. Further, HRQOL measured with the SF-36 and OP were registered in 
the database.  
Sample: Patients who had attended the five-year consultation after bariatric surgery 
(BPD/DS or LSG) were eligible for inclusion. 
Measures: The primary outcome was overall treatment satisfaction measured by 
means of the item How satisfied are you, all things considered, with the treatment 
outcome after bariatric surgery? with the response choices of very satisfied, satisfied, 
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unsure and dissatisfied. Independent variables were BMI (weight measured at the 
outpatient clinic in light clothing without shoes to the nearest 0.1 kg, and height 
measured to the nearest 0.01 meter), generic and obesity-specific HRQOL measured 
with the SF-36 and OP. Covariates were age (years), biological sex (female/male), 
surgical procedure (LSG or BPD/DS) and reoperations (yes/no).  
Analyses: Univariate and multivariable analyses (192) were performed using the 
software SPSS (193). Demographic information was presented as frequencies (N) and 
percentages (%) or means and standard deviations (SD). Results from the univariate 
and multivariable regression analyses were presented as odds ratios (OR) and 95% 
confidence interval (95% CI). A p-value ˂ 0.05 indicated statistical significance. If 
clinical information was missing in the database, the information was accessed 
through the electronic documentation system in the hospital by the outpatient nurse. 
If this information was not accessible, the patient was excluded. The patients were 
included in the analyses if more than 50% of the items in the SF-36 and OP were 
completed according to previous practice (131, 170). The missing items were 
computed by calculating the average of the completed items on each dimension in the 
SF-36 and on the total of completed items in the OP. 
4.2.4 Study 4: Validity of the Norse Feedback in patients undergoing BS 
Study 4 is a validation paper of the Norse Feedback (NF) in BS follow-up care. The 
aim was to assess the psychometric properties of the NF in a population of patients 
undergoing BS and to test whether the NF correlated with the OP in the same 
population. 
Sample: Patients who were accepted for or had already undergone BS and had 
attended a consultation with the outpatient nurse from February 2018 until January 
2020 were eligible and included prospectively. To be accepted for BS, the patients 
had to fulfil the criteria of either BMI ≥ 40 or 35–39.9 with obesity-related diseases. 
In addition, the PRO/CFS had to be completed prior to the consultation with the 
nurse.  
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Analyses: To assess the validity and reliability of the NF, we conducted Principal 
Component Analyses (PCA). PCA loadings, explained variance, corrected item-total 
correlation and eigenvalue were reported. Floor and ceiling effects were estimated for 
all scales and the four single items. Cronbach’s alpha was reported for each scale. 
The analyses were performed using the SPSS version 26 (193). To determine 
satisfactory psychometric properties, we applied the following reference values: 
Loadings ≥ 0.4 (194) and only one eigenvalue 1 or above per scale (194). For the 
explained variance, there is no uniform agreement on the cut-off. Some authors argue 
that the main component should account for at least 20% of the variance, whereas 
others argue in favour of at least 40% (195). We considered an explained variance of 
40% or above as satisfactory. Cronbach’s alpha  ≥ 0.7 was considered acceptable 
(196). Floor and ceiling effects below 15% were considered optimal (194). 
4.3 Ethical consideration 
In studies 3 and 4, written informed consent was obtained from all participants and is 
planned for all patients to be accrued in Study 2.  
Studies 2 and 4 were approved by the Norwegian Centre for Research Data, 
Department of Data Protection Services (ref. no. 282738) and have undergone Data 
Protection Impact Assessments, both at Førde Hospital Trust and St. Olav Hospital 
(registration no. 2016/3912). Study 3 was approved by the Regional Committee for 
Medical and Health Research Ethics (REK 2009-2174).  
Study 1 did not require ethical approval, as this was a review of systematic reviews, 
although ethical considerations should be performed by the authors of the included 
reviews. 
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5.0 Summary of findings 
As regards the descriptions of the characteristics of the four studies, the results will 
be presented separately for each study. 
5.1  Study 1: Effect of PRO/CFS on HRQOL, a review of systematic reviews 
Five systematic reviews, including studies investigating PRO/CFS in cancer 
treatment and mental health treatment, were included. No systematic reviews or 
primary trials from obesity treatment were identified. See Figure 2 for the screening 
process and study selection. 
  
Figure 2 Screening and study selection (reprinted from Paper I with permission from Clinical 
Obesity) 
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The quality of the included reviews was assessed as good (n=2), moderate to good 
(n=1) and moderate (n=2). 
The results from the narrative review showed that three out of the five reviews found 
an effect in favour of the intervention group (PRO/CFS), whereas the remaining two 
reviews found no differences between the two groups. Due to differences in how the 
statistics were reported in the included reviews, the primary trials from the reviews 
were accessed to conduct forest-plot and meta-analyses. The meta-analyses showed a 
trend in effectiveness in favour of the PRO/CFS group, although not statistically 
significant. Overall, the conclusion of the review of systematic reviews was that the 
effectiveness of PRO/CFS on HRQOL seemed promising. However, no clear 
conclusions could be drawn due to statistically insignificant findings and a high risk 
of bias in the included trials. A key finding was also that the concept of the PRO/CFS 
was understood and implemented very differently in the primary trials. Consequently, 
there was uncertainty as to whether the real phenomena of feedback were studied. 
5.2  Study 2: PRO/CFS in bariatric surgery care – study protocol and design 
In Study 2, a detailed description of the development of the PRO/CFS was provided. 
We described how a panel consisting of two patients who had undergone BS, one 
nurse working in the bariatric outpatient clinic and three researchers collaborated to 
choose the most appropriate questionnaires to be included in the PRO/CFS.  
The experiences of patients and nurse were important when assessing whether the 
questionnaires were relevant for the themes important to the patients, whether the 
nurse found the questionnaires to be relevant for the clinical consultations, whether 
the patients thought any important matters were not covered through the 
questionnaires or whether any of the items were experienced as offending. This was 
important to ensure that the PRO/CFS was relevant for follow-up care after BS. The 
patients, outpatient nurse and two of the researchers pilot-tested the PRO/CFS to 
assess the time spent in completing the questionnaires and user-friendliness. 
Furthermore, the nurse was trained to interpret the summary report and implement the 
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findings into the clinical conversation. The first author attended the first consultations 
to assist the nurse. Technical support was also provided by a person dedicated to 
work with implementation of the PRO/CFSs in the Health Trust.  
Furthermore, the implementation of the PRO/CFS is scheduled to be evaluated 
qualitatively through focus group interviews with both patients and healthcare 
professionals and quantitatively of patients by means of the questionnaire GS-PEQ 
(190). To assess fidelity, data on attrition to follow-up consultations, number of 
patients who completed the PRO/CFS, whether there is missing data within the 
questionnaires of the PRO/CFS and the proportion of referrals to other specialities as 
a consequence of the patient responses will be evaluated. 
5.3  Study 3: Overall treatment satisfaction 
Study 3 included 261 patients with a follow-up of five years after BS. Most of the 
included patients (66.3%) were men. The mean preoperative BMI in the sample was 
47.1 kg/m2 and the mean age was 48 years. The BMI decreased on average by 15.6 
units in the sample. The included patients had been operated with BPD/DS or LSG. 
The analyses showed that 82.4% of patients reported being very satisfied or satisfied 
with their overall treatment outcome. The multivariable analyses showed that reports 
of being unsure or dissatisfied were associated with higher BMI, lower scores on 
MCS from the SF-36 and higher scores in the OP. The variables of age, biological 
sex and PCS from the SF-36 and whether the patients had been re-operated showed 
no significant associations with overall treatment satisfaction at five years. See Table 
1for univariate and multivariable analyses. 
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Table 1 Univariate and multivariable analyses of treatment satisfaction (reprinted with 
permission from Obesity Surgery)  
 
5.4  Study 4: Validity of the Norse Feedback in patients undergoing BS 
Out of a total of 259 patients, 213 were included in the study. The main reason for 
exclusion was that the patients had not completed the PRO/CFS prior to the 
consultations (n = 44), while two were excluded due to not consenting to participate 
in the study. We performed PCA on 19 scales of the NF (see Table 2 for information 
on the structure of the scales). The scale Medication consists of only two items and, 
consequently, the psychometric properties could not be assessed. Furthermore, only 
20 patients responded to the scale Substance Recovery, so a PCA or reliability 
analyses were not performed on this scale. 
The PCA analyses showed satisfactory loadings, explained variance, eigenvalues and 
Cronbach’s alpha in the scales Sad Affect, Somatic Anxiety, Substance Use, 
Variable Univariate model 
  OR       95 % CI        p-value 
Multivariable model 
OR       95 % CI        p-value 
 
Age (per 2 SD) 
 
  0.7          0.4 – 1.4              0.31 
 
     1.2          0.5 – 2.7             0.70 
Men (reference women)   0.7          0.4 – 1.5              0.39 
  
     1.9          0.8 – 4.8             0.16 
Body Mass Index (per 2 
SD) 
  7.1          3.4 – 14.5          ˂0.001      6.1          2.7 – 14.0        ˂ 0.001 
Obesity Problem Scale 
(per 2 SD) 
  7.6          3.7 – 15.5          ˂0.001      3.0          1.1 – 7.8             0.03 
Physical Component 
Score (per 2 SD) 
  0.3          0.1 – 0.5            ˂0.001      0.8          0.3 – 2.1             0.65 
Mental Component Score 
(per 2 SD) 
  0.2          0.1 – 0.4            ˂0.001      0.3          0.1 – 0.8             0.02 
LSG (DS reference)    2.6          1.3 – 5.4              0.01      3.3          1.3 – 8.8             0.01 
 
Reoperation at baseline* 
 
  1.5          0.5 – 4.8              0.51      1.9          0.5 – 8.3             0.34 
Reoperation after 
baseline**  
  1.5          0.6 – 4.1              0.38      1.3          0.3 – 4.6             0.72 
 
The odds-ratio represent the odds for being dissatisfied/unsure  
OR= Odds Ratio  
CI= Confidence Interval 
SD= Standard deviation 
LSG= Laparoscopic Sleeve Gastrectomy 
DS= The Duodenal Switch 
Physical and Mental Component Score from the Short-Form 36 
* Reference is not re-operated. 17 patients had a reoperation as the baseline operation due to inadequate weight loss from 
a previous surgery. 
** Reference is not re-operated. Of those re-operated after baseline 68 % had a re-operation due to surgical complications, 
32 % due to weight regain 




Suicidality, Social Safety, Need for Control, Internal Avoidance, Self-Criticism, 
Situational Avoidance; Social Avoidance; Worry and Cognitive Problems. The 
remaining scales showed unsatisfactory psychometric properties. The scales General 
functioning and Readiness for recovery demonstrated Cronbach’s alpha of 0.51 and 
0.40 and a low component value in one out of three items in each scale. The scale 
Irritability demonstrated Cronbach’s alpha 0.40 and low loadings in two out of three 
items.  
The floor and ceiling analyses showed floor effects ranging from 5.7% to 88.2% and 
ceiling effects ranging from 0% to 13.1%. Seven scales demonstrated a satisfactory 
floor effect, whereas the remaining scales and single items all showed floor effects 
above 15%. The high floor effect in some of the scales, such as Sad Affect and 
Suicidality, were somewhat surprising, as we would have expected greater variety in 




Table 2 Structure of domains, scales and number of items included in each scale in the 
Norse Feedback questionnaire (retrieved from Paper IV) 





Eating Problems  
Sad Affect  
Somatic Anxiety  
Substance Use  
Suicidality 
Trauma Reactions  
Resources 
Readiness for Recovery 
Recovery Environment  
Social Safety  
Problem-maintaining Processes 
Need for Control  
Hopelessness  




Social Avoidance  
Worry  
Personal Consequences 
Cognitive Problems  
General Functioning 
Substance Recovery 
Treatment Process Scales 
Alliance* 




I take care of my physical health. 
I am sleeping very badly at the moment. 
My sexuality and/or sex life is difficult for me. 



























*Scales not included in the clinical feedback system, as the 
items were not considered relevant for follow-up to bariatric 
surgery. 
 
The correlation analyses on the NF and OP showed moderate correlations on the 
scales Eating Problems, Sad Affect, Somatic Anxiety, Need for Control, Hopelessness, 
Internal Avoidance, Self-Criticism, Situational Avoidance and Social Avoidance. The 
scales Suicidality, Trauma Reactions, Readiness for Recovery, Recovery 
Environment, Social Safety, Irritability, Worry, Cognitive Problems, and General 
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Functioning showed small correlations, whereas the scales Substance Use and 
Medication showed trivial correlations. For the single items, one item showed 
moderate correlation (sexuality) and three items showed small correlations (physical 
health, sleep and impulsivity) with the OP.  
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6 Discussion 
The implementation of the PRO/CFS in the outpatient clinic has been an important 
part of this project. This thesis therefore starts with a general discussion of the 
questionnaires incorporated into the PRO/CFS. This is followed by a discussion of 
the importance and content of follow-up care for patients undergoing bariatric 
surgery and the utility of a PRO/CFS in this follow-up care. Finally, the 
methodological strengths and limitations of the studies are discussed before the 
implications of this research and future perspectives are provided. 
6.1 Questionnaires incorporated into the PRO/CFS 
Decisions when choosing questionnaires to be included in the PRO/CFS  
The PRO/CFS comprises six questionnaires that measure various aspects that often 
are negatively affected in patients with obesity and after BS and the questionnaires 
were decided on by a panel consisting of patients and outpatient nurse. This increases 
the ecological validity of this project by making the PRO/CFS more clinically 
relevant to patients and healthcare professionals. The questionnaires measuring 
HRQOL, eating self-efficacy and bowel symptoms are well known and validated for 
patients with obesity and patients who have undergone BS (170, 172, 174, 178, 179).  
The total amount of questionnaires was based on several issues. The most important 
one, as already discussed, was to make the PRO/CFS relevant for the clinical 
consultation. However, there are three questionnaires measuring various aspects of 
HRQOL and further analyses of the PRO/CFS will seek to explore whether any of the 
questionnaires are superfluous. The SF-36 questionnaire was included in the 
PRO/CFS because the original plan of the project was to perform analyses with a 
historical control group. The PRO/CFS also comprises two obesity-specific HRQOL 
measures. The OP is a valid and well-used questionnaire in research on obesity and 
BS. The PROS is a questionnaire developed locally by two of the researchers 
involved in the project. The PROS builds on the OP but, in addition to the 
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psychosocial aspects the PROS, it also assesses the physical consequences of obesity. 
The PROS was found valid and reliable in a population of patients undergoing BS, 
although the sensitivity to change is unclear due to the cross-sectional design of the 
study and lack of prospective data (174). Both questionnaires were incorporated into 
the PRO/CFS, as it was necessary to further validate the PROS in patients undergoing 
BS. Future studies will seek to explore whether one of them contributes sufficient 
information in the clinical consultation. 
For assessing mental health, a novel questionnaire developed for clinical use in 
mental health services was used. The NF (175, 176) was chosen even though it had 
not been validated for patients undergoing BS because it measures various 
dimensions of mental health that were considered relevant for this patient population. 
Examples of these dimensions are depression, anxiety, suicidality, eating disorders 
and problematic substance use. The domains measured by the NF are much broader 
than in the questionnaires most frequently used in research on obesity. Furthermore, 
the NF was developed to fit a digital PRO/CFS and is adaptive to the patient’s 
responses, also referred to as idiographic adaptation (103). Thus far in the project, we 
have chosen to not use the idiographic adaptation opportunity of the NF. The reason 
for this is that data from full sets of items were requisite to test the validity and 
reliability of the NF in this patient population. Future plans are to further validate the 
NF and possibly create a version adapted to this patient population. The qualitative 
inquiries may also contribute valuable information on patient experiences with this 
questionnaire for further adaptations. 
Possible consequences of the number of questionnaires 
The total number of items in the PRO/CFS might represent a burden to patients when 
completing the PRO/CFS, especially those who have difficulty reading or writing or 
do not speak Norwegian fluently. However, these patients have the opportunity to 
complete the PRO/CFS at the outpatient clinic with assistance from the healthcare 
professional.  
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Another challenge with the total number of items is that the patient may grow tired of 
answering and not read the questions thoroughly when responding. This will possibly 
be discovered during the consultation, but will most likely reduce the validity of the 
findings in terms of research. When the panel of two patients, nurse and researchers 
selected the questionnaires for the PRO/CFS, the patients confirmed that it was a high 
number of items to respond to, but that they were relevant for them. Hopefully, this 
matter has been properly addressed as a result. If the number of items is too high is a 
topic that will be sought elucidated during the qualitative interviews.   
As one of the members of the research team in this project was one of the developers 
of the NF, there are several potential limitations to the project. The team of 
developers had an interest in receiving full datasets from these patients. This resulted 
in the full questionnaire being incorporated, instead of only using the trigger items, 
thereby increasing the total workload on patients when completing the PRO/CFS. The 
trigger items may possibly provide enough information for the clinical consultation. 
On the other hand, it is necessary to test whether the trigger items are sensitive 
enough for the challenges that this population of patients may experience. Another 
possible limitation may be that the researchers may tend to overestimate the positive 
findings when validating the questionnaire. To prevent this bias, the researcher who is 
also a member of the development team was not involved in performing the validity 
or reliability analyses of the NF. However, the close link to the developers has 
definitely strengthened the project through a deeper knowledge of the development of 
the NF. The NF is not a traditional questionnaire, as items have been included in the 
questionnaire even though they demonstrated poor psychometric properties because 
the patients or therapists found the items useful for opening a conversation about 
certain themes. Knowledge about which items performed poorly has been valuable 
when testing the psychometric properties in the population of patients operated with 
BS. 
When using data from the PRO/CFS for research purposes, an uncertainty about the 
findings is whether the respondent has replied carefully to the items. A qualitative 
study exploring patient experiences with the NF as part of their treatment in mental 
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health services showed that patients found the PRO/CFS useful in their treatment 
process and put an effort into answering the items thoroughly (197). However, some 
patients in this study also stated that they sometimes over- or underestimated their 
challenges. This is, however, a possible bias that is relevant for all PROMS used for 
research purposes and therefore any unexpected findings in results or any ‘outliers’ in 
the data material should receive special attention when analysing the findings. On the 
other hand, PROMS are considered reliable and a valid measure to assess self-report 
data from patients (85, 86, 198). 
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6.2 Follow-up care after bariatric surgery 
Importance of addressing more than just physiologic aspects during follow-up 
To date, the focus of BS follow-up has been primarily on the physical aspects of the 
surgery, such as weight loss, remission of comorbidities and the negative 
consequences of the surgical procedure. A positive development is that healthcare 
professionals in clinical practice have a higher focus on such consequences as mental 
health, HRQOL and treatment satisfaction in their meetings with patients (199, 200), 
in addition to weight and comorbidities. Apart from contributing to more holistic 
patient care, screening for mental health illness may save both money and time in 
clinical practice (201). This broad focus, however, is not implemented equally in 
guidelines for patient follow-up after surgery (70, 114, 202). In these guidelines, it is 
quite apparent that the physical effects of surgery are the main focus, as mental health 
and HRQOL are only briefly mentioned. Following the same line of thought, it is 
quite interesting that a recent Delphi method statement on priorities in BS research 
does not include optimal follow-up of patients after surgery or even mention mental 
health or HRQOL as important areas for investigation (203). The authors themselves 
state that the members of the consensus group only consisted of surgeons and that 
other healthcare professionals would probably have other priorities. It is hard to not 
agree with the authors on this.  
There are, however, promising exceptions to the lack of focus on mental health. The 
British Obesity & Metabolic Surgery Society published guidelines in 2019 with 
specific recommendations for how to provide psychological support to patients before 
and after surgery (13). The guidelines were developed through a review of the 
literature and the involvement of patients, experts in the field and healthcare 
professionals with a broad range of specialities. The main messages in the guidelines 
are pre-operative information about mental health provided to patients, preoperative 
screening of mental health concerns and mental health screening at several time 
points after BS. These aspects fit in well with the purpose of the PRO/CFS 
implemented in the follow-up after surgery in this project, where mental health is 
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assessed through the NF during every consultation. Furthermore, the recently updated 
American guidelines for perioperative support of patients undergoing BS recommend 
a continuous follow-up on mental health concerns (114). 
Even though the focus on mental health and HRQOL after surgery could clearly be 
more prominent in most of the published guidelines, the focus on these topics are 
increasing in research. A prospective cohort study found that pre-surgery screening 
for depression was associated with a smaller Hazard Ratio for postoperative 
depression compared to patients who did not undergo such screening (150). In a 
literature review, Sarwer and Heinberg (110) state that mental health screening is also 
important after surgery. Furthermore, they recommend that the summary of the 
screening be shared with the other participants of the bariatric team. A PRO/CFS is, 
in our opinion, a feasible way to generate and share this summary, as the summary 
report provides a visual view of the patient’s mental health concerns. I would also 
add to the recommendations to not only share the findings with the bariatric team, but 
also with the patient during the consultation. Sarwer and Heinberg (110) also 
recommend that future research focus on specific mental health interventions in the 
follow-up after BS. This is an important aspect, as the screening of mental health 
itself is not a goal but provides additional tools for the healthcare professionals to 
address patient concerns.  
Duration of follow-up 
A lifelong follow-up of patients is recommended (70), although there is no consensus 
on the frequency or content of this follow-up. Continuous follow-up of the patients is 
important, as attrition to follow-up is linked to adverse patient outcomes in long term 
(114).  
The follow-up care of patients after BS varies greatly worldwide, including in 
Norway. Due to the rapid and dramatic changes that many patients experience as a 
consequence of the treatment, there is a need for a good preparation of patients before 
BS. This preparation must focus on the physical, social and mental health changes the 
patients may face, as well as the effort that is needed on the part of the patient in the 
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longer term to prevent negative effects of the surgery and to maintain the positive 
changes over time. The authors of a review of qualitative studies concluded that the 
dramatic changes patients face required a thorough pre-treatment education (204). 
This preparation is important, as a study found that up to 5% of patients reported that 
they regretted undergoing RYGB five years after surgery (205). This is alarming 
considering the fact that BS procedures are often irreversible. Although this is not a 
large number of patients, this accounts for many patients worldwide each year if we 
assume that the number of patients regretting BS in general is around the same level. 
The majority of patients would, in my opinion, benefit from a more thorough 
preparation on the possible negative consequences of BS than many patients receive 
today. These preparations could consist of online preparation material, clinical one-
on-one consultations and support groups.  
There are several challenges to the follow-up after BS. One of them is the manner in 
which the consultations are organised. To get patients to want to participate, they 
must experience that attending the consultations benefits them. In a qualitative study, 
patients stated that they needed to be confident that the consultations at the bariatric 
outpatient clinic would provide them with useful information for them to want to 
attend. Otherwise, the patients may just as well consult their general practitioner 
(116). Patient expectations regarding the content of the consultation may also affect 
their willingness to attend. Patients may think that the healthcare professional is most 
interested in weight and eating habits and not so much in their mental health, sexual 
concerns or family relations. If the healthcare professional is prepared in advance 
regarding the patient’s concerns, the consultation will probably be experienced as 
more relevant. This is in line with Fastenau et al. (48), who developed a disease-
illness model for the treatment of obesity in which they highlighted that the treatment 
should focus on what concerns the patient most. For some patients, this could be 
satisfaction with treatment or mental health, while other patients may be more 
interested in the weight loss aspect. The need to facilitate patient-centred 
consultations in the follow-up is therefore important (116). 
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6.3  PRO/CFS as a tool to structure follow-up after BS 
Utility of a PRO/CFS in follow-up care 
As we documented through Study 1, the understanding of the concept of PRO/CFS 
varies considerably across studies, possibly due to the lack of a universally accepted 
definition. In studies 1 and 2, we proposed some key features we believe should be 
present if the feedback phenomena were to be studied. The features entailed a 
collection of PROMS prior to each consultation, followed by a joint assessment of the 
responses with the patient and healthcare professional during the consultation, as well 
as a discussion on the implications of these findings for the patient. The responses 
should also be interpreted in light of normative data and the patient’s goals with the 
treatment.   
Whether or not a digital PRO/CFS is feasible in clinical consultations after BS needs 
further investigation. A retrospective cohort study that assessed changes in HRQOL 
after BS provided a description of how digital PROMS are routinely collected in a BS 
centre in the United States (162). Patients are surveyed before each consultation and 
have the opportunity to complete the measures at their own computer or on a tablet at 
the outpatient clinic. However, it does not appear as the information from the 
PROMS is discussed with the patient during the clinical consultation. As future 
perspectives, the authors state that they plan to implement the PROMS into the point-
of-care setting. When this research group implements the PROMS into the clinical 
consultation, their approach seems comparable to what we have chosen in this 
project. 
As to our knowledge, one previous study described a PRO/CFS in the treatment after 
BS. Greene and Hutter (206) described a project in which PROMS were to be 
collected before each consultation and the healthcare professional was encouraged to 
discuss the findings with the patient during the clinical consultation. As far as we 
know, no results from this research group assessing this PRO/CFS have been 
published and we welcome these results in the future. This research group may be a 
future collaboration partner when developing a PRO/CFS for BS care.  
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Another study described an intervention in a weight maintenance programme in 
which the participants reported their weight weekly (207). The study had two 
intervention arms, by which the patients were offered face-to-face contact in one arm 
and internet-based via chatrooms in the other. Both interventions resulted in a 
significant prevention of weight regain compared to the control group and a minor 
insignificant difference between the intervention arms favouring the face-to-face 
group. In a study including patients treated with intragastric balloon, the authors 
reported that patients who received an online follow-up with real-time access to 
healthcare professionals had equivalent weight loss to patients who attended standard 
follow-up consultations (208). In these two latter studies, however, the authors did 
not assess other outcomes than excess weight loss.  
How a PRO/CFS might facilitate patient involvement 
The value of a face-to-face consultation was described in a qualitative study with in-
depth interviews of 46 patients who had undergone BS. The patients stated that 
continuity and a relationship with the healthcare professional was important in 
follow-up care. They also highlighted the importance of personalised care and 
ongoing monitoring of their treatment progress (116). These findings fit in well with 
the concept of PRO/CFS, in which the goal of the treatment is personalised follow-up 
through the monitoring and clinical discussion of patient responses. Again, the 
individualisation of the patient care is a core element in the disease-illness model 
developed by Fastenau et al. (48), as each patient demonstrates different areas of 
challenges. A digital PRO/CFS with an idiographic approach may therefore be a 
suitable tool to achieve this goal of patient-centred care.  
In a qualitative study of patients undergoing treatment for obesity, one key finding 
was that patients were aware of whether or not the healthcare professional was 
actually interested in their situation and treated them as whole person (209). A 
PRO/CFS in follow-up care may facilitate such communication between the patient 
and healthcare professional because the focus of the consultation is on the greatest 
concerns of the patient at that time. On the other hand, a PRO/CFS may be an 
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obstacle to this professional relationship if the healthcare professional does not 
handle the technical equipment sufficiently or if he or she does not feel confident in 
how to interpret what the patient has reported in the various questionnaires. In a 
qualitative study assessing patient and therapist experiences with a PRO/CFS in 
mental health treatment, a key finding was that the PRO/CFS itself was not enough to 
improve communication and empower the patient. The manner in which the therapist 
integrated the findings into the clinical conversation was important. The therapists 
also stated that the feedback had to be provided differently according to the patient’s 
preferences and situation (210). In another qualitative study in which the patients had 
experiences with the same PRO/CFS as in the latter study, the patients emphasised 
the importance of receiving feedback from the therapists. Those patients who had not 
received feedback described feeling disappointed that their effort to complete to the 
PRO/CFS was not valued by the therapist (211). 
In our experience, a PRO/CFS will add value to the clinical consultations in BS 
follow-up care. The content of the PRO/CFS has the potential to be adapted to the 
preferences of users, in this case patients and healthcare professionals. Furthermore, 
the idiographic adaptation facilitates the surveying of patients with regard to aspects 
relevant for their situation. In addition, interest is growing in the use of PROMS in 
clinical consultations (212), making a digital PRO/CFS even more relevant. 
As mentioned above, the planning of the PRO/CFS and involvement of service users 
are viewed as important to the implementation process of a PRO/CFS (213). The 
involvement of patients and healthcare professional in designing the PRO/CFS in this 
project is a considerable strength. This also applies to the planned evaluations of the 
PRO/CFS, in which the patients and healthcare professionals are included in a panel 
evaluating the questionnaires included in the PRO/CFS, as well as the content of 
items in the NF adapted to patients with obesity. 
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6.4 Methodological considerations 
When acquiring knowledge in a field through research, the traditional approach is to 
choose either a quantitative or a qualitative approach, depending on the aim of the 
study. When the methodological approach is chosen, the researchers start to design 
the specific study. This approach has led to different researchers often defining 
themselves as either qualitative or quantitative researchers, by which quantitative 
researchers are in the positivist paradigm and qualitative researchers in the 
constructivist paradigm (214). These two paradigms have different ontological and 
epistemological assumptions in that the positivists view reality as something that can 
be measured and counted, whereas the constructivists see the world as subjective 
(215). Luckily, the research community has begun to recognise each other’s 
knowledge as valuable, enabling researchers to study a phenomenon in different ways 
using different methods. This is often referred to as mixed methods, by which the 
phenomenon is explored through qualitative and quantitative methods. Using 
different approaches to acquire knowledge is also called ‘multimethod’, which refers 
to the methods used rather than the combining of ontological and epistemological 
assumptions (216). A multimethod approach means that the researchers can combine 
several quantitative methods, several qualitative methods or a combination of both 
qualitative and quantitative methods to explore the phenomenon. The phenomenon in 
this thesis is follow-up care for patients undergoing BS. Due to the complexity of this 
group of patients, this phenomenon can best be explored using different 
methodology. This has led to different methods being included in this thesis in order 
to gain broader access to this phenomenon.  
As mentioned above, the methods, sample and statistical analyses are different in the 
four studies and, consequently, the methodological strengths and limitations of the 
individual studies are discussed separately. 
6.4.1 Study 1: Effect of PRO/CFS on HRQOL, a review of systematic reviews 
Study 1 is a review of systematic reviews that assess the effects of PRO/CFS on 
HRQOL. A review of systematic reviews is an appropriate approach in fields where 
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several systematic reviews have been published and the aim is to perform a meta-
synthesis of the findings in the systematic reviews (181, 182). The advantage of this 
methodology is that it provides the reader with an overview, for example of the 
effects of an intervention in several patient populations. The aims of a review of 
systematic reviews are often broader than in ordinary systematic reviews (181). No 
systematic reviews from the field of treatment for obesity were identified and one 
may question whether this methodological approach was appropriate for this theme. 
The aim of this study was to summarise the effects of the PRO/CFS on HRQOL in 
any patient population, making this approach eligible. Furthermore, no primary trials 
assessing effects of PRO/CFS on HRQOL in patient under treatment for obesity were 
identified, so a systematic review would not have contributed with further evidence in 
this patient population.  
A strength of this project was that The Cochrane Handbook for Systematic Reviews 
of Interventions version 5.1.0 (217) was used as the methodological guideline. This 
entails a rigorous literature search in relevant databases, screening of reference lists in 
relevant articles, searching for grey literature and contacting experts in the field. 
Another strength of this study is that two authors performed the critical steps in the 
review process independently, including the screening of titles and selection of 
articles for full-text reading. Both read the selected articles in full text before arriving 
at agreement on final inclusion. During the screening process, one author was 
inexperienced in the field in terms of investigations, whereas the other was very 
familiar with the field. This is considered a strength of the review process (184). 
Searches were performed in databases designated for systematic reviews and 
databases indexing journals in the field of medicine, nursing and psychiatry. The 
separate searches to identify systematic reviews and primary trials from obesity 
treatment strengthen the study.  
Data extraction was performed by one author and quality checked by a third author. 
This may represent a limitation of the study, as, optimally, data is extracted by two 
authors independently, followed by an agreement on which data to analyse (218). 
Another limitation of this study is the lack of a universally accepted definition of 
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PRO/CFS methodology. As a result, studies that were eligible for inclusion were 
perhaps not identified, as the authors of the systematic reviews may have used 
different terms to describe the intervention. To prevent this bias, we used several 
synonyms for the PRO/CFS in our searches, including the most commonly used 
terms. However, this may represent a selection bias to this study. 
Quality assessments were performed with two well-used checklists (187, 188) by two 
review authors separately and reviews assessed as having good and moderate quality 
were included. This is a strength of this study because a limitation of the review of 
systematic reviews methodology is that the result of the synthesis largely depends on 
how rigorously the authors have been in conducting the included systematic reviews 
(181, 182).  
Analyses 
Each systematic review was synthesised narratively due to differences in the way in 
which the findings were reported. A challenge to narrative summaries is to present 
the findings in a rigorous manner and to synthesise the findings in a way that gives 
the reader a good overview of the aggregate findings. When conducting meta-
analyses, the weight of the individual study, depending on the number of included 
participants in each study, affects the combined effect estimates and thereby increases 
the precision of these estimates (219). To add to the narrative analyses, the individual 
studies from the systematic reviews were accessed and forest-plot and meta-analyses 
were conducted. This strengthens the study because the reader can use this 
information in addition to the narrative summary to evaluate the findings. 
Furthermore, conducting forest-plot and meta-analyses of individual studies ensured 
that each study was included only once in the analyses. If one study is included in the 
meta-analyses in  several systematic reviews, this leads to overestimating the impact 
of that study in the review of systematic reviews (182).  
On the other hand, a limitation of the presentation of meta-analyses in this study is 
that the interventions, methods and populations in the individual trials are quite 
heterogeneous and the summarised effect estimates in the meta-analyses may have 
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been affected by this clinical heterogeneity. This means that the effect of the 
interventions might be affected by factors not measured if the settings, populations 
and interventions vary considerably across the studies (219). Due to this 
heterogeneity in the primary trials, the meta-analyses were conducted using a random 
effect model suitable for use when the interventions are not identical (219). The 
forest-plot analyses in this study were presented as a visual summary for the reader 
rather than evidence of the effectiveness of the intervention. 
6.4.2 Study 2: PRO/CFS in bariatric surgery care – study protocol and design 
Study 2 presents the design of the PRO/CFS and is a study-protocol for evaluation of 
its feasibility. Consequently, the discussion will entail the planned studies. We are 
planning to conduct both quantitative and qualitative analyses in order to assess the 
feasibility of a PRO/CFS in BS care. 
Quantitative approach 
This is a prospective cohort study in which patients who have undergone BS are 
included at two outpatient clinics, situated in hospitals representing different levels of 
the Norwegian healthcare system (university hospital versus district general hospital). 
The strengths of this study are that the quantitative assessments of patient experiences 
will be performed at two outpatient clinics in two different health trusts. This 
increases the generalisability of the findings (220) and the included patients will 
likely be representative for the population, as the clinics are situated in different parts 
of the country. Furthermore, the intervention is implemented for all patients with an 
appointment at the outpatient clinics. This ensures that the healthcare professionals do 
not treat the patients participating in the study differently due to the intervention.  
For the quantitative assessment, the Generic Short Patient Experiences Questionnaire 
(GS-PEQ) was chosen. The GS-PEQ was developed to measure how appointments in 
outpatient clinics are organised, how the healthcare professionals communicate and 
whether the patients are able to influence the treatment. The strength of this 
questionnaire is that it is developed and validated for evaluations of services at 
Norwegian outpatient clinics (194). The questionnaire is to be used to evaluate the 
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feasibility of a PRO/CFS in follow-up care after BS. There will, however, be some 
uncertainties as to the findings because patient experiences may be affected by other 
factors than the PRO/CFS, such as whether or not the patients have appointments 
with healthcare professionals with the competence to deal with their challenges. 
Furthermore, the alliance with the healthcare professional may also affect patient 
responses.  
A limitation of this study is that the patients are not compared to patients in a control 
group. Non-experimental designs are weak in detecting causal relationships and, 
instead, are eligible for identifying correlations (220). Preferably, a randomised 
controlled trial should be carried out to test the effectiveness of the PRO/CFS. 
However, in this phase of the project, we aim to explore the feasibility of the 
PRO/CFS and further investigate the need for any adjustments to the PRO/CFS. 
Another limitation of this study may be a limited number of eligible participants, as 
more included patients would have provided more robust estimates of associations 
(221), but the power analyses show that a N=100 makes us able to detect a small 
effect size. 
Qualitative approach 
The qualitative assessments of patient and healthcare professional experiences are 
planned as focus group interviews at both outpatient clinics. For patient interviews, 
we are planning to have two focus groups at each outpatient clinic and, for healthcare 
professionals, we are planning one focus group with healthcare professionals from 
both outpatient clinics. Focus group methodology is suitable for gaining knowledge 
about the experiences with a PRO/CFS as an integrated part of the consultation, as 
the informants can expand on each other’s experiences (222). We have considered 
this topic as being not particularly sensitive for participants attending the interview, 
making this methodology appropriate. However, in conducting the interview, the 
facilitator needs to be aware that all participants may contribute their experiences 
(222). This is especially challenging in groups in which some participants are very 
talkative, whereas others are less talkative. The topic may also be more demanding to 
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elaborate on if one of the healthcare professionals has different experiences than the 
rest of the group or if the healthcare professional struggles to implement the PROMS 
in the clinical conversation due to technical or professional issues (222). In these 
cases, individual interviews would possibly generate richer findings.  
The strengths of the project are the involvement of patients and healthcare 
professionals in developing the interview guide and planned pilot interview, as these 
aspects may increase reflexivity (223). When analysing the data from the interviews, 
quotes from the participants will be included to ensure that the analyses are true to the 
informants’ perspectives and enable readers to assess the researchers’ interpretations 
of the findings. Other strengths of this project are that two researchers will conduct 
the analyses independently and discuss them with an experienced researcher in a 
workshop.  
Additional strengths of the study are the planning of four focus group interviews of 
patients at two outpatient clinics. This will probably increase the external validity of 
the findings and increase the information power (224). Only one focus group 
interview is planned for healthcare professionals due to a limited number hired at the 
two outpatient clinics and no quantitative assessment of their experiences is planned. 
This is a limitation of the study. 
A limitation of the project is that only one healthcare professional is using the 
PRO/CFS in one of the outpatient clinics and, consequently, there is only one eligible 
participant from that hospital. This will result in skewness in the representation of 
healthcare professionals in the two health trusts. Furthermore, the patients at one of 
the outpatient clinics meet with the same healthcare professional during all 
consultations, whereas they meet with different healthcare professionals at the other 
outpatient clinic. Consequently, patient experiences may be influenced by other 
aspects than the PRO/CFS itself. On the other hand, this might produce richer 
findings during the interviews. Another limitation is that the healthcare professional 
at one of the outpatient clinics has been a part of the implementation process and is 
physically situated closer to the researchers. This might affect how this healthcare 
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professional experiences the PRO/CFS or what information is shared by this person 
during the interviews. 
6.4.3 Study 3: Overall treatment satisfaction 
Patients operated with BS at Helse Førde Hospital Trust were prospectively included 
in the study and surveyed at their five-year follow-up consultation. Strengths of this 
strategy are that the patients are included before the course or effectiveness of the 
treatment is known and the information is collected in real time (220). All patients 
who were operated were invited to the study, increasing representativeness (220), 
however we lack information on 26% of the patients that attended the five-year 
consultation. A limitation of this study was a relatively limited number of 
participants. Higher numbers of included patients would have provided more robust 
findings (221). Furthermore, we did not contact the patients who did not attend the 
five-year consultation. Contacting these patients could have prevented a selection 
bias if the reason for these patients not attending the consultation was due to any 
particular reason. The study was conducted at only one centre, reducing the 
generalisability of the findings. Helse Førde Hospital Trust was one of the few 
centres operating patients with BS at the time and the patients came from all over 
Norway. This increases the geographical representativeness in the study, but the 
findings are affected by the organisation of the treatment and follow-up and the fact 
that the patients were operated by a limited number of surgeons.  
Analyses 
When assessing overall satisfaction with treatment outcomes, a single item was used. 
This might represent a limitation of the study. Single item ‘questionnaires’ may have 
lower validity, as multiple item questionnaires inhibit a possibility to clarify to the 
respondent the topic under investigation (225). On the other hand, using single items 
for assessing satisfaction is the most frequent measure in the studies that we 
identified. Another potential limitation of this item is that patient satisfaction may be 
affected by aspects not related to the BS itself. This may be events in the patient’s 
personal life or whether the patient and healthcare professional do not have a good 
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alliance. A limitation may thereby be that the patients were asked to rate their 
satisfaction without the possibility to elaborate on what they were dissatisfied or 
satisfied with. A systematic review assessing determinants of patient satisfaction 
found that the interprofessional relationship and organisational aspects were strong 
predictors of patient satisfaction (226). Patients may also avoid choosing the best or 
worst response (called end-aversion) and may tend to respond more positively than 
the actual reality (called positive skewness) (195, 227). In this study 82% of the 
patients reported to be very satisfied or satisfied, which is comparable to other 
studies, nevertheless represents a high level of satisfaction. 
Another limitation of this study was the lack of baseline measures for HRQOL, as 
these measures were implemented during the period of data collection and were 
therefore not available as a co-variate in the analyses. As reduced HRQOL at five 
years showed to be associated with a reporting of dissatisfaction, baseline measures 
on HRQOL would clearly have provided useful information as to whether baseline 
HRQOL was associated with satisfaction five years after BS. Future studies should 
explore this association. Furthermore, another important co-variate in this study 
would have been whether the patients experienced reflux at baseline and five years 
after surgery, as a study showed that the severity of gastroesophageal reflux disease at 
one year after LSG affected patient satisfaction (228). A limitation was also the lack 
of PROMS assessing patient mental health. This variable would possibly have added 
value to the analyses in light of the association between reduced mental HRQOL and 
satisfaction.  
6.4.4 Study 4: Validity of the Norse Feedback in patients undergoing BS 
 Patients with an appointment with a nurse at the bariatric surgery outpatient clinic 
were eligible for inclusion in the study. A strength of the study is the prospective 
inclusion of patients, as the data are collected in real time and recall bias is avoided. 
Furthermore, this enables measurements at several time points for each patient, 
thereby ensuring researchers whether the outcome appeared after the exposure (220). 
Another strength is that the intervention is standard for all patients in the outpatient 
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clinic, ensuring that the healthcare professional does not treat the included patients 
differently.  
Limitations of the study include the fact that only patients from one outpatient clinic 
have been included, who attended consultations with one outpatient nurse. This 
reduces the generalisability of the results, as the findings may have been different at 
other outpatient clinics. The NF therefore needs to be tested out in several outpatient 
clinics in order to establish the validity and reliability of the questionnaire in a 
population undergoing BS. Furthermore, the number of included patients could 
clearly have been higher, as the number of included patients is the lower limit of what 
is recommended when performing PCA. A higher number of patients would have 
made the findings more robust. 
Analyses  
In this study, we did not implement a gold standard questionnaire measuring mental 
health in this patient population. Such questionnaires could have been the Hospital 
Anxiety and Depression Scale (HADS) or the Beck Depression Inventory (BDI), 
which measure anxiety and depression. Implementing one of these questionnaires 
would have provided the opportunity to test criterion validity in this population of 
patients. The face validity of the NF is therefore only evaluated at the item level by 
the panel of patients, nurse and researchers who were involved in creating the 
PRO/CFS. 
The NF is a complex questionnaire that measures numerous aspects of mental health. 
Due to the manner in which the questionnaire is structured, some items were kept in 
the questionnaire despite poor psychometric properties because patients or therapists 
believed that the items added value to the consultation. As a result, the findings from 
the PCA analyses in the present study may be affected by choices made in the 
original development of the NF. The involvement of one of the developers of the 
original NF was valuable when assessing the psychometric properties in this 
population of patients.  
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Another limitation to testing the validity and reliability of the NF is that the 
questionnaires consist of scales that include two or three items. As the structure of the 
NF is already established in populations in mental health care, confirmatory factor 
analyses (CFA) could have been performed to test construct validity, as PCA is 
mainly suited for item reduction, whereas CFA is the preferred method for assessing 
correlations among variables (229). However, the scales with fewer than four items 
cannot be assessed with CFA. We therefore chose PCA as the analysis on all scales. 
The final structure of the NF in a population of patients undergoing bariatric surgery 
is not established. PCA analyses are thereby feasible for assessing the 
unidimensionality in the scales and a CFA can be performed once the final structure 
is established. CFA could, however, have been performed as sensitivity analyses to 
the PCA on scales with four or more items in this study. Furthermore, the lack of 
repeated measures on the patients made us unable to assess test-retest reliability 
(194). 
If a higher number of patients had been included in the study, item-response theory 
analyses could have been performed. The psychometric properties in the original 
version of the NF are evaluated using this approach and evaluating the properties of 
the NF between the patient populations would have been possible. Furthermore, due 
to the number of patients in the various time points of follow-up and that only about 
20% of patients included in the study were assessed at their pre-operative 
consultation, we were not able to test how the NF performs at different times during 
follow-up. The NF also needs to be explored in a population with obesity who have 
not been accepted for BS in order to evaluate whether the NF is a valid measure for 
patients with obesity in general. 
6.4.5  Validity and reliability 
Internal validity 
The internal validity of a study refers to the extent to which the measured outcome is 
a result of the independent variable or whether there are any competing variables that 
affect the outcome, also called confounding factors (230). Study 3 had a quasi-
 75 
experimental design that is especially vulnerable to confounding factors. This means 
that the dependent variable of overall treatment satisfaction could have been affected 
by variables that were not controlled for in the study. 
Patient-Reported Outcome Measures 
The validity and reliability of the PROMS included in the various studies in this 
thesis are generally high. The quality of the self-report instruments may clearly affect 
the findings in a study and so questionnaires found valid for the purpose should 
preferably be used (231).  In Study 3, the SF-36 and OP questionnaires were used, 
whereas the OP was used in Study 4. Both questionnaires have been found valid for 
research on patients who have undergone BS and are frequently used around the 
world. Furthermore, the item used to measure overall treatment satisfaction in Study 
3 has not been validated for a population of patients undergoing BS, but has been 
used in research on this population of patients. However, the validity and reliability 
of this item need to be explored. For the questionnaires incorporated in the PRO/CFS, 
the SF-36, OP, GSRS and WEL-SF have all been validated and found reliable for 
patients undergoing BS. The PROS has also been validated in a population of patients 
undergoing BS, but is still not commonly used in this patient population. The validity 
and reliability of the NF are discussed elsewhere in this thesis (section 6.4.4).  
6.5  Implications for practice and need for future exploration 
BS is a safe treatment and contributes to sustaining positive changes in physical 
comorbidities and HRQOL (232). At the same time, there are still many patients who 
do not have optimal outcomes of the treatment. Due to possible negative lifelong 
consequences of the treatment, there is a need to identify strategies to follow up 
patients in a way that is experienced as meaningful by the patients and that are 
effective for healthcare professionals. The care after BS currently suffers from high 
attrition rates and limited resources in healthcare services.  
In the four studies we carried out, we explored different aspects of BS and follow-up 
to this treatment. Study 1 showed that a digital PRO/CFS in the follow-up after BS is 
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a tool that may add value to clinical consultations. For patients, the PRO/CFS may 
strengthen their possibility to interact during their treatment. Patients are given the 
possibility to report their primary concerns and to learn about the broad range of 
topics that the healthcare professionals are interested in discussing during the 
consultation. For healthcare professionals, the PRO/CFS may be a tool to help them 
prepare for meeting the patient and to start by discussing those areas reported by the 
patient as challenging.  
In Study 1, we also demonstrated that the concept of feedback was poorly reported 
and perhaps also poorly understood in many of the included studies. This resulted in 
Study 2, in which we described how we developed and implemented a digital 
PRO/CFS in the follow-up care after BS and how we plan to evaluate the feasibility 
of this PRO/CFS.  
Study 3 showed that patient overall satisfaction with treatment outcomes was high in 
accordance with other studies. This underpins the belief that BS is a good treatment 
for many patients. This study is one of the few that assesses which variables may 
affect patient overall satisfaction, which is important when improving the healthcare 
services. The finding that BMI was an important factor was not surprising, as weight 
loss is the motivation for many patients undergoing BS. Furthermore, the finding that 
reduced mental HRQOL is associated with being dissatisfied or unsure is important 
and fits in well with the overall project in this thesis, in which both HRQOL and 
mental health are assessed routinely during clinical consultations. 
In Study 4, we report that the NF is a valid instrument for assessing mental health in 
patients after BS, but that it needs some adjustments in order to be more suited to this 
patient population. Using the NF in a PRO/CFS may satisfy patient requests for a 
regular assessment of mental health and may also be a tool for the healthcare 




There is no question that BS is a life-changing event that affects patients in positive 
and negative ways. These dramatic changes trigger a need for counselling and long-
term follow-up in many patients. However, it is necessary to establish which type of 
follow-up care is optimal in terms of content and frequency and this is an important 
topic for future research. Making the consultations relevant for patients would benefit 
both the patients and healthcare services. In a letter to the editor, Chiappetta, Stier 
and Weiner (233) proposed that structured follow-up programmes be developed. 
However, they also stated that the surgeons themselves do not have the capacity to 
perform this follow-up. The authors suggest enhancing general knowledge of obesity 
treatment in general physicians. In our view, the surgeon plays an important role in 
follow-up, but the follow-up should best be organised as a team of healthcare 
professionals that includes nurses, nutritionists and psychologists and strengthens the 
primary healthcare services. As research has shown that patients may experience a 
variety of negative side effects after surgery, this multi-professional approach is 
important in our opinion and also supported by a recent systematic review (234). 
Chiappetta et al. (233) further suggest applying the same follow-up period as for 
cancer patients, with a five-year follow-up period after BS. Research has shown that 
the self-reported HRQOL is relatively stable between five and 10–12 years after BS 
(108, 134). This may indicate that follow-up may be concluded at five years for 
patients with little to no negative side effects after the BS. Furthermore, one 
qualitative study found that, over time, some patients did not experience a need for 
follow-up, as they had adapted to their new life (116). Contrary to this, another 
qualitative study of patients five years after BS found that some patients still felt a 
need for guidance on what they should eat (235). This shows how challenging eating 
may be for some patients after BS. Future research should therefore investigate the 
safety of a shorter follow-up period than lifelong follow-up and which patients who 
would not be harmed by a shorter follow-up than today. 
With the increasing accessibility of PRO/CFS and telemedicine, further research 
should also investigate the feasibility and safety of remote follow-up as an alternative 
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to patients meeting at the outpatient clinic. A study investigating 30-day 
complications found that the complications were detected when the patients contacted 
the healthcare services and not during the scheduled consultations. The authors 
concluded that telemedicine was safe for follow-up in the first 30 days (236). A 
review article that assessed studies with remote interventions aimed at preventing 
weight regain, targeting maladaptive eating patterns and increasing physical activity 
found that remote interventions were feasible in the follow-up after BS (237). On the 
other hand, in other studies, patients emphasised the importance of in-person follow-
up (238) and the importance of a good relationship with the healthcare professional 
(116). A combination of in-person and remote follow-up after BS may be optimal, 
but future research should explore the feasibility of such follow-up. Remote 
consultations via telemedicine would probably be particularly feasible in rural areas 
where the patients must travel a long way to the outpatient clinic and for working 
patients, so they do not have to leave work to attend consultations. Whether this 
combination of follow-up visits will prevent attrition to consultations also warrants 
further exploration. 
The effectiveness of a PRO/CFS in BS care has not been established. A broad 
implementation of the PRO/CFS in the follow-up after BS is therefore not yet 
recommended. Implementing a PRO/CFS in follow-up care is costly, both 
economically and in terms of time. In a healthcare system short on both, the utility of 
a PRO/CFS needs to be explored in more detail before a broad implementation can be 
recommended. There are probably few negative consequences for the patients to 
attending consultations in which a PRO/CFS is an integral part. However, if the 
patient completes the PRO/CFS and the healthcare professional does not 
acknowledge this, this may affect the alliance between the patient and healthcare 
professional. Some patients have reported being disappointed when their efforts to 
complete the PRO/CFS was not valued by the healthcare professional (211). 
Furthermore, if implementing a PRO/CFS, the healthcare services should ensure 
sufficient training of the healthcare professionals in using the system, interpreting the 
findings and integrating them into the clinical consultation. The barriers reported by 
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healthcare professionals to using the PRO/CFS actively in treatment are technical 
challenges and limited time (239). These aspects need to be addressed during the 
implementation process. 
Implementing a digital PRO/CFS into healthcare services is resource demanding and 
therefore requires adequate planning of the implementation. Good planning clearly 
includes the involvement of service users, i.e. patients and healthcare professionals, 
in designing the PRO/CFS, appropriate questionnaires and how to implement the 
PRO/CFS in clinical practice. Such actions that enable the development of a 
PRO/CFS that is relevant for the patients and healthcare professionals will probably 




This thesis contributes knowledge that may inform the phenomenon of follow-up care 
of patients undergoing BS from different perspectives. The findings in the different 
studies have shown that the follow-up in this population needs to focus on far more 
than weight loss and nutrition, even though both are important. We have 
demonstrated that HRQOL and mental health are important additional aspects in the 
follow-up, assessments that until now have been too poorly implemented in follow-up 
care. 
Due to the complexity of the patient population and the diversity in outcomes the 
patients experience after BS, the follow-up care must be adapted to the individual 
patient. This applies to both the content of the consultations and length of follow-up. 
This is a challenging task in a healthcare system in which effectiveness and economy 
play an important role. New strategies to include both patient involvement and 
effectiveness when delivering good patient care are therefore pivotal and can only be 
achieved by including patients in the planning of new interventions. 
In Study 1, we conclude that a PRO/CFS may be feasible in the follow-up care for 
patients undergoing BS as a tool to include HRQOL and mental health assessments in 
the clinical consultation, but the feasibility of this tool clearly needs more 
exploration. In Study 2, we provide a detailed description of a digital PRO/CFS, 
which we find addresses the phenomena of feedback and enables the clinical 
conversation to be adapted to patient needs and expectations. We also provide a study 
protocol in which we describe the plans for evaluating the feasibility of the PRO/CFS 
at a BS outpatient clinic. In Study 3, we found that the mental component of HRQOL, 
obesity-specific HRQOL and BMI were associated with overall treatment satisfaction 
five years after BS. This demonstrates the importance of focusing on many aspects of 
the patient’s life in the clinical meeting with patients undergoing BS. In Study 4, we 
found that the NF is a promising tool for a PRO/CFS in the follow-up care to assess 
mental health in patients undergoing BS. 
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Summary
Patient-reported outcome monitoring with clinical feedback systems (PRO/CFS)
has been employed in many disease states to measure and improve health-related
quality of life (HRQOL). Exploring the role of PRO/CFS in treatment for obesity
may prove valuable. Systematic reviews were summarized to determine the effec-
tiveness of PRO/CFS on HRQOL in any disease area. Primary studies evaluating
the effect of PRO/CFS on HRQOL in treatment for obesity were also considered
for inclusion. Systematic searches were performed in The Cochrane Library,
PROSPERO, Epistemonikos, HTA, DARE, CINAHL, Medline, Embase,
PsycINFO, BMJ Clinical Evidence, PDQ-Evidence and PubPsych. Two reviewers
independently screened references until final inclusion and critically appraised
included reviews using PRISMA checklist. Five systematic reviews and no primary
studies met inclusion criteria. Although results were inconsistent, effectiveness of
PRO/CFS on HRQOL was demonstrated in some diseases/treatments
(e.g. psychiatric treatment; symptom burden in cancer treatment). No trials using
PRO/CFS in treatment for obesity were identified. In some trials, PRO/CFS was
not fully integrated into consultations, thereby PRO/CFS was not extensively stud-
ied. General effectiveness of PRO/CFS on HRQOL is inconclusive due to hetero-
geneous and statistically insignificant findings, and lack of stringency in
conceptualization and execution of PRO/CFS. There are no data relevant to treat-
ment for obesity. Future studies should use rigorous methodology to examine the
effectiveness of PRO/CFS in treatment for obesity.
Keywords: Clinical feedback systems, health-related quality of life, HRQOL,
obesity treatment, routine outcome monitoring, overview of systematic
reviews.
Introduction
Patient-reported outcome monitoring with clinical feed-
back systems (PRO/CFS) is a method of improving health
outcomes through the systematic collection of patient-
reported data, followed by provider feedback on those data
to patients (1). This procedure is referred to by different
terms in the literature, such as routine outcome monitoring
(ROM) with clinical feedback, progress monitoring or
measurement-based care. Patient-reported outcome mea-
sures (PROMs) are acknowledged as valuable for inform-
ing optimal treatment and follow-up for patients (2–4).
Two recently published articles (1, 5) call for the
© 2018 World Obesity Federation Clinical Obesity
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importance of monitoring patient-reported outcomes over
time and incorporating clinical feedback, which consists of
sharing self-reported outcomes with the patient, to direct
clinical consultations toward relevant domains (6–8). A
clinical feedback system collects patient-reported outcomes
before, during, and after treatment, and is easily implemen-
ted using an electronic device, such as a tablet, that displays
visual data for both patient and the health professional (5).
Traditionally, the process of using patient-reported out-
comes to guide patient care has typically been carried out
in three discrete steps. First, the patient completes a paper
questionnaire, then the healthcare provider reviews the
results, and finally he/she shares the findings with the
patient during consultation. New technologies, such as
PRO/CFS, have the potential for making patient-reported
outcomes more immediately accessible to the healthcare
provider, and therefore more easily integrated into the
patient’s treatment (1).
PRO/CFS has been employed in many disease states to
optimize treatment and improve health outcomes, includ-
ing health-related quality of life (HRQOL). This review of
systematic reviews examines the effectiveness of PRO/CFS
on HRQOL in any disease area, with particular emphasis
on any studies relevant to treatment for obesity and/or bar-
iatric surgery.
HRQOL has been defined as ‘…a multidimensional con-
struct of the individual’s perception of the impact of an ill-
ness, capturing the physical, psychological, and social
dimensions of health’ (9). HRQOL impairments are com-
mon among patients with severe obesity (10, 11), and for a
majority of patients sustained improvements in HRQOL
occur after bariatric surgery (9), but not always after other
treatments for obesity (11). A possible novel method to
improve outcomes in obesity treatment could be to assess
HRQOL on a routine basis and use this information in
clinical conversations with patients.
Why might consultations informed by patient feedback,
inherent in PRO/CFS, lead to better outcomes in treatment
for obesity? Feedback Intervention Theory (FIT) (5) aims to
understand and improve these practices. FIT, developed from
theories such as control theory and goal setting theory,
argues that the feedback needs to be related to patient goals
or standards in order to affect behaviour. A focus on the gap
between the current situation and an established standard is
thus considered facilitative of behavioural change. FIT theo-
rizes that behavioural change as well as an increased sense of
control may be accomplished by changing a patient’s locus
of attention through feedback interventions (12).
PRO/CFS has been used more frequently in mental
health settings to measure psychological domains than in
somatic health care settings, and the most commonly used
tools fall into the three broad categories: disorder-specific,
unidimensional and multidimensional. While disorder-
specific tools target one specific category of suffering (such
as depression), unidimensional measures often target the
global construct of burden-of-suffering, and multidimen-
sional tools monitor patterns in symptoms and functioning.
A tension between unidimensional and multidimensional
measures has been noted in the research literature, fol-
lowed by recommendations to use both general (unidimen-
sional or disorder-specific) and multidimensional measures
in PRO/CFS strategies (13). McAleavey et al. (13) further
suggest that particularly significant items should be
brought to the patients’ attention and discussed in order to
assess their experience relative to their report.
The psychological aspects of HRQOL are of particular
interest after bariatric surgery, with a recently published
study showing that, despite significant improvements in psy-
chological HRQOL 10 years after bariatric surgery, as much
as 43% of patients reported low psychological HRQOL,
compared to 16% in the general population (14). These
findings are supported by other studies of long-term follow-
up after bariatric surgery (15–17). Such post-operative chal-
lenges do not seem to only relate to poor weight loss (18),
but also to weight-regain, malnutrition or worsening of
comorbid diseases (17, 19). The concepts of mental health
and psychological HRQOL are different constructs from
each other; however, they seem to be related as studies have
shown that the mental component summary in the question-
naire SF-36 could be used to screen for depressive symptoms
in various patient populations (20, 21).
A recent meta-analysis by Dawes et al. (22) shows that
mental health issues, such as depression and anxiety, are
common among patients seeking bariatric surgery. Another
study shows a higher risk for new-onset depression and
anxiety after bariatric surgery, when compared to patients
undergoing medical treatment for obesity (23). Further-
more, a higher incidence of suicide has been found in
patients after bariatric surgery, compared to both persons
with obesity and healthy controls (24). Studies also suggest
a higher prevalence of alcohol-use disorder after bariatric
surgery compared to baseline measures and matched con-
trols (25, 26). Combined, these findings highlight a need to
develop better strategies for mental health follow-ups of
patients after bariatric surgery (16, 27–29).
Our aims with this overview of systematic reviews were
threefold: (i) to investigate the effectiveness of PRO/CFS on
patients’ HRQOL, regardless of diagnosis or treatment;
(ii) since our main interest is treatment for obesity, to inves-
tigate whether PRO/CFS has been tested in treatment for
obesity and (iii) to discuss the rationales and possibilities
for using PRO/CFS in this setting.
Methods
A published protocol for this review can be found at the
Centre for Reviews and Dissemination with registration
number CRD42016047349.
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Inclusion and exclusion criteria
We included systematic reviews summarizing evidence on
the effectiveness of PRO/CFS on HRQOL in any patient
population, e.g., treatment for obesity, psychiatric treat-
ment or treatment for cancer. Building on the first search,
we also searched for systematic reviews or primary studies
on the effectiveness of PRO/CFS on HRQOL in treatment
for obesity. Inclusion criteria are presented in Table 1.
Identification of studies
Systematic searches were performed in The Cochrane Cen-
tral Register of registered trials, PROSPERO, Epistemoni-
kos, Health Technology Assessment, DARE, CINAHL,
Medline, Embase, PsycINFO, BMJ Clinical Evidence, PDQ-
Evidence and PubPsych. Search words such as routine out-
come monitoring, clinical feedback, PROM, HRQOL and
quality of life, among others were used. See S1 for search
strategy. We screened reference lists of relevant articles for
eligible studies. We applied the filters for systematic reviews,
maximum sensitivity for all database searches. As our field
of interest is obesity, we made a search limited to obesity to
identify primary trials that used this approach in treatment
for obesity. No restrictions on language or time of publica-
tion were applied to any of the searches. We also searched
clinicaltrial.gov and Google Scholar for ongoing or unpub-
lished trials, using the text words ‘routine outcome monitor-
ing’ and ‘clinical feedback.’ Moreover, two experts in the
field were contacted for identification of relevant studies. All
references from the systematic searches were imported to a
reference manager system (EndNote X8), and duplicates
were removed before the screening process.
Selection of studies
Two authors (PAH, SH) independently screened all titles
and abstracts for articles in full text. Subsequently, two
authors (PAH, AA) independently read all full-text articles,
and decided on final inclusion or exclusion. Any disagree-
ment in all stages was resolved through discussions. A third
author (JRA) was available for consultation in case of
uncertainties.
Quality assessment
We assessed the quality of the selected systematic reviews
using the PRISMA checklist (30) and a checklist from the
Norwegian Knowledge Centre for the Health Services (31).
Moderate quality or better systematic reviews were
included in our analysis.
Data extraction and analysis
One author (PAH) extracted data from the included
reviews, and another author (JRA) quality-checked the
extraction. We planned for a meta-analysis, if appropriate,
or a descriptive analysis of the reviews. We extracted the
following data: author(s), year, country, intervention, study
design, outcome(s), included trials in total (n), included tri-
als eligible for our review (n), included patients in total (n),
included patients eligible for our review (n), quality assess-
ment and results (inferential or descriptive statistics).
None of the included reviews reported statistics in a way
that enabled us to perform a meta-analysis, with results
presented as text or P-values with 95% confidence intervals
(CIs). We therefore decided to perform a narrative analysis
of the reviews. We furthermore extracted statistical data
from 11 out of 16 single trials included in the reviews in
order to perform a random effects meta-analysis with stan-
dardized mean difference (SMD) and 95% CI. HRQOL
had to be a primary or secondary outcome in the single tri-
als, and mean with standard deviation (SD) had to be
included in the manuscript to enable us to perform a
forest-plot analysis. We extracted mean as the difference
between baseline and the last measurement point; and we
extracted SD. We used the software Review Manager 5.3
(The Nordic Cochrane Centre, The Cochrane Collabora-
tion, Copenhagen, Denmark) (32) to analyse the extracted
statistics. We extracted global HRQOL where this was pre-
sented, psychological HRQOL from trials in psychiatry,
and physical HRQOL in trials from cancer care.
Results
Inclusion of studies
We completed database searches on 16 August 2016, with
an updated search on 08 May 2018. We identified 1459
titles from database searches, screening of reference lists and
contact with experts. We screened 1311 potentially relevant
studies for inclusion after duplicates were removed, and
35 articles were chosen for full-text-reading. One article
Table 1 Inclusion criteria for systematic reviews and primary studies of
HRQOL in PRO/CFS
Systematic reviews
Evaluated PRO/CFS in any disease area
HRQOL as primary or secondary outcome
Included patients aged 18 and older
Review determined to be good to moderate quality
Primary studies in treatment for obesity
Evaluated PRO/CFS in treatment for obesity
HRQOL as primary or secondary outcome
Included patients aged 18 and older
HRQOL, health-related quality of life; PRO/CFS, patient-reported outcome
monitoring with clinical feedback systems.
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could not be obtained in full-text copy, making 34 full-text
articles available for possible inclusion. Main reasons for
ineligibility were irrelevant outcome measures, interventions
not aimed at PRO/CFS, or study not being a systematic
review. Ultimately, we included five systematic reviews in
this overview. Excluded articles are presented in S2. For the
screening process, see Fig. 1. Moreover, from the searches
limited to treatment for obesity, 259 titles were identified
after duplicate removal. These titles were combed for eligi-
ble systematic reviews and primary trials by three authors
(PAH, SH, AA). The search for trials in treatment for obe-
sity revealed no systematic reviews, only one trial having
used clinical feedback in a population with obesity, and two
studies having used this approach in a population with obe-
sity and binge eating disorder or in a community popula-
tion. None of these three trials met our inclusion criteria.
Quality of included reviews
Two reviews (33, 34) were assessed as being of good quality
due to a comprehensive literature search in relevant data-
bases, contact with experts in the field, and searches for grey
literature. In addition, two or more authors had screened
references, decided upon inclusion, and analysed the data.
Two reviews (35, 36) were assessed as being of moderate
to good quality. The Howell et al. (35) review neither
noted whether included studies had been critically
appraised nor whether experts within the relevant field had
been contacted. The Li et al. (36) review lacked methodo-
logical details concerning the independence of reviewers in
the processes of screening, inclusion and analysis.
Finally, one review (37) was assessed as being of moder-
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Figure 1 Screening and selection of studies. [Colour figure can be viewed at wileyonlinelibrary.com]
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were provided regarding whether any other person had
been involved in the reviewing process.
The quality grading for each review is presented in
Table 2.
Description of included reviews
Characteristics of included reviews are presented in
Table 2.
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The Cochrane review by Kendrick et al. (33) included
17 randomized controlled trials (RCTs) from psychother-
apy settings, all evaluating the effect of feedback of
PROMs on improvement in symptom scores, HRQOL,
number of adverse events, changes in the management of
mental health, social functioning and costs. Only two of
the included trials were eligible for our review, collectively
comprising 2247 patients in psychotherapy. Kendrick et al.
(33) performed a narrative analysis on these two trials and
found no statistical difference in HRQOL between inter-
vention and control groups in either trial. However, the
results tended to favour the feedback-receiving group, with
a slightly higher score in mental HRQOL. The included tri-
als were assessed by the primary authors as having moder-
ate to high risks of bias, making their findings inconclusive.
Howell et al. (35) made a comprehensive literature
search and included 30 trials that all investigated the effec-
tiveness of PROMs at the patient, provider and system
levels. The study-population was patients in cancer treat-
ment. Five of the included trials reported patients’ HRQOL
outcomes and were thus eligible for inclusion in the present
review. Four of these trials were RCTs and one was a
sequential controlled trial. The studies included a total of
838 patients, ranging from 48 to 219. One RCT found a
significant effect of PROMs and feedback on patients’
HRQOL, while the remaining four found no statistical dif-
ference between intervention and control groups. The main
conclusion in the review was that the use of PROMs and
feedback in oncology treatment improves communication
between patient and therapist, making HRQOL-issue-
related discussions more frequent. However, robust evi-
dence that the use of PROM and feedback in oncology
treatment improves patients’ HRQOL is lacking.
Kotronoulas et al. (34) included randomized and non-
RCTs assessing the effects of using PROMs in cancer treat-
ment. A comprehensive literature search revealed 24 pri-
mary trials, of which 10 were eligible for our review
(9 RCTs, 1 longitudinal sequential two-arm cohort; 1180
patients in total). A descriptive analysis found that two
RCTs showed a statistically significant difference in favour
of the intervention, seven trials found no statistical differ-
ences between groups, and one RCT reported that the
intervention group had significantly lower quality of life
scores. Most of the included trials had unclear to high risks
of bias in several domains, whereas two of the RCTs had
low risk of bias in most domains.
The systematic review by Li et al. (36) evaluated sev-
eral outcomes in cancer treatment, whereas only 1 RCT
of 33 included trials evaluated effects of feedback of
PROMs on patients’ HRQOL. The relevant trial
included 286 patients with a 6-month follow-up. The
authors found a statistically significant effect of routine
collection of PROM and feedback, when compared to a
control group not receiving HRQOL assessment
(P = 0.006). However, there was no difference between a
group receiving HRQOL-assessment-related feedback
and one being HRQOL assessed but not receiving feed-
back of the assessment (P = 0.80). The authors found
that the positive effects were linked to the patient being
assessed, and not whether the information from the indi-
vidual patient was fed back to the therapist or not. The
authors of the review assessed the quality of included
trial as moderate.
Alsaleh (37) included RCTs measuring quality of life in
patients undergoing cancer treatment. Six trials with vary-
ing designs were included: cluster randomisation (n = 1),
sequence randomization (n = 1), crossover (n = 1) and par-
allel groups (n = 3). All included studies were eligible for
our review. The number of included patients ranged from
57 to 510, with a total of 1632 patients. Alsaleh (37) did
not perform a meta-analysis due to the heterogeneity of the
included trials. Five of the included trials used the EORTC
QLQ-C30 questionnaire to measure the quality of life. The
quality of included studies were assessed using GRADE,
with two studies being of very low, two of low, and two of
moderate quality. The main reasons for these low ratings
were issues with randomization and allocation conceal-
ment, blinding of patients and healthcare providers, as well
as high dropout rates that were not accounted for. The
results of the included trials varied from positive (n = 3), to
no (n = 1), or even negative (n = 2) intervention effect. The
main conclusion of Alsaleh (37) was that there is lack of
evidence that routine administration of quality of life ques-
tionnaires improves patients’ quality of life.
None of the included systematic reviews reported statis-
tics from the primary trials in a way that enabled us to
make a statistical summary for the outcome HRQOL. We
therefore accessed the primary trials (n = 16) included in
the reviews to extract statistical data if available (references
to primary trials are presented in S3). Eleven of the 16 pri-
mary trials presented results as mean and SD in a way that
they could be extracted and inserted in a forest plot. Fig. 2
is a forest plot of all 16 trials.
We further performed meta-analyses on subgroups of
primary trials, depending on whether feedback to the
patient was given or not (Fig. 3). These meta-analyses show
no statistically significant differences between experimental
and control groups. However, a possible small effect was
observed favouring the experimental group in the subgroup
where feedback was given (SMD: −0.03, 95% CI: −0.13 to
0.07), and no difference (SMD: −0.01, 95% CI: −0.42 to
0.41) in trials where feedback was not given.
We furthermore performed a subgroup analysis in three
trials where the HRQOL data were collected through inter-
views, and feedback was given to either patient or health
worker. In this analysis there was a small but again statisti-
cally insignificant trend favouring the experimental group
(SMD: −0.06, 95% CI: −0.29 to 0.17).
Clinical Obesity © 2018 World Obesity Federation
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In all three subgroup analyses, however, there was sta-
tistical heterogeneity in results, with some trials reporting
results in favour of the experimental group and others in
favour of the control group. One should also be aware of
a substantial clinical heterogeneity in the interventions
used in the primary trials, comprising computer-based
outcome monitoring over time in some and a single
phone call in others. The ways in which PROM data are
used were also quite diverse, with some trials using data
in a structured manner in consultations, whereas others
used it more randomly. This makes the comparisons
highly unsure, and these meta-analyses can thus not be
*
Mean presented as mean difference from baseline to last measuring point 
SD = Standard deviation 
ROM = Routine outcome monitoring 
Statistical data for HRQOL not reported appropriate for extraction as mean and SD
Figure 2 Forest plot primary trials included in systematic reviews. [Colour figure can be viewed at wileyonlinelibrary.com]
Mean presented as mean difference from baseline to last measuring point 
SD = Standard deviation 
PRO = Patient Reported Outcomes 
Figure 3 Meta-analysis effect of routine outcome monitoring and feedback on patients HRQOL. [Colour figure can be viewed at wileyonlinelibrary.com]
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used as evidence either for or against the effectiveness of
the interventions.
PRO/CFS in studies from obesity treatment
In our search for trials in treatment for obesity, we identi-
fied only one RCT evaluating the PRO/CFS approach,
whereas another RCT used PRO/CFS in a population with
binge-eating disorder.
In an RCT, De Niet et al. (38) included 141 children
undergoing treatment for obesity. The intervention con-
sisted of a short message service and personalized feedback
within an already-established obesity-treatment pro-
gramme. After completing the treatment programme, the
children had lowed BMIs and better HRQOLs, but no sta-
tistically significant differences between intervention and
control groups were found; a positive trend, however,
favouring the intervention group was detected. Another
RCT conducted by de Zwaan et al. (39) investigated an
internet-based guided self-help programme for patients
with obesity and binge-eating disorder. In the intervention
group, the coach had access to PROMs and gave feedback
through e-mail and one monthly face-to-face contact over
4 months. The control group received cognitive-
behavioural therapy (CBT). At 6 months follow-up the pri-
mary outcome ‘days with binge-eating disorder symptoms’,
were significantly lower in the CBT group, whereas
HRQOL did not differ between the two groups. At
1.5 years, there were no differences between the groups in
neither of the outcomes. We found no primary trials inves-
tigating PRO/CFS in treatment for adults with obesity.
Discussion
In this review of PRO/CFS, three out of five included
reviews concluded with a benefit of using this methodology
to increase patients’ HRQOL, whereas the remaining two
concluded that the evidence was inconsistent. Results from
the reviews included in our review are thereby inconclusive.
Heterogeneity in results was apparent in the reported trials,
varying from an effect in favour of the intervention (n = 8),
no statistical differences between intervention and control
group (n = 14), to lower quality of life scores in the inter-
vention group (n = 3). One of the primary trials reporting
a significant effect of PRO/CFS is included in four of the
five systematic reviews (34–36). Five of the primary trials
reporting no significant difference were included in two of
the five systematic reviews, and finally one of the trials
reporting negative findings was included in two of the five
systematic reviews (34, 37). Only one review (36) con-
cluded a significant positive effect of PRO/CFS on
HRQOL, but they only found one primary trial assessing
PROM on patients’ HRQOL. The authors of the other sys-
tematic reviews noted a lack of robust evidence for this
methodology due to heterogeneity in results and low qual-
ity of the evidence due to a high risk of bias. In our analy-
sis, we found little correspondence between results in the
primary trials and the risk of bias in the same trials.
In our forest-plot analysis of the primary trials (Fig. 2),
this review confirms the heterogeneity in statistical results
reported in the reviews, but we found no statistically signif-
icant differences between experimental and control groups
in any of the trials, contrary to the conclusions reported in
the included reviews. The reason for this may be that we
report mean differences in score between baseline and last
observation in both groups, whereas the reviews may have
reported group differences in last observations. The reviews
could also have summarized different items from the ques-
tionnaires than we have. A level of uncertainty thus
remains, especially since the included reviews vary in their
reporting of statistical analyses and findings. Our analysis
of primary trials shows a small, non-significant trend
favouring the experimental groups when feedback was
given to both patient and health professional.
Two of the included reviews (34, 36), reporting the same
primary trial, state that the results of the intervention seem
to be influenced by whether HRQOL is discussed during
the consultation or not. This suggests a significant variation
in how the concept of routine outcomes measurement and
clinical feedback is understood and employed in clinical
settings. This variation may lead systematic reviews to
compare significantly different concepts under the same
heading. In our opinion, this underlines the importance of
providing feedback of PROM results to both the patient
and the healthcare provider and using the patient response
as an integral part of the consultation. This notion is sup-
ported by the theory developed by Kluger and DeNisi (12),
which emphasizes that the patient-reported information
has to be used actively in the meeting with the patient to
have a meaningful effect for him or her.
Similarly, in our analysis of the primary trials, we found
substantial diversity in how the PRO results were used in
consultations. As such, some of the trials might not have
studied the actual phenomenon of PRO/CFS, given that the
results of routine monitoring were not integrated into con-
sultations and hence not activated within clinical conversa-
tion; or, in other words, given that this significant key
element of FIT (12) was not met. One hypothesis is that
this partial use might have affected the results on the effec-
tiveness of PRO/CFS. In turn, and from a research point of
view, this calls for further conceptual work to establish
what the necessary core components of PRO/CFS are, fol-
lowed by a standardized protocol for what clinical feed-
back interventions should entail in practice.
Another interesting finding from the reviews—despite
not being the focus of our overview—is that the use of
PRO/CFS shows a significantly positive effect on the expe-
rienced quality or usefulness of the communication
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between patient and therapist (35). These findings have been
documented in other reviews focusing on patient or organi-
zational outcomes (40, 41). Furthermore, two reviews stated
that HRQOL was discussed more often during consultations
when PROM results were collected and fed back to thera-
pist and patient (34, 35), thus establishing a basis for the
utility of this practice. It seems that this type of information
is important to patients and facilitates discussions concern-
ing worries that may not be brought up by patients other-
wise (42). Furthermore, a qualitative trial on patients in
psychiatric treatment found that open conversation and col-
laboration were considered important features in a clinical
feedback system for patients and therapists alike (43).
One reason for the primary-trial researchers not being
able to detect a significantly positive effect of PRO/CFS as
an intervention may be related to participant characteris-
tics. Recent reviews have shown that the effect of ROM in
mental health settings is influenced by patient as well as
provider characteristics. If patients are doing well in treat-
ment, effects of PRO/CFS are small to minimal. However,
if patients are responding poorly to psychiatric treatment,
the use of PRO/CFS has been shown to yield clinically
important effects on treatment outcome (1, 5, 44, 45). The
positive effect on poor responders might be a result of early
discovery of treatment effect or failure, as shown in a liter-
ature review by Fortney et al. (46). We therefore hypothe-
size that if a sub-group analysis had been performed on
patients not doing well in therapy, researchers might have
been able to detect significant effects of PRO/CFS on out-
come HRQOL, just as Gondek et al. (44) found in a sub-
group analysis on the outcome treatment effectiveness.
Taken together, these findings may be applicable to obesity
treatment, as the follow-up of patients after bariatric sur-
gery to a large degree fails to help those patients showing
no improvement or even decline in HRQOL after bariatric
surgery (11, 15–17).
Assuming that PRO/CFS is more useful for patients not
responding optimally to treatment, one may consider
whether this type of intervention should be used routinely,
i.e., for all patients. When offered to all patients PRO/CFS
provides the ability to detect early signs of treatment fail-
ure, and allows for revised treatment plans with improved
outcomes (47). Identifying patients at risk of failure is chal-
lenging (46), making conditional administration of
PRO/CFS unfeasible. In addition, multidimensional mea-
sures such as PRO/CFS have an impressive scope, as they
may indicate worsening in specific HRQOL-related subdo-
mains that unidimensional measures regularly miss.
The reviews included in this overview summarized evi-
dence from patients with cancer (n = 4) and patients in psy-
chiatric treatment (n = 1). We found no difference in
effectiveness of the intervention between these populations.
In the process of conducting the current review, we identi-
fied several systematic reviews assessing PRO/CFS in
diabetes care, cardiology, rheumatology and other patient
populations; however, as these reviews focused on symp-
tomatic, activity-related, or organizational outcomes, they
were not eligible for inclusion. Several of these reviews,
e.g., in psychiatric treatment, found that PRO/CFS is effec-
tive for positive developments in psychiatric conditions and
symptom burden. Furthermore, several of the reviews
found that communication between patient and therapist
was positively affected by the intervention.
Although our results carry some uncertainty, our find-
ings may be clinically important for patients in obesity
treatment, as impaired HRQOL obviously affects daily liv-
ing. The importance of PROMs in clinical consultations
after bariatric surgery has been highlighted in a study
investigating both patients’ and health professionals’ views
on the importance of outcomes after surgery (48). These
authors found a discrepancy between patients and profes-
sionals in terms of which outcomes were rated as impor-
tant, e.g., quality of life, which was rated as more
important by patients than health professionals. Based on
the summarized research (22), a valid expectation when
meeting patients with obesity would be that a significant
portion of patients suffers from mental health distress of
some sort. Additionally, although unidimensional instru-
ments (i.e. those targeting the global construct of burden-
of-suffering) may indicate patients’ distress, they have spec-
ificity limitations unless clinicians take time to provide
feedback at the item level. In contrast, a multidimensional
instrument might indicate elevations on multiple subscales
but fail to capture the overall distress of the patient. Thus,
the type of instrument may inadvertently influence the
quality of feedback and its potential impact.
Our research group is currently implementing clinical
feedback systems in follow-up after bariatric surgery, men-
tal health treatment and patients operated with stoma. The
system we use in treatment for obesity incorporates mea-
sures on areas frequently affecting the patients’ life after
surgery, including measures of mental-health, alcohol
habits, HRQOL, eating habits and side-effects of the surgi-
cal procedure.
Despite considerable use of patient-reported outcomes in
research on obesity treatment, particularly bariatric surgery
(11), only few studies are using PROMs in actual clinical
consultations for obesity treatment (38, 39). The focus on
success after surgery has largely been on clinical parameters
such as weight loss, remission of comorbid diseases or
complications (49), whereas recent guidelines recommend
that follow-up include psychological variables and
HRQOL (29). Busetto et al. (29), also state that there prob-
ably is an under-recognition of mental health disorders
before and after bariatric surgery. PRO/CFS can in our
opinion facilitate the use of this valuable information in
treatment for obesity. Another explanation for PROMs
being rarely applied in the obesity field is that patients have
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been reporting on paper questionnaires, and healthcare
providers have had to interpret results from a paper for-
mat. The new approach with electronic reporting of
PROMs will make results easier to interpret as the technol-
ogy creates a visual summary report, and thereby makes
this information more accessible for use in a clinical setting
in obesity treatment follow-up.
There are several reasons that patients might prefer per-
sonalized follow-ups such as ROM and clinical feedback.
A survey has shown that patients who have undergone bar-
iatric surgery are interested in receiving interventions that
may help them to maintain their weight (50). The majority
of the 154 patients in the survey preferred in-person treat-
ment, with 70% also feeling that interventions could be at
least partly internet-based (50). Furthermore, a qualitative
study investigating the views of both patients and practi-
tioners regarding the post-bariatric surgery experience
found that patients reported unmet needs, most specifically,
psychological aftercare to facilitate adjustment following
drastic weight loss and excess skin, acceptance of their
non-obese self and perceived stigma (49).
Despite our inconclusive findings, both patient dissatis-
faction and procedural issues with the current process of
using PROs suggest the need to explore novel technologies,
such as PRO/CFS. These systems have been proven effec-
tive in symptom management in patients with psychiatric
diseases (1, 33), and may be useful for patients seeking
treatment for obesity, given their high prevalence of psy-
chological issues (22). Such a system collects patient-
reported outcomes before, during and after treatment, and
is easily implemented using an electronic device, such as a
tablet, that displays visual data for both patient and health-
care provider (5). A recent review of qualitative studies of
PRO/CFS in mental health services shows that patients
value this technology as long as it captures the complexity
of challenges and facilitates collaborative conversation with
the healthcare provider (51). This more patient-centred
technology has the potential to empower healthcare pro-
viders to immediately integrate patient-reported data into
consultations, thereby more effectively engaging patients.
Strengths and limitations
For the present paper, we conducted a thorough literature
search in relevant databases, on relevant web pages, and
searched for grey literature. Reference lists of included
reviews and other relevant articles have also been screened.
Furthermore, all critical stages of the review process have
been undertaken by at least two authors in accordance
with the Cochrane handbook for systematic reviews (52).
We have also contacted experts in the field for supplemen-
tal information. This makes us confident that we followed
guidelines for ensuring good quality in reviews (53).
A weakness to any overview of systematic reviews is that
the findings extracted from included literature are influ-
enced by the thoroughness of the original reviews (54, 55).
This is why we assessed the quality of the included reviews
and only included those deemed moderate to good. For
quality assessment, we have used a checklist developed by
the Norwegian Knowledge Centre for the Health Services
(31). This checklist is based on the criteria developed by
Moher et al. (30) for reporting systematic reviews. Further-
more, we have used the PRISMA checklist (30) as a supple-
ment to guide our quality assessment. Together, these tools
ensure a rigid quality assessment, making our analyses
more trustworthy. Regardless, a small degree of uncer-
tainty remains, as we have no means for establishing
whether all relevant primary trials were identified and
included in our source papers.
A weakness of some of the included reviews is the
absence of statistics from the primary trials. Two of the
included reviews presented only P-values, and three others
simply stated that findings were significantly in favour of
the experimental group, or that no significant difference
between groups were found. This lack of reported statistics
was in some cases due to the way in which the primary tri-
als reported their statistics. We consider this a limitation of
the included reviews.
We originally planned to conduct a meta-analysis of
included reviews, but due to the aforementioned lack of
reported statistics and the absence of any meta-analyses
within out subject area, we had to resort to descriptive ana-
lyses. Nevertheless, we managed to identify the primary tri-
als included in the five best-quality systematic reviews,
extract the data, and present results in a forest plot. We
must, however, stress the uncertainties pertaining to this
venture, given the significant clinical heterogeneity in the
primary trials (56).
Another challenge for our overview is that the reviewers
in the included reviews used different tools for evaluating
the quality of included trials. Some used the Cochrane Col-
laboration’s Risk-of-Bias tool, and one used criteria devel-
oped by the Effective Public Health Practice Project. This
makes any quality comparison of the included primary tri-
als in the reviews challenging (54), and it makes our over-
view somewhat less robust.
Implications for future feedback interventions and
research
We have documented a need to establish a common defini-
tion of the concept PRO/CFS, and based on the literature
on PRO/CFS, we propose the following: (i) patient-
reported outcomes should be routinely collected before all
consultations, preferably via electronic devices, (ii) both
patient and clinician should have the report available dur-
ing the consultation and (iii) patient-reported findings and
Clinical Obesity © 2018 World Obesity Federation
10 Overview of effect of CFSs on HRQOL P. A. Hegland et al. clinical obesity
their implications should be discussed with the patient dur-
ing the consultation.
The characteristics of feedback systems should be stan-
dardized to ensure efficiency in patient treatment. First, the
specific measures used to monitor patient outcomes have to
be relevant for the patient population, and the question-
naires should be validated for the specific population and
setting. Second, the presentation of the outcome measures
has to be easily accessible for the healthcare professional
and the patient, enabling uniform and unequivocal under-
standing and easy analysis. Third, the results of outcome
monitoring should be used continuously in a structured
fashion in the consultation, thus facilitating the addressing
of areas of struggle and the development of plans of action.
Finally, health professionals need thorough training in
using the feedback system, analysing results, and respond-
ing to specific problem areas. This should all be included in
a system that is designed to meet the needs of the patient.
A major implication of the present overview is that the
lack of stringency in how PRO/CFS technology is concep-
tualized and carried out yields difficulties when comparing
results. A clear definition of the practice of PRO/CFS
should hence be sought. As a working hypothesis for future
research, we suggest that any PRO/CFS should be found
on three constituent themes as described above.
Our included reviews carry no clear conclusions as to
whether PRO/CFS is an effective strategy for enhancing
patients’ HRQOL. However, some reviewers have noted
that this type of intervention is positively related to out-
comes (e.g. treatment effectiveness and patient–therapist
communication), which, in our opinion and in turn, should
be positively related to HRQOL. However, it is clear that
more research on the topic is needed.
Future trials should have a robust quantitative design to
be able to detect differences between groups, and follow
design rules strictly. The intervention should be pilot- or
feasibility tested (57) to ensure elimination of potential
weaknesses that may ultimately influence results. Future
trials should also perform sub-group analyses, paying spe-
cial attention to groups of patients not responding well to
therapy; these patients seem most likely to respond posi-
tively to PRO/CFS treatment. Finally, it would be interest-
ing to investigate the potential efficiency of PRO/CFS in the
context of surgical as well as non-surgical treatment for
obesity. Complimentary to the above, studies employing
solid qualitative designs would provide valuable informa-
tion into patients’ experiences of consultations that employ
PRO/CFS methods.
Conclusion
Although three out of the five included reviews indicated
that PRO/CFS was positively related to patients’ HRQOL,
the remaining two concluded that the evidence was
inconsistent. A lack of stringency in conceptualization and
execution of PRO/CFS might have contributed to these
findings. Future studies should use rigorous methodology
to determine the effectiveness of PRO/CFS on HRQOL in
treatment for obesity. For successful application of
PRO/CFS we have proposed the following: (i) patient-
reported outcomes should be routinely collected before
consultations, (ii) both patient and clinician should have
the report available during the consultation and
(iii) patient-reported findings and their implications should
be discussed with the patient during the consultation.
Because new technologies, such as PRO/CFS, have the
potential for making patient-reported outcomes more
immediately accessible to the healthcare provider and are
therefore more easily integrated into the patient’s treat-
ment, they may be of benefit in the treatment of chronic,
refractory diseases such as obesity. We are encouraged by
the documented effectiveness of this technology in symp-
tom management in patients with psychiatric disease. The
high prevalence of psychiatric comorbid conditions in per-
sons with obesity also suggests that PRO/CFS may be of
utility in this population.
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AbstrACt
background Consultations before and after bariatric 
surgery should include structured assessments of patients’ 
health- related quality of life (HRQOL) and mental health. 
One way to conduct this assessment is to implement 
patient- reported outcome monitoring with a clinical 
feedback system (PRO/CFS).
Aim We will explore patients’ and healthcare 
professionals’ experiences when a PRO/CFS is an 
integrated part of bariatric surgery care.
Methods and analyses This is a design paper in 
which a PRO/CFS will be implemented in two bariatric 
outpatient clinics. All patients who have an appointment 
with a healthcare professional prior to, and 3 and 12 
months after surgery, will be asked to complete six 
digital questionnaires measuring HRQOL, mental health, 
bowel symptoms and eating self- efficacy prior to each 
consultation. A digital summary report generated from 
the patient’s responses will form the basis for the clinical 
consultation. A team of patient representatives, healthcare 
professionals and researchers will be involved in all 
phases of designing the PRO/CFS to ensure its relevance 
for clinical consultations. The patients’ experiences will be 
explored with a generic 12- item questionnaire, developed 
for use in outpatient clinics, prior to and 12 months after 
bariatric surgery. We will conduct focus- group interviews 
with patients and healthcare professionals to explore 
their experiences when PRO/CFS is integrated into the 
consultations.
Ethics and dissemination Written informed consent will 
be obtained for all participants in the study. The project 
is approved by the Norwegian Centre for Research Data, 
Department of Data Protection Services (ref. no. 282738). 
The project has also undergone Data Protection Impact 
Assessments, both at Førde Hospital Trust and at St. 
Olav Hospital (registration no. 2016/3912). Data from the 
qualitative and quantitative studies will be kept in de- 
identified form in a secured research database, and the 
findings will be published in international peer- reviewed 
journals and presented at scientific conferences.
bACkground
The term patient- reported outcome moni-
toring with a clinical feedback system (PRO/
CFS) refers to the systematic collection 
of patient- reported outcome measures 
(PROMS) for immediate use in clinical 
consultations.1 PRO/CFS is synonymous with 
the term ‘routine outcome monitoring and 
clinical feedback systems’ (ROM/CFS), which 
is mostly used in mental health settings. For 
consistency in the present paper, we use the 
term PRO/CFS for both concepts/contexts. 
In PRO/CFSs, the patient responds to a set 
of questionnaires providing psychometrically 
valid information prior to consultation with 
a healthcare professional.1 The PROMS are 
collected before each clinical consultation, 
and clinical information from the patient, as 
well as comparisons to normative data, are 
fed back to the healthcare professional to be 
used in the clinical conversation.2 PRO/CFSs 
have been implemented in several health-
care services to assess mental health, somatic 
symptoms and health- related quality of life 
(HRQOL).3 A systematic review of qualita-
tive studies found that healthcare profes-
sionals experienced clinical use of PROMS 
as useful when they were intended to guide 
patient management and when findings 
were presented clearly. Sufficient training in 
use and interpretation were also considered 
strengths and limitations of this study
 ► The involvement of patients and healthcare profes-
sionals in the design of the patient- reported out-
come monitoring with a clinical feedback system 
(PRO/CFS) is a strength.
 ► A strength of the evaluation of the PRO/CFS is that 
it combines qualitative and quantitative methods to 
explore patients’ experiences.
 ► A limitation may be differences in follow- up proce-
dures in the two outpatient clinics.
 ► Another limitation is that the experiences of the 
healthcare professionals are explored using quali-
tative methods only.
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important. Barriers were lack of technical support, work-
load and when the PROMS were not considered relevant.4 
In a recent qualitative study of patients’ and health-
care professionals’ experiences with PROMS, patients 
found that the PROMS helped them to address topics 
that were important for them. Furthermore, they could 
track their changes in symptoms and problems. Disease- 
specific measures were considered to be most relevant. 
Barriers for both patients and healthcare professionals 
were lengthy questionnaires, and complicated summary 
reports that were difficult to interpret. This could serve 
as a hindrance for communication and professional rela-
tions.5 Common findings in both studies were the poten-
tial of PROMS to give patients a sense of control and 
facilitate patient- centred care.
PROMS can be collected on paper or digitally; however, 
a digital PRO/CFS has the advantage of providing instan-
taneous availability of the patient’s responses,1 and, in 
novel systems, comparison to relevant norm data. An 
important feature for a PRO/CFS is the ability to combine 
nomothetic and idiographic approaches to under-
standing a given patient. In the nomothetic approach, 
individuals are characterised in terms of traits or dimen-
sions that are based on mean scores of known groups. In 
the idiographic approach, the focus is on the individual 
and emphasises his/her unique personal experience, 
in PRO/CFS concretised, for example, by measuring 
person- generated goals.6 The flexibility of PRO/CFS and 
its adaptation to the patient’s needs and resources was 
found to be important in a qualitative study in mental 
health treatment, as patients experienced feedback as 
being part of treatment if their responses were discussed 
in the consultation.7 New approaches to PRO/CFS aim 
to contain both nomothetic and idiographic strategies 
through computer- adaptive testing.
Numerous studies from the field of psychotherapy 
have explored PRO/CSF both qualitatively and quanti-
tatively, and therefore, they inform the use of PRO/CSF 
in bariatric surgery care. Meta- analyses and reviews show 
that PRO/CFS have a small to moderate general positive 
effect on patient outcomes, particularly for patients not 
responding well to treatment interventions in its initial 
phases of psychotherapy.8 9 However, the results are not 
uniform, and some clinicians manage to use feedback 
better than others.10
To facilitate positive effects of PRO/CFS, the topics 
addressed have to be relevant for the group of patients. 
A review of systematic reviews found positive effects of 
bariatric surgery on HRQOL, especially with respect to 
obesity- specific and physical health concerns.11 Although 
improvements were seen in both the mental and physical 
domains of HRQOL, changes in the physical domains 
were greater.
Strategies to include assessments of psychological 
outcomes in the follow- up after treatment of obesity 
have been called for by patients12 and healthcare profes-
sionals.13 The European Association for the Study of 
Obesity guidelines for postbariatric surgery medical 
management recommend a structured mental health 
assessment,14 although they make no specific recommen-
dations for how this assessment should be conducted. 
One strategy to structure the follow- up of patients after 
bariatric surgery is to implement a PRO/CFS to optimise 
HRQOL and mental health outcomes.3
In a recent overview of systematic reviews assessing 
the effectiveness of PRO/CFS on HRQOL, the authors 
found that the understanding and use of a PRO/CFS was 
quite variable across the included studies in both somatic 
and mental health services. The authors recommended 
that future studies should include detailed descriptions 
on how the concept of PRO/CFS is understood by the 
researchers3 to clarify if the actual phenomenon of 
PRO/CFS is being studied. Based on a systematic review 
of the PRO/CFS literature, the authors proposed three 
elements as being important for the successful implemen-
tation of PRO/CFS: (i) patient- reported outcomes should be 
routinely collected before all consultations, preferably digitally, 
(ii) the report should be available to both the patient and clini-
cian during the consultation and (iii) patient- reported data and 
their implications should be discussed during the consultation.3 
Considering these suggestions for the current study, we 
argue that in addition patient- reported outcomes should 
be understood in the context of normative data—that is, 
how similar or different is this patient’s scores from other 
patients with the same condition and/or the healthy 
population.
Integrating knowledge from the mental health field 
with experiences from somatic health services, this 
project aims to develop, implement and evaluate a PRO/
CFS for use in an outpatient setting in bariatric surgery in 
Western Norway. The purpose of this article is, therefore, 
to describe the development and implementation of the 
PRO/CFS, and our plan to evaluate the feasibility of the 
PRO/CFS in bariatric surgery care. We hypothesise that 
using a digital PRO/CFS will add value to the collabora-
tive relationship between patients and healthcare profes-
sionals in bariatric surgery care. The following research 
questions will be addressed in the planned study:
1. How do patients experience the clinical consultation 
when a PRO/CFS is an integrated part it?
2. How do healthcare professionals experience the clini-




This paper describes the design of a PRO/CFS that will be 
implemented in the bariatric surgery outpatient clinics 
at Førde Hospital Trust and St. Olav Hospital Trust in 
Norway, and a plan for evaluating the feasibility of this 
intervention. The aims of the planned study are to eval-
uate experiences of patients and healthcare professionals 
with the consultations, using quantitative and qualitative 
methods. The quantitative assessment of patients’ experi-
ences started August 2019 and will be completed during 
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Table 1 The organisation of the bariatric surgery follow- up in the two outpatient clinics
Helse Førde Hospital Trust St. Olav Hospital Trust
First contact with the specialist healthcare services
Patients attend a one- day preoperative information course. A 
bariatric surgeon, nutritionist, physical therapist, psychologist 
and bariatric outpatient nurse provides information about BS 
and a lifestyle intervention programme during the course.
First contact with the specialist healthcare services
Patients seeking BS have a consultation with a physician and a 
nurse during which the choice of treatment is decided.
Patients who seeks BS as preferred treatment are referred to a 
psychologist for a mental health assessment before surgery.
Patients eligible for BS attend mandatory group sessions 
over 4 months, where a physician, psychologist, nurse and 
nutritionist educate the patients.
The patients meet for a preoperative consultation with a 
bariatric surgeon and a nurse, where the best choice of 
treatment for the patient is decided.
After the mandatory group sessions, the patient will meet with 
the surgeon for preoperative information.
Follow- up after surgery
At:
 ► 6 weeks, telephone consultation with a nurse;
 ► 3 months, consultation with a bariatric surgeon and a 
nurse;
 ► 6 and 12 months, consultation with a nurse;
 ► 12–18 months, a one- day group- based course at the 
outpatient clinic;
 ► 24, 60 and 120 months, consultation with a nurse.
Other healthcare specialities are consulted as needed.
The GP is intended to follow up the patient yearly in between.
Follow- up after surgery
At:
 ► 1 week, telephone consultation with a nurse;
 ► 6 weeks, consultation with a bariatric surgeon;
 ► 1–3 months, one group session with a nutritionist;
 ► 6 months, consultation with a nutritionist;
 ► 12 months, consultation with a medical doctor;
 ► 24 months, consultation with a medical doctor;
 ► 36, 48 and 60 months, consultations with a nurse.
BS, bariatric surgery; GP, general practitioner.
December 2022. For the qualitative inquiries, we plan to 
recruit informants and conduct the focus- group inter-
views during autumn 2020.
Patient and public involvement
Two patients have been involved in choosing the appro-
priate questionnaires in the PRO/CFS and have also been 
involved in the pilot- testing of the PRO/CFS.
the standard bariatric care programme at the outpatient 
clinics
Patients with severe obesity are referred from their general 
practitioner (GP) to the bariatric outpatient clinic. An 
evaluation of the best choice of treatment to the indi-
vidual patient (surgical vs non- surgical treatment) is then 
performed by the specialist healthcare services. Further-
more, the preparation before surgery and the follow- up 
consultations in the two outpatient clinics are somewhat 
different from each other (see table 1 for further details).
designing the Pro/CFs
Because user involvement is a key element in evidence- 
based medicine,15 to ensure that the research is relevant 
and ecologically valid for users of the services,16 17 we had 
a panel consisting of two patients who had undergone 
bariatric surgery, and one nurse working at the bariatric 
outpatient clinic to assist in the design of the PRO/CFS. 
The panel also included three researchers with experi-
ence in obesity treatment and research. One of the nurse 
researchers (PhD) had a combined position in obesity 
outpatient clinic and research, whereas the other two 
(PhD student and Professor) worked as researchers.
The purpose of the included questionnaires was that 
they should be clinically relevant for both patients and 
healthcare professionals, facilitate patient- centred care 
and improve patient- clinician communication. To achieve 
this end patients, outpatient nurse and researchers held 
a workshop where the relevance and utility of each of the 
questionnaires were assessed. Special attention was paid 
to whether the questionnaires included aspects that the 
patients considered important for the follow- up, or if any 
questionnaires were found offensive for the patients.
Intervention
The theoretical basis for the intervention in this study is 
Feedback Intervention Theory (FIT),18 which considers 
it important to have a discussion between the patient and 
healthcare professional, and focuses on the gap between 
the patient’s current situation and an established bench-
mark. FIT is a theory commonly applied to the field of 
PRO/CFS implementation.2
The intervention is a digital PRO/CFS, composed of 
questionnaires assessing HRQOL,19–21 mental health,22 
bowel- specific symptoms23 and eating self- efficacy24 
(see online supplementary file 1 for details on the 
questionnaires).
The invitation letter asks the patients to complete the 
PRO/CFS prior to the consultation with a healthcare 
professional. The patients can enter the PRO/CFS via 
a link in the hospitals’ web page, on either their own 
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Figure 1 Flow diagram of the process and use of the patient- reported outcome monitoring with a clinical feedback system 
(PRO/CFS) in consultation between the patient and the healthcare professional in the bariatric outpatient clinic at two 
Norwegian hospitals.
computer or a tablet in the waiting area in the clinic. 
To access the system, we will use the highest public data 
security- level in Norway—password- protected two- factor 
authentication system. If the patient does not have access 
to this system, the healthcare professional can generate 
a unique login for the patient. The PRO/CFS platform 
is delivered by the manufacturer CheckWare in Norway.
Method for completing the PROMs
Using the PRO/CFS- software, the patients answer a set 
of questionnaires. As not all questionnaires include the 
possibility for the patient to answer Not relevant/Do not 
want to answer, the patient can choose not to respond to 
an item in all questionnaires except the Norse Feedback. 
If the patient has reported one or more Not relevant/Do not 
want to answer in the Norse Feedback, the average of the 
other items in the scale is shown in the summary report. 
In the other questionnaires, the average of the items is 
shown if >50% of the items are completed. On comple-
tion, a digital report becomes available for the health-
care professional. The report represents a summary of 
each questionnaire, colour- coded red, yellow and green 
(see online supplementary file 2). The responses in the 
red areas are domains in which the patient has the most 
concerns. The yellow responses are domains where the 
patient has some concerns and green responses are 
domains where the patient has few or no concerns. The 
thresholds for the colour categories are defined by norm- 
population standards, where available, or by the clinical 
judgement of the research group (see online supplemen-
tary file 1 for further details). The thresholds are set to be 
sensitive for impairment, as we find it important that the 
healthcare professionals do not overlook any concerns the 
patient may have. Prior to the consultation, the health-
care professional will be provided with an overview of 
the patient’s responses, and during the consultation, the 
patient and the healthcare professional are instructed to 
begin by discussing the domains in which the patient has 
reported the most concerns (see figure 1). The different 
questionnaires incorporated into the PRO/CFS will be 
evaluated separately, within their separate interpreta-
tive frameworks during the consultations. The patient’s 
responses from the current and earlier consultations are 
visualised in the same report, to enable evaluation of the 
patient’s progression in treatment. The patient and the 
healthcare professional will agree on how to deal with 
any concerns that cannot be addressed adequately during 
the initial consultation. In most cases, the solution will be 
a detailed clinical report to the GP. If the concerns are 
urgent, the GP will be called to discuss further. In other 
cases, the healthcare professional may refer the patient to 
consult with the specialist healthcare services if this level 
of expertise is required. Another alternative is to offer 
the patient a new consultation with the healthcare profes-
sional at the obesity clinic.
Implementation phase
We will start the implementation of the PRO/CFS at 
Førde Hospital Trust.
Focus on change management is vital for a successful 
implementation of this intervention. To that end, we have 
secured management commitment in both outpatient 
clinics. Furthermore, informational sessions, training 
and follow- up is planned for all healthcare professionals 
at project launch and throughout the programme. We 
have planned up to 3 days of training of the healthcare 
professionals, depending on the needs of the individual. 
Average training duration will be measured.
Prior to implementing the project, a team of patients, 
outpatient nurses, and researchers will fill out the PRO/
CFS to test the functionality and feasibility of the system. 
The outpatient nurse will receive further training to inter-
pret the results from the report, and learn how to incor-
porate these findings in clinical conversations with the 
patient. Such training is recommended for a successful 
implementation.25 26 Two researchers serving as proxy 
patients will conduct the training of the nurse. This 
training will have special attention on interpreting the 
mental health findings, as the assessment of the patient’s 
mental health is more thorough than the healthcare 
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professional has experience with. After implementation 
starts, the first author will join the initial patient consulta-
tions to guide the outpatient nurse in the interpretation 
and use of the PRO/CFS. Moreover, a person hired by 
the hospital to work on the implementation of PRO/CFS 
will be available to answer technical questions. The first 
author also will continue to join selected consultations 
to: evaluate adherence to the incorporation of patient- 
reported information in the clinical consultations; 
support the healthcare professional; serve as a fidelity 
check of how the feedback is being incorporated into the 
consultation. Such follow- up over time has been shown 
to be important to facilitate successful implementation in 
complex systems.27 At St. Olav Hospital Trust, the imple-
mentation of the PRO/CFS will also include training of all 
involved healthcare professionals in how to interpret the 
report, and to incorporate these findings in the conver-
sation with the patient. The healthcare professionals will 
have the assistance of a researcher with experience with 
the PRO/CFS, as well as technical support. Fidelity to the 
use of PRO/CFS is defined as the healthcare professional 
and the patient studying the summary report together 
and discussing the patient’s responses during the consul-
tation. Adherence to fidelity will be evaluated by the 
researcher attending the consultations. Furthermore, the 
healthcare professionals will complete a fidelity check-
list for a random selection of consultations, and a sepa-
rate question will be added to the Generic Short Patient 
Experiences Questionnaire (GS- PEQ) asking the patient 
whether feedback was given during the consultation.
outcomes and analyses in the feasibility study
The aim of the study is to assess the feasibility of this 
PRO/CFS in bariatric surgery care. We plan to accom-
plish this by assessing patients’ experiences using both 
quantitative and qualitative methods, and the healthcare 
professionals’ experiences using qualitative methods. 
We will collect data on number of planned consulta-
tions, attrition to the follow- up, whether the patient has 
completed the PRO/CFS prior to the consultation and 
the presence of any missing data within the completed 
PRO/CFS. In addition, we record the proportion of 
consultations requiring contact with, or referral to, other 
healthcare specialties to assess how the PRO/CFS affects 
the course of the follow- up. The qualitative interviews and 
the quantitative findings of the experiences will be used 
to evaluate the utility of the PRO/CFS. Indications that 
PRO/CFS is operating as intended are if satisfaction with 
consultations are high as measured with GS- PEQ, and if 
the overall impression from the qualitative interviews is 
positive. An overall impression of dissatisfaction in the 
qualitative interviews or low scores in the GS- PEQ indi-
cates a need for refinement of the PRO/CFS.
Quantitative assessments and analyses of patient experiences
The GS- PEQ28 is a set of 10 core items developed to 
measure patient- reported experience measures in 
different somatic and psychiatric health services in 
Norway. We will use the version validated for use in somatic 
outpatient services, which consists of 12 items measuring 
experiences regarding information and communication 
(eg, Did the clinicians talk to you in a way that was easy to 
understand?), whether the patient had any influence on 
the treatment (eg, Were you involved in decisions regarding 
your treatment?) and the perceived benefit from the treat-
ment (Overall, was the help and treatment you received at the 
institution satisfactory?). The items are rated on a 5- point 
scale ranging from Not at all to To a very large extent. The 
items will be analysed separately, without a total score, 
and the responses To a large extent and To a very large extent 
will be regarded as an indication that the PRO/CFS is 
operating as intended. We will pay special attention to the 
following four questions: Did the clinicians talk to you in a 
way that was easy to understand?; Did you perceive the treatment 
as adapted to your situation?; Were you involved in decisions 
regarding your treatment? and Overall, was the help and treat-
ment you received at the institution satisfactory? as indicators 
of the utility of the PRO/CFS. This questionnaire will not 
be incorporated in the PRO/CFS but will be answered by 
pen and paper after the consultation and delivered to the 
healthcare professional in a closed envelope.
The patients’ experiences will be presented through 
descriptive statistics. Further, their associations in rela-
tion to gender, age, body mass index, HRQOL, compli-
cations of the surgery and bowel symptoms (from the 
Gastrointestinal Symptoms Rating Scale) will be investi-
gated using univariate and multivariable regression anal-
yses. Analyses will be conducted on patients with at least 
1 year of follow- up after surgery. Given sample size=100, 
power=0.8 and p=0.05, the study would be able to detect 
an unadjusted standardised coefficient=0.27 (G*power 
3.1.9.4). This corresponds to a small effect size.29 The 
computer software IBM SPSS statistics30 will be used for 
the statistical analyses.
Qualitative inquiries into patients’ and healthcare professionals’ 
experiences with PRO/CFS
We plan to conduct separate focus group interviews of 
patients and healthcare professionals in the obesity 
outpatient clinic to explore their experiences when the 
PRO/CFS is an integrated part of the consultation. Focus 
group methodology is particularly apt for health service 
research, as different participants can expand on each 
other’s perspective in formulating their experiences in 
the shared context. The participants for the focus group 
interviews will be recruited from obesity outpatient clinics 
at the two hospitals. The patients will be recruited by clin-
ical staff, whereas the healthcare professionals will be 
recruited on an information meeting, followed by an invi-
tation on email. We plan to report how many patients and 
healthcare professionals are invited to the study, and how 
many accept/decline to participate.
We plan four focus group interviews with patients, two 
from each outpatient clinic, and one focus group with 
healthcare professionals in the initial data collection. We 
plan to accrue six to eight participants in each group. 
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Follow- up focus groups will be implemented after 12 
months. The interviews will be audio- recorded and tran-
scribed verbatim for analyses.
A researcher will serve as the moderator of the focus 
groups, and a co- researcher will be present to take notes 
and handle the audio- recording. The role of the moder-
ator is to make sure that all participants get to tell their 
story, to stimulate interaction between different perspec-
tives in the group and to make sure that the conversations 
relate experiences relevant to the research questions. The 
interviews will be implemented within the hospital areas, 
but not in the outpatient clinic. This will be done to allow 
the participants to convey their own perspectives. We will 
prepare a brief introduction stating the aim of the conver-
sation, and a schedule of open- ended questions for the 
group to discuss. An interview guide will be developed in 
collaboration with patient- representatives and an outpa-
tient nurse (see online supplementary file 3 for interview 
guide). We will conduct a pilot interview to evaluate the 
relevance of the interview guide.
For analysis of the transcribed data, we plan to apply 
systematic text condensation (STC),31 where we will 
synthesise the data in four steps. STC is a structured qual-
itative method for analyses that is well documented for 
research in medical settings. The first step is to get an 
overall impression of the transcribed text to get familiar 
with the content and create themes. The next step is to 
identify units of meaning and code these to sort out units 
of text related to each other. The third step is to abstract 
the units of text into a condensate of units from the 
different participants. In the final step, the content from 
the condensates are synthesised, which means that the 
condensates are interpreted by the researches. The inter-
pretation must be loyal to the voices of the participants, 
and at the same time be influenced by the researcher’s 
interpretation.31 We will have two researchers conducting 
the analyses separately and come to agreement through 
discussion. In addition, we will present the anonymous 
transcribed interviews and the preliminary analyses to an 
experienced qualitative researcher, to perform the role of 
independent critical auditor, to secure correspondence 
between results and data.32
dIsCussIon
The purpose of this project is to implement a PRO/CFS 
in bariatric surgery care. We aim to explore the patients’ 
and healthcare professionals’ experiences with consulta-
tions, where PRO/CFS is an integrated part of the clinical 
conversation.
structured assessment
This project is a novel approach to meeting the chal-
lenges of a structured assessment of patients’ HRQOL 
and mental health, as called for by both patients and 
healthcare professionals, and highlighted in guidelines 
for follow- up after bariatric surgery.12 14 The measures 
of mental health symptoms are more thorough than 
the measures previously used in this patient population 
in Norway. The multidimensionality of Norse Feedback 
ensures that clinical constructs are not evaluated alone 
but are viewed through their relationships with other clin-
ical dimensions within the measure, the patient’s ability 
to change and social support. This means, for example, 
that two patients who have the same symptom load on 
depressive symptoms but experience their situations 
differently because one has good social support whereas 
the other has not, are viewed differently. Furthermore, for 
a patient with an elevated suicidality score, the situation 
will often be more concerning if he or she at the same 
time has elevated scores in the scales Hopelessness and 
Social avoidance, than if he or she scores low on these 
same scales. We hypothesise that this will allow for a more 
detailed understanding of mental health processes and 
better decisions in the clinical conversation.
Because the PRO/CFS incorporates questionnaires 
assessing diverse issues related to bariatric surgery, such 
as bowel symptoms and eating self- efficacy, the battery of 
questionnaires will make the PRO/CFS clinically relevant 
to the patients and healthcare professionals.
Pro/CFs methodology
To simplify the integration of PROMS in clinical consul-
tations, we have chosen a digital PRO/CFS, as this has 
the advantage of instant and easy to interpret summary 
reports.1 The summary report from the PRO/CFS is 
colour- coded to make the results more comprehensible 
for patients and healthcare professionals in order to 
facilitate more active use of the PROMS during consulta-
tions. The active use of the PRO/CFS methodology that 
focuses on the feedback process is an important aspect 
of the FIT, as described by Kluger and DeNisi,18 as feed-
back has been found to improve communication between 
patients and healthcare professionals3 and to improve 
treatment outcomes.33 34 Patients have also emphasised 
the importance of feedback and discussion about their 
responses.7 Through this conversation the healthcare 
professional can address the topics and highlight whether 
the patient’s responses have changed surprisingly in one 
way or another.
technology as a barrier
As described by Bradley et al,35 technology can be a barrier 
for patients and healthcare professionals. This might 
affect how patients respond to the questionnaires, as 
well as whether they complete the PRO/CFS prior to the 
consultation. However, our initial experiences are that the 
system is easy to log into and navigate. Most patients are 
familiar with using tablets in their daily life. As an attempt 
to overcome this potential barrier, we have secured tech-
nical support for the healthcare professionals, as well 
as training for them about using the system and inter-
preting the PRO/CFS results. A recent qualitative study 
which explored the implementation of Norse Feedback 
found that training and support were important for the 
clinicians to incorporate the PRO/CFS in consultation. 
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The psychologists reported that learning and incorpo-
rating a new technological system was challenging in their 
everyday work, and characterised it as an overwhelming 
workload.36
strengths and limitations
The PRO/CFS package chosen for this project needs to 
be adapted and validated for the population of patients 
in surgical treatment for obesity, as its relevance to the 
patients and healthcare professionals is crucial for the 
PRO/CFS to be useful.37 38 A strength of this project is 
the involvement of both patients and healthcare profes-
sionals who, in collaboration with researchers, will design 
and evaluate the PRO/CFS. This involvement of patient 
representatives and outpatient nurses is considered 
important for producing the final version of the PRO/
CFS—thereby increasing the ecological validity of this 
project. Other strengths include tutoring healthcare 
professionals about how to incorporate the PRO/CFS in 
clinical conversations with patients, and the availability of 
both technical and methodological support.
The two outpatient clinics have organised their bariatric 
care differently, as the clinic at St. Olav Hospital has a 
mandatory course for the patients over 4 months before 
surgery. Furthermore, at Førde Hospital Trust the patients 
always have consultations with a nurse, and the surgeon 
meets the patients after 3 months and is consulted when 
it is beneficial for the patient. These differences in the 
organisation of bariatric care may strengthen the gener-
alisability of the quantitative findings, as the results of the 
study will not be solely determined by the characteristics 
of a single clinic. Such differences may also contribute 
to richer findings in the qualitative inquiries. However, 
a potential limitation is that patients in one clinic meet 
primarily with the same healthcare professional, whereas 
patients at the other clinic meet with a larger number 
of healthcare professionals. It is possible that as more 
healthcare professionals are involved, there may be 
greater variability in how the PRO/CFS is used. We need 
to be aware of these differences when reporting results 
from the study. Furthermore, the recruitment of patients 
for the qualitative interviews may result in a selection bias. 
We will be aware of this possible bias when conducting the 
interviews and synthesising the findings, and report this 
as a potential limitation of the study.
In this project, we do not conduct a quantitative measure 
of how the healthcare professionals manage the feedback 
process, display provider empathy or demonstrate self- 
efficacy. This may represent a limitation. However, these 
aspects will be addressed during the qualitative inquiries.
Future perspectives
If we find that PRO/CFS is appropriate in bariatric surgery 
follow- up, and that patients and healthcare professionals 
believe it adds value to the consultations, the effective-
ness of the PRO/CFS will be tested on a larger scale, 
preferably as a randomised controlled trial. Whether 
some clinicians use feedback in a more effective way than 
others, demonstrate greater provider empathy, create a 
stronger working alliance or demonstrate self- efficacy will 
be important measures when we test the PRO/CFS on a 
larger scale.
In conclusion, PRO/CFS may be a useful tool for the 
structured assessment of HRQOL and mental health 
before and after bariatric surgery. The consultations at 
the outpatient clinic are intended to be more patient- 
centred and may thus improve the follow- up rates over 
time at clinical consultations. As obesity is considered 
a complex chronic disease, and the positive effects of 
bariatric surgery go beyond weight loss in itself, a patient- 
centred model for follow- up is recommended.39 Ulti-
mately, using PRO/CFS in clinical consultations may lead 
to improvements in patients’ mental health and HRQOL 
after bariatric surgery.
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Supplementary file 1 Patient-reported outcome measures included in the 
PRO/CFS 
Obesity-specific HRQOL 
The Obesity-related Problems Scale (OP) is an 8-item HRQOL questionnaire measuring how 
obesity affects psychosocial functioning. It includes eight aspects of psychosocial functioning 
with a 4-point scale that has response categories ranging from Definitely not bothered to 
Definitely bothered. The scores range from 0 to 100, where lower scores indicate better 
psychosocial functioning. The eight individual items are useful in the clinical conversation 
with the patient. The questionnaire has been used in a Norwegian setting. Based on 
recommendations from the developer, cut-off levels for the summary report were set as 
follows: A score under 19 was designated green, 20-59.9 yellow, and 60-100 red. (Karlsson, 
J., Taft, C., Sjostrom, L., Torgerson, J. S., & Sullivan, M. (2003). Psychosocial functioning in 
the obese before and after weight reduction: construct validity and responsiveness of the 
Obesity-related Problems scale. International Journal of Obesity, 27(5), 617-630). 
The Patient Reported Outcomes in Obesity (PROS) is a 10-item questionnaire measuring the 
impact obesity has on a person’s daily life. It was developed and validated in a Norwegian 
setting. The questionnaire has eight questions on daily activities and two questions on the 
consequences of bariatric surgery, such as negative side effects and excess skin. The response 
categories are rated on a 4-point scale from Considerably bothered to Not bothered. The total 
score can be used to discuss overall obesity-specific HRQOL; however, the individual scores 
are preferred for use in clinical consultation as they give more specific information about the 
source of the negative impact of obesity. In addition to the 10 items measuring HRQOL, the 
questionnaire has one question on social support and one on overall treatment satisfaction, 
both measured on 4-point scales, with the response categories Very satisfied, Satisfied, Unsure 
and Dissatisfied. In the summary report each item is presented with set cut-off values as 
follows: not bothered green, mildly bothered yellow, and moderately and considerably 
bothered as red. 
Generic HRQOL 
The Short Form-36 (SF-36), Norwegian version 1.2, is a 36-item questionnaire measuring 
HRQOL, which is widely used for research on obesity. The questionnaire has eight 
dimensions of physical and mental functioning, with a total score ranging from 0 to 100, 
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where higher scores indicate better HRQOL. The dimensions are divided in two summary-
scores — the Physical Component Score (PCS) and the Mental Component Score (MCS) — 
based on factor analysis with oblique rotation. For the analyses of both the sub-scores and 
summary scores, we used T-scores where a score of 50 approximates the average of the 
general population. Thresholds for the cut-off values in the summary report were set 
according to the norm-score (T-score 50), and previous research on clinical significance of 
impairment. This resulted in cut-off values as follows: Over 45 was designated as green, 42.1-
45.0 yellow and under 42.0 red. (Loge et al., 1998). 
Mental health 
Norse Feedback (NF) is a multidimensional computer-adaptive questionnaire developed 
primarily to assess PROMS for use in mental health treatment (20). Structured interviews of 
the needs of patients and clinicians in treatment for mental health disorders were the basis for 
the development of Norse Feedback. Responding to clinicians’ and patients’ needs, Norse 
Feedback aims to measure discrete clinical phenomena, such as sad affect, rumination and 
interpersonal problems, for use in clinical conversations. In turn, multidimensional patterns of 
scores on discrete scales form hypotheses of higher order constructs, such as depression in a 
diagnostic context. Moreover, the measure adapts to the individual’s presentation after an 
initial broad screening.  
In addition to the factorial structure of the measure, information values within constructs for 
individual items in the questionnaire are evaluated through item-response theory (30, 31). The 
questionnaire consists of 93 items assessing symptoms related to mental health and addiction. 
Norse Feedback assesses 20 different dimensions in four domains (symptom expression, 
dysfunctional processes, functional consequences and resources). The questions use 7-point 
response categories, which range from Is not correct for me at all to Is correct for me; the 
patient can also choose the response Not relevant/do not know/refuse to answer.  
The visual report of the NF is presented as raw scores in the obesity setting. Visually the 
categories green, yellow and red are carried over from a mental health treatment setting. In 
mental health the Y-axis presents standard deviations from a norm population, matching the 
colour categories. In this project, the presentation as raw scores in the summary report was 
chosen to represent face valid information for the healthcare professionals in the exploratory 
phase. Through the current project, data for establishing new standard deviations for a patient 
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population after bariatric surgery will be collected, and a presentation where Y-axis and 
colour categories match will result. 
 
Eating self-efficacy 
The Weight Efficacy Lifestyle Questionnaire - Short Form (WEL-SF) is a questionnaire that 
measures the confidence patients have in their ability to resist overeating in various situations. 
There are eight questions that are rated on a 10-point scale, from Not confident to Very 
confident about their eating self-efficacy, with a total score ranging from 0 to 80. Higher 
scores indicate better eating self-efficacy. The questionnaire is used for patients after bariatric 
surgery in Norway. Based on clinical judgement, we defined the following thresholds in the 
summary report: 70-80 green, 60-69.9 yellow, and under 60 red. 
Bowel symptoms 
The Gastrointestinal Symptoms Rating Scale (GSRS) measures gastrointestinal symptoms 
relevant to patients after bariatric surgery. The questionnaire measures 15 bowel symptoms on 
a 7-point scale (ranging from 1 to 7), with response categories ranging from Not bothered at 
all to Severely bothered. The 15 symptoms can be interpreted as 5 dimensions; Abdominal 
pain, Reflux, Indigestion, Diarrhoea and Constipation, or a total score that ranges from 15 to 
105. The questionnaire has been used for research on patients after bariatric surgery in 
Norway. For the colour categories in the summary report we set the following thresholds for 
cut-off of the five dimensions, based on clinical judgement: 3-6 green, 9-12 yellow, and 15-21 
red.  
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Supplementary file 2. The visual report available for the healthcare professional after the patient has 
completed all questionnaires in the PRO/CFS* at two Norwegian Hospitals 
 
*PRO/CFS = Patient-reported outcome monitoring with a clinical feedback system 
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2018/993  NORSE: Klinisk tilbakemelding og psykometri i psykiske og somatiske helsetenester
Vi viser til søknad om forhåndsgodkjenning av ovennevnte forskningsprosjekt. Søknaden ble behandlet av
Regional komité for medisinsk og helsefaglig forskningsetikk (REK nord) i møtet 31.05.2018. Vurderingen
er gjort med hjemmel i helseforskningsloven § 10.
 Helse Førde HFForskningsansvarlig institusjon:
 Christian MoltuProsjektleder:
Prosjektleders prosjektomtale (original):
NORSE er eit andregenerasjons system for rutinemessig utkommemåling og klinisk tilbakemelding i
helsetenester. NORSE har fått høg nasjonal og internasjonal merksemd, som dynamisk lærande og
persontilpassa gjennom empiriske algoritmer. NORSE stiller pasientar spørsmål digitalt om korleis dei
opplever ulike livsområder, behov i behandlinga og korleis dei opplever denne, på ein strukturert måte som
gir valide målingar av lidingstrykk, ressursar og behov. Dette vert nytta i behandlingsplanlegginga. Klinisk
tilbakemelding kan tredoble nytta av behandling for utvalde pasientgrupper i psykisk helsevern. Tidlege
profilar kan predikere utfall og behandlingsbehov. I fedmebehandlingsfeltet er behovet for strukturert
psykisk helsekunnskap ein nasjonal prioritet men kunnskapen låg. Prosjektet vil utvikle klinisk kunnskap
som forbetrer tenester gjennom prediktive mønsteranalyser av behandlingsløp. Det vil utgreie kva behov for
psykisk helsekunnskap som finnast i fedmefeltet, og prøve ut denne.
Framleggingsplikt
Søker beskriver at man gjennom dette prosjektet «vil utvikle klinisk kunnskap som forbetrer tenester
gjennom prediktive mønsteranalyser av behandlingsløp. Det vil utgreie kva behov for psykisk helsekunnskap
som finnast i fedmefeltet, og prøve ut denne.»
Søker beskriver datainnsamlingen slik:
«Prosjeketet samlar inn kliniske data i tre arbeidspakkar, på fastlegekontor, i psykisk helsevern og på
fedmepoliklinikk i spesialisthelsetenesta, samt ein frisknormpopulasjon. Merk at pasientar som inkluderast i
studien brukar dei inkluderte instrumenta som er brukt i deira vanlege kliniske kontekst, sett bort frå ei
sub-gruppe som deltek med svar på yttarlegare nokre psykometriske instrument for å etablere konvergent
validitet for Norse Feedback. Det vil seie at forskingsprosjektet ikkje vil krevja av pasientane ekstra innsats
eller bidrag, utover det som dei nyttar seg av i behandlinga.» 
De prosjektene som skal framlegges for REK er prosjekt som dreier seg om "medisinsk og helsefaglig
forskning på mennesker, humant biologisk materiale eller helseopplysninger", jf. helseforskningsloven (h) §
2. "Medisinsk og helsefaglig forskning" er i h § 4 a) definert som "virksomhet som utføres med
vitenskapelig metodikk for å skaffe til veie ny kunnskap om helse og sykdom". Det er altså formålet med
studien som avgjør om et prosjekt skal anses som framleggelsespliktig for REK eller ikke.
REK vurderer at prosjektet ikke faller innenfor helseforskningsloven. Datainnsamlingen skal skje med
hjemmel i samtykke og det er derfor heller ikke behov for dispensasjon fra taushetsplikten/eller samtykke.
Godkjenning fra andre instanser
Det påhviler prosjektleder å undersøke hvilke eventuelle godkjenninger som er nødvendige fra eksempelvis
personvernombudet ved den aktuelle institusjon eller Norsk senter for forskningsdata (NSD).
Kvalitativ del av prosjektet
Det opplyses at «Protokollen inneheld i tillegg ei kvalitativ studie der ein inviterer pasientar frå
fedmebehandlingskonteksten til individuelle intervju og/eller fokusgruppeintervju om deira opplevingar av
psykisk helse og uhelse, og behov for dette integrert i behandlinga. Dette kvalitative prosjektet er knytt til ei
post.doc-stilling. Kandidaten som er tilsett i post.doc-stillinga startar opp juli 2018. Vedkommande vil
definere innhald, intervjuguide og design i detalj etter oppstart, og denne delen av prosjektet vil ettersendast
.»til REK for vurdering når kandidaten har starta
Komitéen har ikke grunnlag til å ta stilling til denne delen av prosjektet. Denne delen av prosjektet må
sendes som selvstendig søknad, dersom prosjektleder mener at den er fremleggingspliktig.
Vedtak
Etter søknaden fremstår prosjektet ikke som et medisinsk og helsefaglig forskningsprosjekt som faller
§ innenfor helseforskningsloven. Prosjektet er ikke framleggingspliktig, jf. hfl 2.
Klageadgang
Du kan klage på komiteens vedtak, jf. helseforskningsloven § 10 og forvaltningsloven § 28 flg. Klagen
sendes til REK nord. Klagefristen er tre uker fra du mottar dette brevet. Dersom vedtaket opprettholdes av
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Dersom det er sannsynlig at en type behandling, særlig ved bruk av ny teknologi og idet det 
tas hensyn til behandlingens art, omfang, formål og sammenhengen den utføres i, vil medføre 
en høy risiko for fysiske personers rettigheter og friheter, skal den behandlingsansvarlige før 
behandlingen foreta en vurdering av hvilke konsekvenser den planlagte behandlingen vil ha 
for personopplysningsvernet. 
 
Styringssystem for informasjonssikkerhet og personvern har omtalt hvordan en utfører en 
vurdering av konsekvenser i dokumentene GXY – 21.6 og GXY. Hvis en vurderer behov 
utover de minimumskrav som der er oppstilt har direktoratet for e-helse utarbeidet en mer 
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Data Protection Impact Assessment (DPIA) –  
Personvernkonsekvensutredning etter GDPR 
 
Denne malen er utviklet på bakgrunn av krav i GDPR. Det er tatt hensyn til 
Datatilsynets veiledning om DPIA. En del av teksten er hentet fra 
Datatilsynets sjekkliste for vurdering av personvernkonsekvenser. Malen 
gir et bilde av momentene som bør vurderes i en DPIA. Den enkelte 
virksomhet som bruker malen må selv konkret vurdere innhold og omfang 
av egen DPIA. Tabellene i malen er ikke uttømmende og må tilpasses de 
enkelte behandlingene som omfattes av en DPIA.  
 
 
DEL I. Vurdering av behov for DPIA 
 
[I denne delen er det kun nødvendig å besvare spørsmålene i tabellen nedenfor, ingen 
analyse.] 
 
Når må DPIA gjennomføres? 
«Dersom det er sannsynlig at en type behandling, særlig ved bruk av ny teknologi og 
idet det tas hensyn til behandlingens art, omfang, formål og sammenhengen den 
utføres i, vil medføre en høy risiko for fysiske personers rettigheter og friheter, skal 
den behandlingsansvarlige før behandlingen foreta en vurdering av hvilke 
konsekvenser den planlagte behandlingen vil ha for vernet av personopplysninger.» 
(GDPR art.35.1) 
 
Kriterier når DPIA kan bli et krav: 
1. Evaluering eller scoring, spesielt knyttet til arbeidsresultater, økonomisk situasjon, 
helse, personlige preferanser eller interesser, oppførsel og adferd, lokasjon og 
bevegelser osv. 
2. Automatiserte beslutninger med juridisk eller tilsvarende betydning. 
3. Systematisk overvåking av registrerte. 
4. Særlige kategorier personopplysninger eller andre sensitive personopplysninger 
av høy personlig karakter (sistnevnte spesielt knyttet de enkeltes «friheter», men 
kan også omfatte f.eks. økonomiske og finansielle opplysninger). 
5. Databehandling i stort omfang, som at det er et stort antall registrerte involvert, 
store mengder data, mange ulike typer data, lang varighet av behandlingen, stor 




6. Kombinering eller sammenstilling av datasett. 
7. Personopplysninger vedrørende spesielt sårbare registrerte (som barn, ansatte, 
psykisk syke, asylsøkere, eldre, pasienter mv.). 
8. Innovativ eller nyskapende bruk av personopplysninger, som f.eks. bruk av 
biometriske data for tilgangskontroll, Internet of Things-løsninger, 
velferdsteknologi osv. 
9. Når behandlingen i seg selv forhindrer eller begrenser de registrertes mulighet til 
å utøve sine rettigheter etter loven eller avtale, eller bruke tjenester. 
 
Vurderingsspørsmål om behov for DPIA: 
 
Nr. Vurderingsspørsmål Ja/Nei 
1. Er dette et nytt prosjekt eller prosess? Ja 
2. Vil prosjektet innebære innsamling av ny informasjon om 
enkeltpersoner? 
Ja 
3. Vil prosjektet be enkeltpersoner om å gi informasjon om seg 
selv? 
Ja 
4. Vil informasjon om enkeltpersoner bli delt med organisasjoner 
eller personer som ikke tidligere har hatt rutinemessig tilgang til 
informasjonen? 
Ja 
5. Skal du bruke informasjon om enkeltpersoner som er innsamlet 
for et formål, men der opplysningene for tiden ikke er eller ikke 
lenger er i bruk (ikke behandles utover lagring)? 
Nei 
6. Innebærer prosjektet at du bruker ny teknologi som kan 
oppfattes som inngripende for personvernet? For eksempel, bruk 
av biometri eller ansiktsgjenkjenning? 
Nei 
7. Vil prosjektet resultere i at du tar beslutninger eller gjennomfører 
tiltak mot enkeltpersoner på måter som kan ha en betydelig 
innvirkning på dem? 
Nei 
8. Basert på typen informasjon om enkeltpersoner, er det spesielt 
sannsynlig at bekymringen for eller forventninger til 
personvernet vil øke? 
Ja 
9. Vil prosjektet kreve at du kontakter personer på måter som de 
kan finne inngripende? 
Nei 
 
Dersom svaret er "ja" på ett eller flere av spørsmålene ovenfor, kan det bety at det er 






DEL II. Grunnleggende utgangspunkter og beskrivelser 
 
II.1.  Bakgrunn 
 
Forutsetninger og avgrensning 
Grunnlaget for dette DPIA-dokumentet er gjennomføringa av forskingsprosjektet «NORSE: 
Building bridges between psyche and soma through personalized and dynamic mental health 
systems» (heretter «Prosjektet»). Prosjektet går frå 2018-2023 og er finansiert av Helse 
Førde, Noregs Forskingsråd, Høgskulen på Vestlandet, Førde Kommune og St. Olavs Hospital. 
Helse Førde er prosjekteigar og forskingsansvarleg institusjon. Prosjektet hentar 
sjølvrapporterte data frå pasientar for å gjennomføre forskingsaktivitetar og utbetre nye og 
betre tenester og tenesteteknologi. 
To eksterne instantsar har tidlegare vurdert ulike sider ved forskingsprosjektet. Norsk 
forskingsråd har vurdert prosjektet til å høg vitskaplege kvalitet og nytteverdi. På grunnlag av 
dette tildelte dei prosjektet 10 millionar kroner.    
https://www.forskningsradet.no/prosjektbanken/#/project/NFR/269097 
Prosjektet er også vurdert av Regional komite for medisinsk og helsefaglig forskningsetikk 
(REK) (saksnummer: 2018/993) der ein konkluderte med at prosjektet fell utanfor REK sitt 
mandat. Prsaka er prosjektet er ein obervasjonsstudie der ein skal nytte opplysningar som 
uansett samlast inn som ein del av behandlinga.  
https://helseforskning.etikkom.no/prosjekterirek/prosjektregister/prosjekt?p_document_id
=1017645&p_parent_id=1029900&_ikbLanguageCode=n 
Helse Førde gjer difor ei sjølvstedig vurderinga av projektet.  
 
Kven tek del i DPIA-teamet? 
Prosjektleiar Christian Moltu, forskingskoordinator John Roger Andersen, seksjonsleiar 
forsking og innovasjon Guro Mjanger, personvernombod Frode Hatten, 
datatryggleiksansvarleg Lars Inge Eikefjord, foretaksjurist Bård Eikeset. Alle desse er tilsett i 
Helse Førde. 
Interessentar 
 Pasientar i Klinikk for psykisk helse (PHV), tverrfagleg fedmepoliklinikk (KIR), 
fedmepoliklinikken St.Olavs Hospital (STO) og Førde legesenter (FL) som samtykkar 
og tek del i prosjektet med sine data. 
 Klinisk tilsette og leiing ved dei inkluderte klinikkane nemd i første kulepunkt. 







II.2.  Løsning, tjeneste og system 
 
Prosjektet samlar inn sjølvrapporterte data elektronisk frå pasientar som er i pågåande 
behandling, eller frå den genrelle befolkinga etter fullstendig informert samtykke. 
Datainnsamlinga skjer gjennom to teknologiske løysingar. Høgaste tryggleiksnivå i Noreg 
(nivå 4) blir brukt til pålogging.  
 
1. Checkware AS  
Checkware AS, organisasjonsnummer 990 808 414, er eit firma som utviklar teknologi 
for digitalisering av pasientskjema for helsesektoren. Checkware AS har sidan 2015 hatt 
ein rammeavtale med Helse Vest, og leverer desse tenestene til dei fire føretaka gjennom 
HVIKT. Checkware AS inngår i regional portefølje i Helse Vest, og har vore vurdert i 
HVIKT med tanke på datalagring, datatryggleik og risiko. Checkware er rulla ut i dei fire 
foretaka for klinisk bruk. Prosjektet nyttar ikkje Checkware på anna måte enn slik det vert 
brukt i klinisk drift. 
 
For detaljert informasjon om Checkware, driftsmiljø, ROS-analyse og vidare visast det til 
Checkware i regional portefølje i Helse Vest. 
 
2. Norse Feedback AS 
Norse Feedback AS, organisasjonsnummer 921 192 622, er eit firma som utviklar 
teknologi for å levere det digitale persontilpassa pasientsystemet NORSE til 
helsevesenet. Norse Feedback AS har sidan 2018 utvikla teknologien i møte med ønske 
frå helseorganisasjonar om å ta i bruk fullversjon av systemet NORSE. Norse Feedback 
er forprosjektkandidat i den regionale portefølja i Helse Vest, og dokumentasjon med mål 
om regional utrulling i vanleg klinisk drift er under utvikling.Prosjektet skal nytte Norse 
Feedback AS sin teknologi for datafangst ved Førde Legesenter. 
 
Informasjon om Norse Feedback, driftsmiljø, og ROS-analyse blir ettersendt.  
Dataflyt 
Pasientar som inngår i prosjektet er i ordinær behandling ved ein av dei deltakande 
klinikkane. I det vanlege behandlingsløpet brukar dei ei rekke sjølvrapporterte skjema for å 
følgje med på effekt og opplevd nytte i behandlinga. Pasientar vil verte informert om 
målsetnandene og innhaldet i prosjektet og invitert til å samtykke til deltaking. Ved eksplisitt 
skriftleg samtykke vert den gjeldande pasient sine data merkt som tilgjengeleg for prosjektet 
sine forskingsspørsmål. Berre opplysningar som er naudsynte for prosjektet vert nytta.  
Checkware lagrar pasientdata fullidentifisert på eigne servarar. På desse ligg kliniske data 
med gjeldande sletterutiner for den ordinære driftssituasjonen. For dei pasientar som har 
samtykka til forsking vil prosjektet bruke Checkware sitt system for å transportere data frå 
dette miljøet til Helse Vest sin forskingsserver ein gang i kvartalet i prosjektperioden. Kliniske 
data vil etter dette ligge att på det kliniske driftsmiljøet til Checkware og  vert handtert etter 
ordinære kliniske rutiner. 
Norse Feedback AS lagrar ikkje identifiserbare data på eigne servarar. Data samla inn over 




pasientar som har samtykka til forsking vil Førde Legesenter i tråd med partnarkontrakt 
utlevere data til prosjektet. Norse Feedback sitt system for å transportere data Førde 
Legesenter til Helse Vest forskingsserver ein gang i kvartalet i prosjektperioden, vil nyttast til 
dette. 
Norse Feedback AS tek ut anonyme data (svar på einskildspørsmål utan identifiserande 
informasjon, sjå detaljar om innhald i kapittel under) og lagrar på eigne servarar. Desse 
dataene brukast til å kalibrere spørsmålsformuleringar kontinuerleg, for optimal validitet. Eit 
forklarande døme kan vere frå eteforstyrringsdomenet. Eit av spørsmåla som pasientar 
svarar på kan vere formulert slik: «Eg brukar for mykje tid på å tenkje på og planlegge måltid 
slik at dette går utover det sosiale livet mitt». Spørsmålet er meint å gi empirisk informasjon 
som hjelper med graderingar av vanskar med høg alvorsgrad innanfor domenet. 
Kontinuerlege analyser kan vise at denne formuleringa gir mest diskriminant informasjon 
rundt den moderate alvorsgrada av vansken. På bakgrunn av denne anonyme informasjonen 
om korleis dette spørsmålet fungerer empirisk kan Norse Feedback AS endre spørsmålet 
noko, til dømes til: «Eg brukar lange tidsperiodar kvar dag på å tenkje på og planlegge måltid 
slik at dette går utover det sosiale livet mitt». Statistikk som ligg til grunn for slike analyser 
går under namnet Item Respons Theory, og gir informasjonskurver for ulike alvorsgrader for 
alle einskildspørsmål i eit sjølvrapportert instrument. 
Data som er samtykka til bruk i prosjektet og transportert til Helse Vest forskingsserver vil 
ligge der for analyser i SPSS etter ordinære system for lagring og trygg bruk av forskingsdata i 
Helse Vest. Helse Vest si prosedyre/teneste for trygg lagring vil bli nytta når ein treng 
mellomlagring før endeleg plassering på foreskingserver.  Data blir lagra utan 
personidentifiserbare kjenneteikn. Ein koplingsnøkkel knyt pasientane til desse 
opplysningane. Koplingsnøkklen vert oppbevart seperat frå dei andre opplsyingane på eige 
område på ein server i samvar med Helse vest sine rutinar. Koplingsnøkkelen vert sletta ved 
prosjektslutt.  Prosjektleiar og arbeidspakkeleiarar (Christian Moltu og John Roger Andersen) 
vil ha full tilgang til forskingsdata, og har ansvaret for å gjere desse tilgjengeleg for 
prosjektdeltakarar som skal gjere analyser på materialet etter prosjektplan. Tilgang til 
forskingsdata vil berre bli gitt innanfor Helse Førde sitt IKT-system ved at det vert gjeve 
tilgang til spesifikt område på forskingsver, men ikkje område for koplingsnøkkel.  
Prosjektdeltakarar som har samtykka til prosjektet samtykker i utgangspunktet til at 
personopplsyingar kan lagrast i den definerte datalagringsperioden. Denne er definert til å 
vare fram til prosjektslutt 31.12.2022. Grunnlaget for at data lagrast identifisert fram til 
prosjektslutt er at ein må kunne kople nye innsamlingstidspunkt med eksisterande data for 
individ over tidsperioden som datainnsamlinga varer. 
Dersom ein deltakar ønskjer å trekkje sitt samtykke kan dette gjerast utan konsekvensar og 
utan å oppgi grunn gjennom heile datalagringsperioden. Framgangsmåte for å gjere dette 
vert oppgitt i samtykkeskjema, og på prosjektetskildringa på Noregs Forskingsråd sine sider. 
For å få sletta data må ein sende ein epost til prosjektleiar, som søkjer i data som ligg 
transportert til Helse Vest sin forskingsserver, og slettar manuelt alt vedkomande har 




har blitt publisert ikkje kunne slettast fullt, men anonymiserast på forskingsserver slik som 
definerast i neste avsnitt. 
Ved publisering av vitskaplege artiklar i prosjektperioden kan det komme førespurnad frå 
redaktørar i tidskrift, andre forskarar eller kontrollorgan, om å få undersøke 
grunnlagsmaterialet publikasjonen byggjer på. Dette er ein del av kontrollmekanismane i 
forsking, og på rimeleg førespurnad vil vi derfor dele data utan direkte personidentifiserbare 
kjenneteikn. Dersom dette skulle bli aktuelt i prosjektperioden, vil PVO vil bli rådspurt for 
vidare sakshansaming.  
Den 31.12.2022 vil heile datamaterialet i prosjektet anonymiserast ved at koplingsnøkkelen 
blir sletta. For at datamaterialet skal være heilt anonymt, vil vi saman med NSD—Norsk 
senter for forskningsdata AS, sikre at ingen kombinasjonar av bakgrunnsopplysningar svarar 
til færre enn tre til fem personar. Etter dette kan data gjerast tilgjengeleg for open deling for 
andre forskarar ved førespurnad. Data vil bli lagra hos NSD, i samsvar med Norsk 
Forskingsråd sine retningsliner for «Tilgjengeliggjøring av forskningsdata».  
 
II.3.  Behandlingens omfang 
 
Prosjektet skal samle inn data inntil 6000 deltakarar. Prosjektet følgjer dei 
behandlingsprosessane som pasienten er i i sitt vanlege behandlingsløp. Prosjektet samlar 
inn data ved skjemaet NORSE for alle deltakarar. For dei om lag 800 som er ein 
fedmekontekst samlar ein i tillegg inn data frå dei normerte skjema Short Form 36, Obesity 
related problem scale, PROSURG, Gastrointestinal Symptom Rating Scale, og Weight Efficacy 
Short Form. For ei subgruppe på 500 personar frå deltakarar som ikkje er i fedmekonteksten 
samlar prosjektet inn tilleggsdata (ikkje som del av helsehjelp) på dei normerte skjema BDI, 
BAI og SCL90, som ikkje ordinært ville bli innsamla, for å sikre konvergent validitet for NORSE 
data. Desse samtykkar til tilleggsdata for validering ved ein eigen eksplisitt signatur til dette 
på samtykkeskjema. 
Alle dei ulike skjema som benyttast i prosjektet samlar inn opplysingar som fell under 
særlege kategoriar. I tillegg samlast demografiske data som namn, alder, arbeidslivsstatus, 
relasjonsstatus, sosioøkonomisk status og utdannningsnivå, for å kunne beskrive utvalet og 
for å kunne undersøke om det er helseforsjellar vi må vere merksame på.  Alle data i 
prosjektet handlar om deltakarane sjølv, som har samtykka til å gi denne informasjonen til 
prosjektet. Ingen data handlar om tredjepersonar. Alle data (unnateke valideringsdata for 
BDI, BAI og SCL90) som vert innsamla vert allereie bruk i ordinær klinisk behandling, slik at 
innsamlinga ikkje fører til vesentleg tilleggsbelastning for deltakarar anna enn noko meir tid 
på utfylling av skjema (om lag 15 minuttar). Prosjektet vil samle inn data når dei elles ville 
blitt innsamla i klinikken. For fedme- og primærhelsetenestekonteksten vil difor data bli 
samla inn ved eitt til tre møtepunkt, medan i PHV-konteksten vil data kunne verte samla inn 
ved NORSE vekentleg i ein behandlingsperiode. 




NORSE samlar ein inn strukturert kunnskap om psykisk helse, ressursar og behov gjennom 
95 spørsmålsledd. Desse 95 spørsmålsledda utgjer dei empiriske faktorane/dimensjonane: 1. 
Depressiv affekt, 2. Somatisk angst, 3. Ete- og kroppsbiletevanskar, 4. Traumereaksjonar, 5. 
Rusvanskar, 6. Rusmeistring, 7. Irritabilitet, 8. Håpløyse/demoralisering, 9. Kognitiv 
ruminering, 10. Situasjonell unnviking, 11. Sosial unnviking, 12. Indre unnviking, 13. 
Sjølvkritiske prosessar, 14. Kontrollbehov. 15. Daglegdags sjølvopplevd fungering 16. Vanskar 
med merksemd og hukommelse 17. Sosial tryggleik, 18. Endringskapasitet og 19. 
Tilfriskningsmiljø 
Short-Form-36 måler generell helsestatus ved hjelp av 36 spørsmål som utgjer 
dimenasjonane: 1. Fysisk funksjon, 2. Fysisk rollefunskjon, 3. Kroppsmerter, 4. Generell 
helse, 5. Vitalitet, 6. Sosial funksjon, 7. Emosjonell rollefuksnjon, 8. Mental helse. 
Obesity-related problem scale måler i kva grad kroppsvekt eller kroppsform påverkar 
psykososial funskjon ved hjelp av åtte spørsmål knytt til vanlege sosiale aktivitetar i 
dagleglivet, slik som å gå på fest, ete ute, handle klede og bade offentleg. 
PROSURG måler i kva grad kroppsvekt eller kroppsform plagar ein ved hjelp av åtte spørsmål 
knytt til: 1. fysisk aktivitet, 2. Smerter, 3. Diskriminering, 4. Søvn, 5. Seksualliv, 6. Sosial 
omgang, 7. Arbeid/skule, 8. Sjølvkjensle. PROSURG måler også tilfredsheit med behandlinga 
og grad av biverkander etter fedmekirurgi. I tillegg vert kroppsvekt, kroppshøgde og om ein 
får behandling for psykisk lidingar (depresjon og angst) og fedmerelaterte sjukdommar 
(diabetes o.s.b) kartlagt.  
Gastrointestinal Symptom Rating Scale nyttar 16 spørsmål for å kartlegge i krad ein er plaga 
av 6 hovudgrupper av gastrointestinale symptom. 
Weight Efficacy Short Form er eit kort spørreskjema på 8 spørsmål som kartlegg 
eigenmeistring kring mat. 
BDI er eit mykje brukt validert skjema som måler affektivt og kognitivt depresjonstrykk over 
21 spørsmål. 
BAI er eit mykje brukt validert skjema som måler affektiv og kogntiv angstsymptomatologi 
over 21 spørsmål. 
SCL90 er eit mykje brukt validert skjema som er eit screeninginstrument over 
symptomdimensjonane somatisering, tvangssymptomer, interpersonleg sensitivitet, 





  Tabell 1. Oversikt over dei fire delstudiane i prosjektet 
Utval  Datakjelder/lagring Lagring  av data i 
prosjektperioden 
Lagring av data etter 
prosjektslutt 
NORSE Feedback – 
tilbakemelding om 
psykisk helse i 
behandling 
 
Personar i psykisk 
helsevern i Helse Førde,  





Data blir samla inn via 
Checkware og NORSE 
FEEDBACK. Høgaste 
tryggleiksnivå i Noreg (nivå 
4) blir brukt til pålogging.  
 
Data blir brukt i  
pasientbehandling.  




Data har separat lagra 
koplingsnøkkel. 
 
Data er lagra på Helse 
Førde sin forskingsserver.  
 
 










Det er open tilgang på 
data for alle forskarar på 
førespurnad.   
NORSE Feedback - om 
psykisk helse. 
 
Personar frå den 
generelle norske 
befolkninga, 






Data blir inn via NORSE 
FEEDBACK og høgaste 
tryggleiksnivå i Noreg (nivå 
4) blir brukt til pålogging.  
 
Data blir ikkje brukt i 
pasientbehandling.   
 




Data har separat lagra 
koplingsnøkkel. 
 
Data er lagra på Helse 










Data blir lagra hos Norsk 
samfunnsvitskapleg 
datateneste.   
 
Det er open tilgang på 
data for alle forskarar på 




psykisk helse i fedme 
behandling 
 
Helse Førde,  
n = 400 
 
St. Olav Hospital,  




Data blir samla inn via 
Checkware og høgaste 
tryggleiksnivå i Noreg (nivå 
4) blir brukt til pålogging.  
 
Det blir laga avtale om 
tilgang på data til prosjektet  
frå St. Olav hospital.  
 
Data blir brukt i  
pasientbehandling.  




Data har separat lagra 
koplingsnøkkel. 
 
Data er lagra på Helse 










Data blir lagra hos Norsk 
samfunnsvitskapleg 
datateneste.   
 
Det er open tilgang på 
data for alle forskarar på 
førespurnad.   
NORSE Feedback – 
tilbakemelding om 
psykisk helse i 
fastlegekonsultasjonen 






Data blir samla inn via 
NORSE FEEDBACK og 
høgaste tryggleiksnivå i 
Noreg (nivå 4) blir brukt til 
pålogging.  
 
Det blir laga avtale om 
tilgang på data drå Førde 
kommune Førde kommune.   
 
Data blir brukt i 
pasientbehandling.  




Data har separat lagra 
koplingsnøkkel. 
 
Data er lagra på Helse 
Førde sin forskingsserver.  






Data blir lagra hos Norsk 
samfunnsvitskapleg 
datateneste.   
 
Det er open tilgang på 
data for alle forskarar på 





II.4.  Formålsbeskrivelser 
Formålet med databehandlinga er å gjennomføre forskingsprosjektet «NORSE: Building 
bridges between psyche and soma through personalized and dynamic mental health 
systems». Formålet til forskingssprosjektet er definert til å svare på forskingsspørsmåla: 
Psykisk helsefeltet 
Kva er psykometrisk valide normar for menneske med psykiske helseplager for Norse 
Feedback? 
Korleis samsvarer Norse Feedback med andre mål på helse? 
Korleis er psykisk helse i Noreg samanlikna med USA? 
Utvikle prediktive analyser for betre kliniske beslutningar. 
Overvektsfeltet 
Kva er psykometrisk valide normar for mennesker med behandlingstrengande overvekt for 
Norse Feedback? 
Utvikle kunnskap om når psykiske helsevanskar for menneske i behandling for alvorleg 
overvekt treng merksemd og behandlign 
Utvikle prediktive analyser for å betre kliniske beslutningar. 
Kva treng pasientar og klinikarar i overvektsfeltet frå ein psykisk helse-system? 
Utvikle protokoll for gode psykise helsetenester integrert i overvektsklinikkar. 
Fastlegefeltet 
Korleis kan psykisk helsekunnskap gjerast meir tilgjengeleg i fastlegemøtet for å betre 
tenester? 
Utvikle protokoll for gode psykiske helsetenster integrert i fastlegemøta. 
 
Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Hva er formålet med behandlingen? Samtykkebasert 
forsking. Sjå punkt 
II.4.  
2. Vil formålet være å treffe avgjørelser om enkeltpersoner 
basert på systematisk og omfattende analyse av personlige 
aspekter? 
Nei. Forskinga skal 
bidra til å utvikle 
betre helsetenester.  
3. Vil behandlingen av personopplysninger ha som mål å ta 
beslutninger som får betydning for den registrerte? 
Nei. Forskinga skal 
bidra til å utvikle 
betre helsetenetster.  
4. Skal opplysningene brukes til å profilere den registrerte? Nei. Forskinga 
fokuserar på  
analysar for å nå 
studien sine føremål. 
5. Brukes personopplysninger for å avdekke ukjente sider eller 
for å gjenkjenne mønstre ved den registrerte? 
Nei. Forskinga 
fokuserar på  
analysar for å nå 





DEL III. Behandlingens lovlighet 
 
 III.1. Hjemmelsgrunnlag 
 
Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Finnes det hjemmelsgrunnlag i forskrift eller lov for 




2. Finnes det annet rettsgrunnlag for behandlingen (for 
eksempel samtykke, avtale, verne vitale interesser, 
utførelse av myndighetsoppgave, oppfylle rettslig 
forpliktelse, jf. GDPR art.6)? 
Informert samtykke. 
GDPR artikkel 6(1)a og 
artikkel 9(2)a 
3. Finnes det konsesjon eller forhåndsgodkjenning fra REK 
eller Datatilsynet, eller dispensasjon fra taushetsplikten? 
Nei. Fritak frå teieplikta 




III.2.  Samtykke 
Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Forutsettes det samtykke for behandlingen? Ja, fordi opplsysingane vert brukt til 
anna enn behandling.  
2. Hvordan vil samtykke bli innhentet? Infomert skriftleg samtykke , sjå 
vedlagt informasjonsbrev og 
samtykkeskjema. 
3. Er alle kravene til samtykke oppfylt? 
Samtykke fra den registrerte må være frivillig, 
spesifikk, informert og utvetydig (GDPR art.4). 
Ja. Sjå vedlagt informasjonsbrev.  
4. Dokumenteres samtykke?  Ja, skriftleg/elektronisk.  
 5. Kan samtykke trekkes tilbake like enkelt som 
det gis? 
Ja. Melding til prosjektansvarlege 
om dette gir sletting av data frå 
forskingsserver. 
6. Foreligger det informasjon til den registrerte 
om muligheten til å trekke tilbake samtykke? 
Ja, sjå vedlagt informasjonsbrev.  
7. Omfatter samtykket alle behandlinger og 
behandlingsformål som nevnt i DEL IV? 
Ja, sjå vedlagt informasjonsbrev.  
 
- Gjennomgang av samtykke og vilkår for samtykke. Kontroller at samtykke ikke 
sammenblandes med kontrakt eller personvernerklæring.  
- Gjennomgang av begrensninger eller mulighetsrom som samtykket gir. Beskriv 





III.3.  Viderebehandling 
 
[Dette punktet besvares kun dersom behandlingen er en viderebehandling av 
personopplysninger som tidligere er samlet inn for et formål.] 
 
Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Behandles opplysninger videre til andre formål enn 
opprinnelig formål (for eksempel forskning)?  
Ja. Opplysingar som er 
brukt som ein del av 
praksis vil også bli brukt til 
forsking.  
2. Dersom rettsgrunnlag for opprinnelig behandling av 
personopplysninger er lov eller forskrift, åpner lov 
eller forskrift for viderebehandling av 
personopplysninger? 
Ja. Helseregisterlova §. 9.  
3. Dersom opprinnelig behandling er basert på 
samtykke, dekker samtykket viderebehandlingen av 
de samme personopplysningene?  
Ja, samtykket dekkar dette.  




nyttast berre for 
forskingsmessige formål.  
   
   
 
III.4.  Vurdering av formålet sett opp mot rettsgrunnlag 
 
Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Er formålet eller formålene klart definert?  Ja. Sjå punkt. II.4.  
2. Er formålet nedfelt i forskrift eller lov? Ja. Sjå punkt III. 1-3.  
3. Vil det være kontrollformål (for eksempel i annen 
lovgivning innenfor skatt, NAV, toll, politi, forsikring?) 
Nei. Sjå punkt III. 1-3. 
4. Er det noe i egen forskrift eller andre forskrifter eller 
lover som begrenser formålet? 
Nei. Sjå punkt III. 1-3. 
5. Er formålet beskrevet i løsning, tjeneste eller system 
utfordrende sett opp mot rettsgrunnlaget? 
Nei. Sjå punkt III. 1-3. 
6. Omfatter rettslig grunnlag både egne formål og 
utlevering?  
Utlevering av 




Nr. Vurderingsspørsmål Svar (forklar svar) 
aktuelt.  
Det kanvere aktuelt med 
tilgjengeleggjering av 
anonyme datasett for 
vitskaplege tidsskrift saman 
med publikasjonar etter 
31.12.2022. 
7. Er formålet definert slik at det samsvarer med 
forventningene de registrerte kan ha ut fra egen 
forskrift, lov eller samtykkevilkår? 




III.5.  Oppsummering 
 
Forskingsprosjektet «NORSE: Building bridges between psyche and soma through 
personalized and dynamic mental health systems» samlar inn data frå 6000 mennesker 
om ulike helseaspekt, som definert i denne utgreiinga, for å svare på 
forskingsspørsmåla som er definert over. Målet er å betre helsetenster. REK Vest har 
vurdert at prosjektet ikkje fell inn under helseforskingslova. Det påligg ansvarleg 
institusjon Helse Førde å ivareta personvernmessige og etiske aspekt ved prosjektet. 
Lovheimelsgrunnlaget til dette er eksplisitt samtykke etter Personopplysingslova 2018, 
og GDPR artikkel 6(1)a og artikkel 9(2)a. Det er ikkje aktuelt med vidarebehandling av 
data utover formålet, og identifiserbare data skal ikkje delast. 
 
 
DEL IV.  Behandling av personopplysninger 
 
IV.1.  Oversikt over behandling og behandlingsaktiviteter 
 
Nr. Behandling 
Detaljert beskrivelse av 
behandlingsaktiviteter 
1. Innsamling Skildra i II.2, Tabell 1 og 
informasjonsbrev.   
2. Lagring Skildra i II.2, Tabell 1 og 
informasjonsbrev.   
3. Deling Skildra i II.2, Tabell 1 og 
informasjonsbrev.   
4. Gi tilgang til Skildra i II.2, Tabell 1 og 
informasjonsbrev.   
5. Retting Skildra i II.2, Tabell 1 og 





Detaljert beskrivelse av 
behandlingsaktiviteter 
6. Sletting Skildra i II.2, Tabell 1 og 
informasjonsbrev.   
   
   
   
IV.2. Systematisk beskrivelse og vurdering av behandling av 
personopplysninger 
 
Denne delen av malen er gjennomgått over i detalj, og det visast gjennomgåande 
til punkt II om ikkje anna er definert.  
 
IV.2.1.  Innsamling 
 
Nr. Vurderingsspørsmål Svar (forklar svar) 




(sjå punkt II.3.).  
2. Er noen av personopplysningene over kategorisert som 
særlige kategorier av personopplysninger? (for eksempel 
helseopplysninger, rase, fagforening osv.) 
Helseopplysingar (sjå 
punkt II.3.). 
3. Hvordan samles personopplysningene inn? Ved overføring av data 
frå e-plattform til 
forskingsserver innan 
Helsevest sitt IKT 
system.  Eigne avtalar 
vert gjort med Førde 
kommune og St.Olav 
Hospital om overføring 
av data frå dei. Skildra i 
II.2, Tabell 1 og 
informasjonsbrev.   
4. Samles personopplysningene inn direkte fra de registrerte 
selv eller fra andre kilder? 
Ja, direkte frå den 
registerte, via 
Checkware og/eller 




Er det noe som er særlig inngripende ved måten 
personopplysningene samles inn (for eksempel ved hjelp 
 




Nr. Vurderingsspørsmål Svar (forklar svar) 
av fingeravtrykk, kamera- eller lydopptak, eller sporing av 
en persons lokasjon, biometri)? 
6. Samles det inn flere opplysninger enn det som er 
nødvendig ut fra formålet? 
Nei, berre opplsyingar 
knytt til foremålet med 
prosjektet (sjå punkt 
II.3.). 
7. Får den registrerte all informasjon som er påkrevd etter 
GDPR art.13 og 14? 
Ja, sjå vedlagt 
informasjonsbrev.  
   






IV.2.2. Lagring  
 
          Sjå også tabell 1.  
 
Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Hvordan skal opplysningene lagres? På Helse Førde sin 
forskingssever.  
2. Hvor og hvor lenge lagres personopplysningene?  
 




3. Hvilke kriterier brukes for å bestemme lagringstid?  Ferdigstilling av valide 
datasett med alle 
planlagte 
måletidspunkt.   
4. Når skal personopplysningene slettes? Kodenøkkel slettast 
ved prosjektslutt 
31.12.2022.  
5. Etter at formålet ved behandlingen er oppnådd, hvor lenge 
lagres personopplysningene før de slettes? 
Personopplysingar blir 
ikkje lagra etter at 
behandlinga er 
oppnådd.  
6. Er det utarbeidet rutiner for sletting? Ja. Personopplysingar 
blir sletta av Christian 
Moltu og John Roger 
Andersen ved 
prosjektslutt.  
7. Gis det informasjon til den registrerte om muligheten til å 
slette opplysninger og hvordan sletting kan gjøres? 
Ja, sjå vedlagt 
informasjonsbrev.  
   








Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Utleveres eller tilgjengeliggjøres det personopplysninger til 
andre utenfor virksomheten? 
 
Nei personopplysingar 
vil ikkje bli delt. Men 
data er utan direkte 
personidentifiserbare 
kjenneteikn blir gjort 
tilgjegeleg for 
samarbeidspartnar i 
prosjektet. Sjå punkt 
2- 4 nedanfor.  





ikkje utlevert.  
Data utan direkte 
personidentifiserbare 
kjenneteikn blir delt 
innafor Helse Førde 
sitt IKT-system.   
3. Er alle mottakere av personopplysninger identifisert og 
dokumentert (for eksempel ansatte, databehandlere, 
tredjeparter, eksterne virksomheter osv.)?  
 
Ja, Christian Moltu og 
John Roger Andersen, 
er anvarlege for dette.    
 
4. a. Hvordan deles personopplysningene mellom avdelinger 
internt i virksomheten? 
Personopplysingar blir 
ikkje utlevert. 
b. Hvilke personopplysninger deles med hvilke avdelinger 
og hva er formålet med hver av disse delingene? 
Personopplysingar blir 
ikkje utlevert. 
5. a. Hvilke eksterne virksomheter deles 




b. Hvilke personopplysninger deles eksternt, for hvilket 
formål og med hvilke rettslige grunnlag? 
Personopplysingar blir 
ikkje utlevert. 
6. Vil personopplysningene overføres til andre land utenfor 
EU/EØS-området, og hva er det rettslige grunnlaget for 
overføringen? 
Nei.  
7. Vil personopplysninger overføres til tredjestater eller 
internasjonale organisasjoner (GDPR art.44-49)? 
Personopplysingar blir 
ikkje utlevert. 
8. Hvordan sikres etterlevelse av forordningen ved overføring 
til utlandet? 
Personopplysingar blir 




9 Finnes det annet regelverk, atferdsnormer/bransjenormer og 
retningslinjer som må følges? 
Ikkje aktuelt. 
Personopplysingar blir 
ikkje delt.  
   




Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Hvem har tilgang til opplysninger? Christian Moltu og 
John Roger Andersen 
2. Finnes det dokumentert rutiner for tilgangsstyring? Ja jmfr Helse Vest sine 
rutinar.  
3. Vil tilgangsstyringen for brukergruppene være rollebasert og 
tidsbegrenset? 
Ja jmfr Helse Vest sine 
rutinar. 
4. Dersom det gis tilgang utenfor virksomheten, er det signert 
databehandleravtaler eller taushetserklæring? 
Dette vil bli gjort ved 
behov for data er utan 
direkte  
personidentifiserbare 
kjenneteikn. Sjå punkt 
I.V. 2-3. 
   




Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Finnes det mulighet for retting av feil i den registrertes 
opplysninger? 
Ja, opplysingar kan 
rettast manuelt på 
forskingsserver.  
2. Gis det informasjon til den registrerte om muligheten til å 
rette opplysninger og om hvordan retting kan gjøres?  
Ja, i 
informasjonsbrevet.  
3. Finnes det dokumenterte rutiner for retting? Ja, sjå punkt II og 
informasjonsbrev.   
4. Dersom den registrerte ikke selv kan rette feil i egne 
personopplysninger, finnes det andre måter å gjøre det på? 
Den registrerte kan 
ikkje  rette feil i eigne 
personopplysninger. 
Dette må gjerast av  
Christian Moltu eller 




   




Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Finnes det mulighet for sletting av den registrertes 
opplysninger? 
Ja, før data 
annonymiserast ved 
prosjektslutt.  
2. Gis det informasjon til den registrerte om muligheten til å 
slette opplysninger og om hvordan sletting kan gjøres? 
Ja, dette er beskrive 
informasjonsbrevet.  
3. Finnes det dokumenterte rutiner for sletting? Ja, er beskrive i   
informasjonsbrevet. 
Sjå også punkt IV.2.2.  
4. Dersom den registrerte ikke selv kan slette egne 
personopplysninger, finnes det andre måter å gjøre det på? 
Ja, ved å kontakte 
Christian Moltu  eller 
John Roger Andersen.  
5. Finnes det rettsgrunnlag i lov eller forskrift som gir grunnlag 
for å nekte sletting?  
Nei, opplysingar vil 
alltid bli sletta når den 
registerte ønskjer det.   
   




IV.3. Vurdering av sammenheng behandlingen utføres i (kontekst) 
 
[I denne delen vurderes behandlingen i et større bilde. Alle interne og eksterne 
faktorer som kan påvirke forventninger eller konsekvenser vurderes her.] 
 
Nr. Vurderingsspørsmål Svar (forklar svar) 
1.  Vil det behandles personopplysninger fra ulike datasett, som 
er innsamlet for ulike formål og fra ulike 
behandlingsansvarlige?  
Nei, berre data til 
formåla i prosjektet vil 
bli behandla (sjå punkt 
II.3).  
2.  Hvilke kilder brukes for innhenting av personopplysninger? Klinisk 
tilbakemeldingssystem 
(Checkware og NORSE 
FEEDBACK). Sjå punkt 




3.  a. Kobles systemene der opplysninger behandles opp mot 
andre informasjonssystemer? 
Nei, data som skal 
samlast inn er kun på 
forskingsserver som 
beskrive.  
b. Finnes det tidligere erfaring med tilsvarende type 
behandling? 
Ja, liknande 
prosedyrar for lagring 
og handtering av data 
har blitt nytta før i 
Helse Førde.  
4.  Finnes det noen nåværende tilfeller av allmenn bekymring 
for den beskrevne måten å behandle personopplysninger på?  
Nei. Ingen slike er 
kjende.  
5.  Hvilken relasjon har den behandlingsansvarlige med de 
registrerte? Beskriv maktforholdet mellom dem.  
Christian Moltu driv 
pasientbehandling i 
psykisk helsevern, 
medan John Roger 
Andersen ikkje gjer 
dette.  
6.  Med tanke på at kompleksitet i den sammenheng 
behandlingen utføres i (kontekst), i hvilken grad har de 
registrerte kontroll over sine opplysninger? 
Vi brukar berre 
opplsysnigar som 
beskrive til formålet, 
og den registerte kan 
få innsyn i sine 
opplysingar gjennom 
Christian Moltu eller 
John Roger Andersen.  
7.  Beskriv hvordan behandlingen vil oppfattes fra den 
registrertes synsvinkel. Kan for eksempel de registrerte 
oppfatte behandlingen som lite forutsigbar? 
Behandlinga er stabil 
og beskrive i 
informasjonsbrev.  
8.  Vil den registrerte ha en særskilt forventning om 
konfidensialitet (for eksempel dersom det omhandler helse, 
velferd, arbeidsforhold, kommunikasjon, lokasjon)? 
Ja, dei vil forvente at 
vi vernar om deira 
personopplysingar i 
høve til gjeldane 
regelverk og 
informasjonsbrev.  
   
   
 
 
IV.4.   Innebygd personvern 
 




1.  Hvordan tenkes innebygd personvern og personvern som 
standardinnstilling ivaretatt i løsningen med tanke på:  
Det ligg føre godkjent 
ROS analyse på Chekware 
og forskingsserver. ROS 
analyse på NORSE 
FEEDBACK plattform vil 
ligge føre før bruk. Begge 
verktøy vil vere ein del av 
vanleg praksis i Helse 
Førde.  
a. kravene til design? Ivaretatt som ein del av 
praksis. Sjå punkt. 1.  
b sikker koding? Ivaretatt som ein del av 
praksis. Sjå punkt. 1. 
c. testing og godkjenning før produksjonssetting? Ivaretatt som ein del av 
praksis. Sjå punkt. 1. 
d. kontinuitets- og beredskapsplaner? Ivaretatt som ein del av 
praksis. Sjå punkt. 1. 
e. jevnlige revisjoner? Ivaretatt som ein del av 
praksis. Sjå punkt. 1. 
f. opplæring? Ivaretatt som ein del av 
praksis. Sjå punkt. 1. 
2.  Er alle prinsippene for behandling av personopplysninger 
ivaretatt i løsningen? – Se DEL V.1 
Ja.  
3.  Hvordan er den registrertes rettigheter ivaretatt i 
løsningen? – Se DEL V.2 for hvilke rettigheter er det snakk 
om. 
Er ivaretatt tilfrestillande. 
Sjå punkt II.2, Tabell 1 og 
informasjonsbrev.   
4.  Tas ny teknologi i bruk? Sjå punkt.1.1. og 1.2.  
Teknologien alt er i bruk 
som ein del av klinisk 
praksis i Helse Førde.  
5.  Brukes eksisterende teknologi på en ny måte? Teknologien alt i bruk i 
klinisk praksis i Helse 
Førde.  
   
   
 
IV.5.   Ansvarsforhold* 
 




1.  a. Er det noen avtale eller kontrakt med eksterne 




kommune og St. Olav 
hospital vil ligge føre 
innan datasamlinga 
startar. PVO vil blir 
rådspurt.  
b. Gjenspeiler avtalen hvilke begrensninger som gjelder for 
behandling av personopplysningene? 




Sjå også punkt a 
ovenfor.  
2. a. Brukes det databehandler? Ja, i prosjektet med 
Førde kommune og 
St.Olav hospital vil 
Helse Førde vere 
databehandlar.  
b. Er alle databehandlerne identifisert og er forholdet til 
dem avklart gjennom avtaler (GDPR art.28 nr.3)? 
Sjå punkt 1. a–b og 
2.a.  
3. Om databehandleravtale:   
a. Gir databehandleren tilstrekkelige garantier for at egnede 
tekniske og organisatoriske tiltak som sikrer at 
behandlingen er i samsvar med forordningen (GDPR 
art.28 nr.1) vil gjennomføres? 
Ja, det er ein 
føresetnad at dette 
ligg føre.  
b. Er personvernprinsippene, for eksempel 
formålsbegrensning, dataminimering, lagring med videre 
ivaretatt i avtalen? 
Ja, avtalar skal 
ivareta dette.  
c. Er de registrertes rettigheter og friheter ivaretatt i 
avtalen? 
Ja, avtalar skal 
ivareta dette.  
   
   
 
          Merknad: Helse Førde skal ta imot data frå Førde kommune og St. Olav hospital som   
          ein del av prosjeket (vere databehandlar). Desse organisasjonane vil gjere sine  
          sjølvstendige vurderingar om dette etter at Helse Førde si DPIA ligg føre. Etter dette vil  
          avtalar om overføring av data til Helse Førde bli utvikla.  
 





Nr. Vurderingsspørsmål Svar (forklar svar) 
1. Vil planlagte behandlinger gjøre det lett eller vanskelig for den 
registrerte å utøve sine rettigheter? 
Lett. Sjå punkt II.2, 
tabell 1 og 
informasjonsbrev.   
2. Vil planlagte behandlinger ut fra den registrertes synsvinkel 
preges av uforutsigbarhet eller lite åpenhet? 
Nei.  Sjå punkt II-2, 
tabell 1 og 
informasjonsbrev.   
3. Er det usikkerhet knyttet til hvordan grunnleggende prinsipper 
for behandling av personopplysninger ivaretas (GDPR art.5)? 
Nei. Det er ikkje 
utryggleik relatert 
til dette.  
   
   
 
Her oppsummeres vurderingene om behandlingene som er gjort i DEL IV. 
 
 
Del V. Nødvendighet og forholdsmessighet av behandlingen 
 
[Denne delen inneholder en vurdering av om behandlingsaktivitetene er nødvendige og står i 
rimelig forhold til formålene med behandlingen.] 
 
V.1.  Personvernprinsippene 
 
Nr. Vurderingsspørsmål Svar (forklar svar) 
1 Er behandlingen basert på lovlighet, rettferdighet og åpenhet 
(GDPR art.5.1 bokstav a og art.6 og 9)? 
Ja, sjå punkt. II.2-3, 
tabell 1 og 
informasjonsbrev.  
a. Kommer det rettslige grunnlaget/behandlingsgrunnlaget 
tydelig frem? 
Ja, sjå punkt. II.2-3, 
tabell 1 og 
informasjonsbrev. 
b. Vurder rimeligheten av behandlingen: Hva er forventede 
fordeler ved behandlingen? For virksomheten, den 
registrerte, samfunnet for øvrig osv. 
Behandlinga er 
rimelig, sjå punkt. 
II.2-3. Prosjektet skal 
gi  betre og meir 
forsvarlege 
helsetenester.  Noko 
helsetenesta er 





c. Hva vil konsekvensene være dersom behandlingene ikke 
gjennomføres? 
Forsking på utvikling 
av betre 
helsetenester blir 
ikkje gjort. Dette kan 
poensielt føre til 
pasientskadar og 
unødvendig liding.  
d. Vurder hvordan åpenhet ivaretas i behandlingen. God informasjon til 
implserte partar om 
alle forhold. Sjå 
punkt II.2, tabell 1 
og informasjons-
brev.  
2 Formålsbegrensninger  
a. Er formålet definert slik at det samsvarer med 
forventningene til de registrerte? 
Ja, sjå punkt. II.2-4 
og 
informasjonsbrev.  
B Har det vært vurdert andre alternativer for å oppnå 
formålet med behandlingen? 
Det finnest ingen 
andre gode 
alternativ.  
c. Finnes det mindre personverninngripende alternativer for 
å oppnå det samme formålet? 
Nei. Vi har lagt stor 
vekt på å gjere dette 
så lite inngripande 
som mogleg.  
D Vurder hvorvidt formålet kan oppnås med anonyme eller 
pseudonyme alternativer. 
Ikkje mogleg pga 
hantering av reperte 
målingar og at 
høgaste 
tryggleiknivå (nr 4) 
skal nyttast i 
datasamlinga.  
3 Dataminimering. 
Kan formålet oppnås ved for eksempel: 
 
a. å begrense innsamling av personopplysninger? Nei, minimum er 
som planlagt.  
b. med mindre detaljerte personopplysninger? Nei, minimum er 
som planlagt. 
c. uten fortrolige eller sensitive personopplysninger? Nei, minimum er 
som planlagt. 
Begrunn nødvendighet og relevans relatert til formål for alle 
opplysninger som behandles. 
Sjå punkt. II.2-4 og 
informasjonsbrev. 





naudsynt for å 
forske på utvikling 
av betre 
helsetenester.  
4 Riktighet  
a. Vurder hvordan personopplysninger holdes korrekte og 
oppdaterte, med og uten den registrertes involvering. 
Ivaretatt som ein del 
av praksis, samt ved 
dobbeltsjekking av 
forskingsserver av 
dei ansvarlege.  
b. Vurder om det finnes nødvendig funksjonalitet for å rette 
og slette uriktige personopplysninger, ref. punkt IV.2.5 og 
IV.2.6. 
Ja, sjå punkt. II.2.  
c. Har dere rutiner som ivaretar kravet til korrekte og 
oppdaterte personopplysninger? 
Ja, ivaretatt som ein 
del av praksis.  
5 Lagringsbegrensning  
a. Vurder om personopplysninger lagres etter at formålet er 




b. Vurder når personopplysninger anonymiseres eller 




c. Vurder hvilke garantier som må være plass dersom 
personopplysninger skal lagres i lenger perioder grunnet 
arkivformål i allmennhetens interesse, for formål knyttet 
til vitenskapelig eller historisk forskning eller for statistiske 
formål (GDPR art.89 nr.1).  
Ikkje aktuelt.  
6. Integritet og konfidensialitet – se DEL VI.1. Er ivaretatt. 
   
   
 
V.2.  Ivaretakelse av de registrertes rettigheter 
 
Nr. Vurderingstemaer Vurdering 
1. Vurder hvordan informasjon til de registrerte gis (prinsippet 




2. Vurder hvordan den registrertes rett til innsyn ivaretas (GDPR 
art.15). 
Ved å kontakte 








3. Vurder hvordan den registrertes rett til retting og sletting 
ivaretas (GDPR art.16 og 17). 
Ved å kontakte 
Christian Moltu eller 
John Roger 
Andersen. Dei kan 
også kontakte 
personvernombodet. 
4. Vurder hvordan den registrertes rett til innsigelser og 
begrensning av behandling ivaretas (GDPR art.18, 19 og 21). 
Ved å kontakte 





5. Vurder hvordan den registrertes rett til dataportabilitet 
ivaretas (GDPR art.20). 
Den registerte kan få 
tilgang til alt som er 
registert på 
forskingsserver om 
seg sjølv.  
6. Vurder hvordan forbud mot automatiserte individuelle 
avgjørelser, herunder profilering håndheves (GDPR art.22). 





   
   
 
V.3.  Ivaretakelse av de registrertes friheter 
 
Nr. Vurderingstemaer Svar (forklar svar) 
1. Vurder hvordan de registrertes friheter i forhold til Den 
europeiske menneskerettskonvensjonen (EMK) er tatt hensyn 
til:  
 
  Retten til privatliv og kommunikasjonsvern Deltaking er frivillig 
samtykkebasert.  






og fører ikkje til 
forskjellbehandling.  
  Tanke-, tros- og religionsfrihet Ingen forhold ved 
prosjektet skal truge 
dette.  
  Ytrings-, og informasjonsfrihet Ingen forhold ved 
prosjektet skal truge 
dette. 
   
   
 
 
V.4.  Oppsummering 
 
Her oppsummeres vurderingene om prinsippene, ivaretakelse av de registrertes 
rettigheter og ivaretakelse av de registrertes friheter som er gjort i DEL V. 
 
 
Del VI. Personvern risikoanalyse og planlagte tiltak 
 
[Denne delen inneholder vurdering av risiko for de registrertes rettigheter og friheter, samt 
planlagte tiltak for å håndtere risikoene]. 
 
VI.1. Risiko, konsekvenser og sannsynlighet 
 
VI.1.1. Sikkerhet ved behandlingen 
 [Fokuset i denne delen bør være sikkerhet i løsningen] 
 
Nr. Vurderingsspørsmål Svar (forklar svar) 
1.  Er personopplysningssikkerheten tilstrekkelig ivaretatt?   
a. Er det gjort en risikovurdering av løsningen (også ved 
endringer)?  
 
Ved vurderingen av egnet sikkerhetsnivå skal det særlig 
tas hensyn til risikoene forbundet med behandlingen, 
særlig som følge av utilsiktet eller ulovlig tilintetgjøring, 
tap, endring eller ikke-autorisert utlevering av eller 
tilgang til personopplysninger som er overført, lagret 
eller på annen måte behandlet. 
Innhenting av data 
med Checkware/ 
NORSE FEEDBACK 
baserast på  ROS 
analysar for bruk i 
klinisk praksis.  
 








naudsynt, blir Helse 
vest si løsing «Trygg 
lagring» brukt. Data 
på sever for «Trygg 
lagring» blir sletta når 
data er komt på 
forskinsgserver.  
 
b. Er det gjennomført tiltak for å håndtere risiko? 
 
Ved valg av tiltak skal det tas hensyn til den tekniske 
utviklingen, gjennomføringskostnadene og 
behandlingens art, omfang, formål og sammenhengen 
den utføres i, samt risikoene av varierende 
sannsynlighets- og alvorlighetsgrad for fysiske 
personers rettigheter og friheter. 
Ja, det er lagt vekt på 
å berre samle inn 
naudsynte data og 
bruke standard 
løysingar som er 
rekna som er 
vuerdert som trygge 
av Helse Vest IKT.  
c. Er restrisiko håndterbar og akseptabel? Ja.  
2. Er alle iverksatte og planlagte tekniske og organisatoriske 
tiltak egnet til å sikre personopplysningenes konfidensialitet, 
integritet og tilgjengelighet? 
Ja. Sjå punkt II.2. 
tabell 1 og 
informasjonsbrev.   
3. Beskriv hvilke forhåndsregler som tas for å beskytte 
personopplysninger (taushetserklæringer, 
databehandleravtale, atferdsnormer/bransjenormer, 
sikkerhetstiltak osv).  
Sjå punkt II.2, tabell 1 
og informasjonsbrev.  
Vi føl dei til ei kvar tid 
gjeldande reglar for å 
beskytte 
personopplysningar 




   




Nr. Vurderingstemaer Vurdering 
1. Med utgangspunkt i den registrertes perspektiv for hver 
risiko kan for eksempel følgende vurderes:  
 
a. Manglende reell medbestemmelse - den registrerte har 
ikke et valg, får ikke informasjon, får ikke innsyn, og så 
videre. 
Nei. Sjå punkt II.2 og 




b. Manglende reell åpenhet - virksomheten evner ikke å 
forklare komplekse behandlinger eller forventet resultat 
ved sammenstilling av personopplysninger med andre 
datasett og så videre 
Nei. Sjå punkt II.2 og 
informasjonsbrev.  
c. Manglende forutsigbarhet ved behandlingen - 
behandlingen er utenfor det den registrerte vil forvente 
og så videre. 
Nei. Sjå punkt II.2 og 
informasjonsbrev.  
2. Hvilke konkrete rettigheter og friheter står i fare for å ikke 
innfris, jf. GDPR art.12-22 (rettigheter) og retten til privatliv, 
kommunikasjonsvern, ytringsfrihet, tanke-, tros- og 
religionsfrihet, retten til ikke å bli diskriminert og så videre 
(friheter)? 
 
Ingen. Sjå punkt II og 
informasjonsbrev.  
   
   
 
Generelt for vurdering av "Sikkerhet ved behandlingen" og "Personopplysningsvernet":  
- Vurder risikoens opprinnelse, art, særegenhet og alvorlighetsgrad. 
- Avklar potensielle konsekvenser for den registrertes personopplysningsvern for 
hvert risikoscenario. 
- Anslå alvorlighetsgrad for hver risiko, særlig avhengig av hvilken inngripen en 
potensiell virkning har på den registrerte. 
- Identifiser trusler og egenskaper ved løsningen som kan føre til hendelser og 
hvilke risikokilder som kan forårsake dem. Hvordan kan dette skje? 
- Anslå sannsynlighet for at en hendelse oppstår, særlig ut fra en 






VI.2. Vurdering av planlagte tiltak 
 
Nr. Vurderingstemaer Vurdering 
1. Beskriv tiltak for å håndtere risikoene for de registrertes og 
andre berørte personers rettigheter og berettigede 
interesser. 
 
Eksempler på tiltak kan være: 
- Garantier: krav til fornyet samtykke, rett til 
reservasjon osv. 
- Sikkerhetstiltak: tilgangskontroll, anonymisering, 
kryptering osv. 
- Mekanismer: funksjonalitet som er 
personvernfremmende for eksempel logging og 
sperring av tilgang eller sperring av informasjon  




Studien har tydeleg 
føremål om betring 
av helsetenester og 







med rutinar for 
innsyn, å gjere 




av datalagring på 
forskingsserver med 
seperat lagring av 
ID-nøkkel.  
Avgrensa tilgang til 
forskingsserver 







2. Ut fra tiltakene, vurder om:  
a. sikringen av vernet av personopplysninger er tilstrekkelig Er tilstrekkeleg. Sjå 
ovanfor og punkt 
II.2.  
b. de registrertes og andre berørte personers rettigheter og 
berettigede interesser er hensyntatt 
Er tilstrekkeleg. Sjå 





c. identifiserte risikoer er håndtert og akseptable Er tilfredstillande 
ivaretatt. Sjå ovanfor 
og punkt II.2.  
d. det er restrisiko etter alle planlagte tiltak Nei.  
   
   
 
Kontroller om det er nødvendig eller mulig å forbedre hvert tiltak etter 
personvernregelverket og beste praksis innen sikkerhet. Hvis ikke, foreslå ytterligere 





1. Prosjektsøknaden som fekk 10 mill NOK hos Norsk Forskingsråd.  
2. Den vitskaplege kommiten hos Norsk Forskingsråd si vurdering av prosjektet basert 
på kvalitet og nytte.  
3. Etisk komite si vurdering av prosjektet. 






Del VII. Involvering av personvernombudet 
 
[I denne delen legges det opp til en vurdering fra personvernombudet. Personvernombudet 
involveres etter at DEL I – VI av denne malen er gjennomført.] 
 
 
Vurdering fra personvernombudet 
NSD har gått gjennom personvernkonsekvensvurderingen og anbefalt enkelte endringer og 
presiseringer i vurdering og informasjonsskriv. Vurderingen og informasjonsskrivene er revidert i 
henhold til dette, og NSD stiller seg bak vurderingen slik den foreligger. Det er dermed NSDs 
vurdering at behandlingen kan gjennomføres i samsvar med personvernforordningen, uten behov 
for forhåndsdrøfting med Datatilsynet. 
 
Med vennlig hilsen  
 
Lasse Raa 
Seniorrådgiver | Senior Adviser 
Seksjon for personverntjenester | Data Protection Services 
T: (+47) 55 58 20 59  
 
NSD - Norsk senter for forskningsdata AS | NSD - Norwegian Centre for Research Data Harald 
Hårfagres gate 29, NO-5007 Bergen 
T: (+47) 55 58 21 17 









[I denne delen legges opp til en validering av DPIA av ledelsens gjennomgang, beslutning og 
godkjenning.] 
 
Nr. Vurderingstemaer Vurdering 
1. Ledelsen vurderer hvorvidt de planlagte tiltakene, restrisikoen og 
handlingsplan er akseptable. 
Ein tek NSD si 
vurdering til 
vitende, og legg 






2. Ledelsen beslutter og begrunner om DPIA er  
o Godkjent/validert: Behandling kan starte opp.  
o Betinget av forbedringer (forklar på hvilken måte): Revidert DPIA 
skal legges frem for ledelsen på nytt.  






   
 
 
Dersom en DPIA har blitt behandlet i ledergruppen mer enn én gang, risikoen fremdeles er 
høy og viljen til å gjennomføre fremdeles er stor, må dere anmode Datatilsynet om 
forhåndsdrøftelse i tråd med GDPR art.36. Virksomheten må dokumentere at den ikke greier 





























© 2018. Direktoratet for e-helse. Malen er utviklet av GDPR-prosjektet i Direktoratet for e-helse, og tilpasset egne forhold i 
direktoratet. Alle virksomheter er selv ansvarlige for å vurdere om innhold i malen er dekkende for egne behov. Merk at 
direktoratet jobber kontinuerlig med å oppdatere malen for internt bruk, og anbefaler alle virksomheter som bruker malen 
til å gjøre vurderinger av når det er nødvendig med egne oppdateringer. 
Etter GDPR art.83.4 bokstav a kan manglende eller feil utførelse av DPIA, eller manglende rådføring med korrekte instanser, 
innebære administrative bøter for Behandlingsansvarlig opptil 10 millioner Euro, eller, om det gjelder en virksomhet, bøter 
på opptil 2 % av den totale globale årsomsetningen under foregående budsjettår, avhengig av hvilken verdi som er høyest.  
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FORESPØRSEL OM DELTAKELSE I FORSKNINGSPROSJEKTET  
 
NORSE FEEDBACK OBESITY – 
TILBAKEMELDING OM PSYKISK HELSE I 
FEDMEBEHANDLING 
Du blir med dette invitert til å delta i et forskningsprosjekt i regi av Helse Førde. Bakgrunnen er at 
forekomsten av psykiske plager ofte er høy blant personer som gjennomgår fedmekirurgi. Tiltak for å 
som kan gi bedre oppfølging i behandlingsforløpet er derfor blitt etterlyst av pasienter, 
helsepersonell og forskere.  
Formålet med prosjektet er å fremskaffe kunnskap som gir helsehjelp som er bedre tilpasset den 
enkelte, slik at vi kan øke kvalitet på, og effekt av, behandlingen i tverrfaglig fedmepoliklinikk.  
Fordi det er viktig å ha med pasienter både med og uten psykiske plager i prosjektet, går denne 
invitasjonen i utgangspunktet til alle pasienter som skal gjennomgå eller har gjennomgått 
fedmekirurgi i Helse Førde.  
 
HVA INNEBÆRER PROSJEKTET? 
På konsultasjonene på fedmepoliklinikken er det en del av behandlingen å svare på et digitalt skjema 
om hvordan du har det på ulike områder i livet, hvordan helsen din er, hvilke ressurser du opplever å 
ha tilgang til for å støtte helsen din, hva du opplever som utfordrende og din tilfredshet med 
behandlingen. Disse spørsmålene inngår i et klinisk system som heter «Norse Feedback Obesity» som 
på en visuell og oversiktlig måte beskriver din situasjon og respons på behandling over tid. I tillegg 
blir opplysninger om alder, kjønn, arbeidssituasjon, utdanning, sivilstatus, kroppsvekt, kroppshøgde 
og om du får behandling for psykisk lidelser og fedmerelaterte sykdommer kartlagt som en del av 
behandlingen.  
Forespørselen gjelder om vi kan få din tillatelse til forske på disse opplysningene, som blir samlet inn i 
perioden d.d. til 31.12.2022.  
Kunnskapen som vi får fra prosjektet vil bli delt på konferanser i forskingsartikler slik at andre 
sykehus også kan øke sin kvalitet på, og effekt av, behandlingen i tverrfaglige fedmepoliklinikker.  
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MULIGE FORDELER OG ULEMPER 
Siden vi i prosjektet kun bruker opplysninger som uansett blir samlet inn som en del av 
behandlingen, medfører ikke deltakelse noe ekstra arbeid eller andre ulemper for deg.  
En fordel med å delta i prosjektet er at du bidrar til en utvikling som kan hjelpe oss å forbedre den 
tverrfaglige fedmebehandlingen. Dette kan være til direkte nytte for deg eller noen du bryr deg om 
ved eventuelt behov for hjelp i fremtiden, og det vil være til nytte for fremtidens kvalitet på denne 
type helsehjelp mer generelt. 
 
FRIVILLIG DELTAKELSE OG MULIGHET FOR Å TREKKE SITT SAMTY KKE 
Det er frivillig å delta i prosjektet. Dersom du ønsker å delta, undertegner du samtykkeerklæringen 
på siste side. Du kan når som helst og uten å oppgi noen grunn trekke ditt samtykke. Dette vil ikke ha 
noen negative konsekvenser for din videre behandling.  
Dersom du trekker deg fra prosjektet, kan du kreve å få slettet innsamlede opplysninger, med mindre 
opplysningene allerede er inngått i analyser eller brukt i vitenskapelige publikasjoner.  
Dersom du senere ønsker å trekke deg eller har spørsmål til prosjektet kan du kontakte 
forskningsleder: John Roger Andersen, forsker i Helse Førde og professor ved Høgskulen på 
Vestlandet, på epost: john.roger.andersen@helse-forde.no eller på telefon 48278186. 
 
HVA SKJER MED INFORMASJONEN OM DEG?  
Informasjonen som registreres om deg skal kun brukes slik som beskrevet i hensikten med 
prosjektet. Du har rett til innsyn i hvilke opplysninger som er registrert om deg og rett til å få 
korrigert eventuelle feil i de opplysningene som er registrert. 
Dersom du samtykker til å delta i forskningsprosjektet vil de relevante opplysningene som blir brukt i 
pasientbehandlingen kopieres over til forskingsserveren i Helse Førde, der dataanalysene i 
forskingsprosjektet gjennomføres. Opplysningene på forskningsserven blir behandlet og analysert 
uten navn og fødselsnummer eller andre direkte gjenkjennende opplysninger.  
En kode som knytter deg til dine opplysninger på forskingsserveren gjennom en navneliste, blir 
oppbevart på sikker dataløsning i Helse Førde, separat fra de øvrige opplysningene om deg. Koden 
brukes til å systematisere opplysningene som blir samlet inn over tid, og for å kunne sjekke og 
korrigere eventuelle feil. Koden blir kun bli brukt til disse formålene.  
Det er prosjektleder og Christian Moltu og forskningsleder John Roger Andersen som jobber i Helse 
Førde, som har ansvaret for den daglige driften av forskningsprosjektet og at opplysninger om deg 
blir behandlet på en sikker måte, som har tilgang til denne koden. 
Koden vil bli destruert, og informasjonen om deg i prosjektet anonymisert ved prosjektslutt 
(31.12.2022). Etter denne datoen vil det ikke lenger være mulig å koble opplysningene på 
forskningsserven til din person. Personopplysningene i prosjektet, og som er en del av behandlingen, 
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vil derimot finnes i pasientjournalen din, på samme måte som hos pasienter som eventuelt ikke har 
deltatt i prosjektet.  
 
UTLEVERING AV OPPLYSNINGER TIL ANDRE  
Under prosjektperioden vil prosjektleder Christian Moltu og forskningsleder John Roger Andersen gi 
tilgang på opplysninger til andre forskere innen Helse Førde når dette er nødvendig for å gjøre 
statistiske analyser. Opplysningene vil derimot alltid ligge på Helse Førde sin forskingsserver. Merk at 
ingen utenom Moltu og Andersen vil ha tilgang til ditt navn og fødselsnummer eller andre direkte 
gjenkjennende opplysninger.     
Når prosjektperioden er slutt (31.12.2022) vil vi fjerne informasjon i datasettet, og ødelegge 
koblingsnøkkelen, slik at ingen skal kunne koble opplysningene vi har til din person. For at 
datamaterialet skal være helt anonymt, vil vi sammen med NSD—Norsk senter for forskningsdata AS, 
sikre at ingen kombinasjoner av bakgrunnsopplysninger svarer til færre enn tre til fem personer.  
Dette datasettet vil deretter bli oppbevart hos NSD og gjort tilgjengelig for andre forskere ved 
forespørsel. 
GODKJENNING 
På oppdrag fra Helse Førde har NSD vurdert at behandlingen av personopplysninger i dette 
prosjektet er i samsvar med personvernregelverket. Prosjektet har gjennomgått en 
personvernkonsekvensvurdering i tråd med personvernforordningen art. 35, og at lovlig 
behandlingsgrunnlag foreligger i personvernforordningen art. 6-1a og 9-2a. 
DINE RETTIGHETER 
I tillegg at du kan tekke ditt samtykke når som helst i prosjektperioden har du også rett til innsyn i 
alle opplysninger som er blitt registret om deg, og få gjort retting og/eller sletting av opplysninger.  
Dersom du ønsker å få utlevert dine opplysninger vil du motta en Excel-fil sammen men en 
hjelpetekst som forklarer innholdet.  Personvernombudet i Helse Førde eller Datatilsynet er 
klageinstans i forhold til ivaretakelsen av dine rettigheter.   
KONTAKTOPPLYSNINGER 
Dersom du har spørsmål om prosjektet og dine rettigheter kan du ta kontakt med: 
 
John Roger Andersen, forsker i Helse Førde og professor ved Høgskulen på Vestlandet.  
Epost: john.roger.andersen@helse-forde.no  
Telefon: 48278186. 
Frode Hatten, Personvernombudet i Helse Førde.  
Epost: personvernombodet@helse-forde.no 
Telefon: 57831321.  
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SAMTYKKE TIL DELTAKELSE I PROSJEKTET 
 
JEG ER VILLIG TIL AT DATA FRA MIN BRUK AV NORSE FEEDBACK OBSESITY OG ANDRE 
SPØRSMÅL SOM JEG SVARER PÅ I BEHANDLINGEN (SOM BESKREVET I 
INFORMASJONSBREVET) BRUKES I FORSKNINGSPROSJEKTET  
 
 




 Deltakers navn med trykte bokstaver 
 
 
Deltakers mobiltelefonnummer  
 
Spørreskjemaet er utviklet av  
 
Pasientopplysninger registrert i lokal fedme-database 
  
  
Spørreskjemaet er utviklet av  
 
 




Spørreskjemaet er utviklet av  
 
Norse Feedback versjon 2.0 
 
 



















Spørreskjemaet er utviklet av  
 









Spørreskjemaet er utviklet av  
 
Patient-Reported Outcomes in Obesity (PROS) 
 
  
Spørreskjemaet er utviklet av  
 
 
Spørreskjemaet er utviklet av  
 
The Short Form 36 (SF-36) Versjon 1 
 
SF-36 SPØRRESKJEMA OM HELSE 
 
 
Dette spørreskjemaet handler om hvordan du ser på din egen helse. Disse opplysningene vil hjelpe oss 
til å vite hvordan du har det og hvordan du er i stand til å utføre dine daglige gjøremål. 
 
Hvert spørsmål skal besvares ved å krysse av det svaralternativet som passer best for deg. Hvis du er 
usikker på hva du skal svare, vennligst svar så godt du kan.  
 
1. Stort sett vil du si din helse er 
 
Utmerket…………………………............ 1  
 
Meget god………………………………. 2  
 
God………………………………........... 3  
 
Nokså god………………………………. 4  
 







2. Sammenlignet med for ett år siden, hvordan vil du si at din helse stort sett er nå? 
 
Mye bedre enn for ett år siden…......... 1  
 
Litt bedre enn for ett år siden………… 2  
 
Omtrent den samme som for ett år siden 3  
 
Litt dårligere nå enn for ett år siden…... 4  
 
Mye dårligere nå enn for ett år siden…. 5  
 
 
Spørreskjemaet er utviklet av  
 
3. De neste spørsmålene handler om aktiviteter som du kanskje utfører i løpet av en vanlig dag. Er din 










meg ikke i det 
hele tatt 
a. Anstrengende aktiviteter som å løpe, løfte 
tunge gjenstander, delta i anstrengende idrett 
 
1  2  3  
b. Moderate aktiviteter som å flytte et bord, 
støvsuge, gå en tur eller drive med hagearbeid 
 
1  2  3  
c. Løfte eller bære en handlekurv 
 1  2  3  
d. Gå opp trappen flere etasjer 
 1  2  3  
e. Gå opp trappen en etasje 
 1  2  3  
f. Bøye deg eller sitte på huk 
 1  2  3  
g. Gå mer enn to kilometer 
 1  2  3  
h. Gå noen hundre meter 
 1  2  3  
i. i. Gå hundre meter 
 1  2  3  
j. Vaske deg eller kle på deg 







4. I løpet av de siste 4 ukene, har du hatt noen av de følgende problemer i ditt arbeid eller i andre av 






a. Du har måttet redusere tiden du har brukt   
    på arbeid eller på andre gjøremål 
 
1  2  
b. Du har utrettet mindre enn du hadde   
    ønsket 
 
1  2  
c. Du har vært hindret i å utføre visse typer arbeid eller gjøremål 
 1  2  
d. Du har hatt problemer med å gjennomføre arbeidet eller andre gjøremål 
(f.eks. fordi det krevde ekstra anstrengelser).  
 
1  2  
 
 
Spørreskjemaet er utviklet av  
 
 
5. I løpet av de siste 4 ukene, har du hatt noen av de følgende problemer i ditt arbeid eller i andre av 
dine daglige gjøremål på grunn av følelsesmessige problemer (som for eksempel å være deprimert 





a. Du har måttet redusere tiden du har brukt på arbeid eller på andre gjøremål 
 1  2  
b. Du har utrettet mindre enn du hadde ønsket 
 1  2  
c. Du har utført arbeidet eller andre gjøremål mindre grundig enn vanlig? 





6. I løpet av de siste 4 ukene, i hvilken grad har din fysiske helse eller følelsesmessige problemer hatt 
innvirkning på din vanlige sosiale omgang med familie, venner, naboer eller foreninger? 
 
Ikke i det hele tatt………………………….. 1  
 
Litt …………………………………………... 2  
 
En del.……………………………............. 3  
 
Mye……………….…………………………. 4  
 




7. Hvor sterke kroppslige smerter har du hatt i løpet av de siste 4 ukene 
 
 
Ingen…………….………………………….. 1  
 
Meget svake …………………………….... 2  
 
Svake...……………………………............. 3  
 
Moderate.…….……………………………. 4  
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8. I løpet av de siste 4 ukene, hvor mye har smerter påvirket ditt daglige arbeid (gjelder både arbeid 
utenfor hjemmet og husarbeid)? 
 
 
Ikke i det hele tatt………………………….. 1  
 
Litt …………………………………………... 2  
 
En del.……………………………............. 3  
 
Mye……………….…………………………. 4  
 




9. De neste spørsmålene handler om hvordan du har følt deg og hvordan du har hatt det de siste 4 
ukene. For hvert spørsmål, vennligst velg det svaralternativet som best beskriver hvordan du har hatt 


















Ikke i det 
hele tatt 
a. Følt deg full av tiltakslyst? 
 1  2  3  4  5  6  
b. Følt deg veldig nervøs? 
 1  2  3  4  5  6  
c. Vert så langt nede at   
    ingenting har kunnet   
    muntre deg opp? 
 
1  2  3  4  5  6  
d. Følt deg rolig og harmonisk 
 1  2  3  4  5  6  
e. Hatt mye overskudd? 
 1  2  3  4  5  6  
f. Følt deg nedfor og trist? 
 1  2  3  4  5  6  
g. Følt deg sliten? 
 1  2  3  4  5  6  
h. Følt deg glad? 
 1  2  3  4  5  6  
i. Følt deg trett? 
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10. I løpet av de siste 4 ukene, hvor mye av tiden har din fysiske helse eller følelsesmessige problemer 
påvirket din sosiale omgang (som å besøke venner, slektninger osv)? 
 
 
Hele tiden…………………………………... 1  
 
Mye av tiden…….…………………………. 2  
 
En del av tiden……………………………... 3  
 
Litt av tiden……..…………………………. 4  
 
Ikke i det hele tatt………………………… 5  
 
 















a. Det virker som jeg blir syk litt lettere 
enn andre 
 
1  2  3  4  5  
b. Jeg er like frisk som de fleste jeg 
kjenner 
 
1  2  3  4  5  
c. Jeg tror helsen min vil forverres 
 1  2  3  4  5  
d. Jeg har utmerket helse 
 1  2  3  4  5  
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Weight Efficacy Lifestyle Questionnaire Short-Form (WEL-SF) 
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The Generic Short Patient Experiences Questionnaire 
 
[Fedmepoliklinikken, Førde Sentralsjukehus]  
Hvilke erfaringer hadde du på 
Fedmepoliklinikken? 
 
Ettersom du nylig har hatt kontakt med Fedmepoliklinikken, Førde Sentralsjukehus, spør vi deg med dette 
om du vil besvare dette spørreskjemaet. 
De 12 spørsmålene handler om hvilke erfaringer du hadde ved avdelingen. 
Svarene blir brukt som informasjon om kvaliteten på tjenestene, sett med brukernes øyne. 
Det er helt frivillig å svare.  
 
Med ”behandlerne” mener vi: 
De som har hatt hovedansvar for undersøkelser og behandling.  Oftest er dette leger, men mange får 
behandling av psykologer eller annet helse- og sosialpersonale. 
 













Snakket behandlerne til deg slik at du forsto dem?       
        2 Har du tillit til behandlernes faglige dyktighet?       
        3 Fikk du vite det du syntes var nødvendig om 
hvordan prøver, tester eller undersøkelser skulle 
foregå? 
      
        4 Fikk du tilstrekkelig informasjon om din diagnose / 
dine plager? 
      
        5 Opplevde du at behandlingen var tilpasset din 
situasjon? 
      
        6 Var du involvert i avgjørelser som angikk din 
behandling? 
      
        7 Opplevde du at institusjonens arbeid var godt 
organisert? 
      
        8 Fikk du inntrykk av at institusjonens utstyr var i god 
stand? 
      
        9 Var hjelpen og behandlingen du fikk på 
institusjonen, alt i alt, tilfredsstillende? 
      
                












Spørreskjemaet er utviklet av  
 
10 Mener du at du på noen måte ble feilbehandlet 
(etter det du selv kan bedømme)? 










11 Måtte du vente for å få tilbud ved 
institusjonen? 
















12 Hvilket utbytte har du hatt, alt i alt, av 
behandlingen på institusjonen? 










Paper 2: In Supplementary file 1, the description of thresholds for colour categories 
for the Gastrointestinal Symptom Rating Scale questionnaire has been corrected: For 
the colour categories in the summary report, we set the following thresholds for cut-off of 
the five dimensions (total score in the dimension/number of items), based on clinical 
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